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CHAPTER 1  
Introduction 
1.1 Protein-RNA Interactions 
According to the central dogma of molecular biology, genetic information is 
transformed from DNA to RNA during a process called transcription (1). In 
eukaryotes, after transcription the pre-mRNA undergoes several processing 
events including 5’ end capping, splicing, editing and 3’ end polyadenylation 
before entering the ribosome for protein synthesis (Figure 1.1). RNA has 
structural, catalytic and regulatory roles in the cell (2). Perhaps in the cell, most 
functional RNAs interact with proteins to carry out functions, such as processing, 
nuclear export, transport and localization (2-4). For example, during 
posttranscriptional regulation of gene expression, RNA interacts directly with 
proteins to form ribonucleoprotein particles (RNPs) (5). These RNPs are 
important for recognition of specific sequence elements present in RNA in order 
to control the function of the RNA molecule (6). Since there are many RNAs and 
a very large number of RNA-binding proteins, the biogenesis of RNPs must be 
performed with high fidelity. Incorrect formation of RNP complexes or aberrant 
expression of RNA binding proteins can cause genetic disorders that may lead to 
diseases, such as neuromuscular and neurodegenerative disorders and cancers 
(7, 8). Therefore, understanding the molecular mechanism of protein-RNA 
interactions and their applications to function is an important aspect of structural 
and biological research (9). 
  
2 
RNA molecules can adopt different secondary and tertiary structures from 
standard Watson-Crick base pairs to non-cannonical base pairs, creating a 
platform that allows for interaction with a wide variety of ligands. These structures 
include single-stranded RNA (ssRNA), double-stranded RNA (dsRNA), hairpin 
loops, bulge loops, internal loops, junction loops, and pseudoknots and are 
recognized by various proteins to form protein-RNA complexes (10). These 
protein-RNA complexes have a wide variety of structural and functional roles. 
 
Figure 1.1 Central dogma of molecular biology representing the general cellular 
processes in eukaryotic cells. 
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Despite their functional importance in biology, the actual mechanisms of 
protein-RNA interactions are poorly understood. Over the last several years, 
much work has been done to understand the structural and functional 
relationships of different types of protein-RNA interactions (4, 9, 11-13). Several 
biophysical methods have been used to characterize protein-RNA interactions. 
For example, X-ray crystallography can be useful to obtain information 
concerning the detailed molecular interactions of a structured system, while, 
cryo-electron microscopy (cryo-EM) can provide the overall shape of a protein-
RNA complex. However, both of these methods have certain restrictions for a 
system with structural heterogeneity (9, 14). Recent advances have made 
nuclear magnetic resonance (NMR) one of the best techniques to study protein-
RNA interactions in solution by using specific isotope-labeling strategies. Several 
solution-based protein-RNA structures have been reported in the Protein Data 
Base (PDB). Furthermore, computational modeling has also added insight into 
the structural analysis of protein-RNA complexes on the basis of different 
experimental interpretations. The recent advancement on single-molecule 
spectroscopic techniques have been added an effort to understand both the 
structural and dynamic behavior of protein-RNA interactions. 
In this chapter, a comparison of structural and functional aspects of 
important known RNA-binding proteins will be discussed. Some important 
examples of common RNA-binding domains are summarized in Table 1.1 with 
their PDB entry numbers. 
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Table 1.1 Common RNA binding domains and their properties (4) 
Domain Topology RNA-recognition 
Motif 
Protein-interaction Examples 
(PDB ID) 
RRM !"!!"! ! sheet makes a 
flat, solvent-
exposed RNA-
binding surface 
Interacts with ssRNA 
through stacking, 
electrostatic interactions 
and hydrogen bonding 
PTB (2ADC) 
(15)  
Fox-1 (2ERR) 
(16) 
KH !""!!" 
"!!""! 
 
A cleft formed by 
GXXG loop and 
variable loop 
Recognizes at least 4 
nucleotides of ssRNA 
through hydrophobic 
interactions, backbone 
contacts from the loop 
and hydrogen bonding 
with bases 
Nova-1 (1EC6) 
(17) 
NusA (2ATW) 
(18) 
TRAP !-
sandwich 
Edges of !-strand Bind GAG triplet through 
protein-base interactions, 
stacking or hydrogen 
bonding 
TRAP (1C9S) 
(19) 
 
Sm/LSm 
Proteins 
"!!!!! Loops formed by 
!2-!3 and !4-!5  
Recognizes poly U of 
ssRNA through stacking 
and hydrogen bonding 
Sm core 
protein (1M8V) 
(20), Hfq 
(1KQ2) (21) 
Pumilio-
homology 
" Helix "2 provides 
the RNA interacting 
pocket 
Stacking interactions and 
two amino acids in "2 
makes hydrogen bonds 
with Watson-Crick edge 
of a base 
Pumilio 1 
(1M8Y) (22) 
Zinc- 
Finger 
"! Amino acid 
residues in " 
helices 
Sequence-specific 
(UAUU-Tis11d (23, 24)), 
hydrogen bonding to the 
protein backbone, and 
shape determines the 
specificity 
Tis11D 
(1RGO) (24) 
PAZ  "!  
(!-barrel) 
Hydrophobic pocket 
formed by !-barrel 
and inserted "! 
motif 
Single-stranded RNA 
(ssRNA), and the 5’-
phosphate and 3’-OH 
contribute to specificity 
PAZ (1SI3) 
(25) 
dsRBM "!!!" "1 helix and !1-!2 
loop 
Shape specific 
recognition of RNA minor 
groove of A-form helix 
(stem-loop), and 
sequence-specific (G-Xn-
A/G) contact with the 2’-
OH of sugar and 
phosphate backbone  
ADAR2 (2L3C) 
(26)  
Staufen 
(1EKZ) (27) 
SAM """""" Hydrophobic core 
packed with 
electropositive 
regions 
Shape-specific 
recognition of RNA stem-
loop, and interaction with 
phosphate backbone and 
a single nucleotide G at 
position 3 of the 
pentaloop 
Vts1p (2ESE) 
(28) 
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1.2 RNA-binding proteins are modular 
Most RNA binding proteins have a modular structure formed by RNA 
binding domains. These RNA binding domains are encoded by sequences of 70-
150 amino acids that are important for RNA recognition and interaction (4, 29). 
Most of the RNA binding proteins (RBPs) consists of one or more RNA binding 
domains (Figure 1.2). These include the RNA binding domain (RBD), often 
called RNA recognition motif, (RRM); K-homology (KH) domain; zinc finger 
(ZnF); Pumilio/FBF (PUF) domain; Piwi/Argonaute/Zwille (PAZ); sterile alpha 
motif (SAM) domain; double-stranded RNA binding domain (dsRBD); and the Sm 
domain. These modular architectures allow RBPs to recognize RNA with high 
specificity and affinity, as well as, create functional diversity within the RBPs (2, 
4, 30). Proteins with multiple domains can bind long RNA strands or also interact 
with multiple RNAs; furthermore, modulation of RNA binding domains with other 
auxiliary functional domains help to recognize RNA as well as perform enzymatic 
activity. For example, adenosine deaminases that act on RNA 2 (ADAR2) and 
protein kinase R (PKR) have similar dsRBD but different auxiliary functional 
domains. ADAR2 converts adenosine to inosine while PKR have a kinase activity 
in its target RNA (31, 32).  
Frequently, RNA binding domains are connected with interdomain linkers 
of variable length. The importance of these linkers is in recognition of the discrete 
target and they may act as spacers to regulate the catalytic action of each 
domain (4). In some cases, linkers can interact with the RNA binding domains to 
allow two domains to function synergistically as observed in polypyrimidine tract 
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binding protein domains 3 and 4 (PTB34) (15). Eukaryotic genomes have been 
shown to have higher numbers of modular RBPs, which might reflect the 
evolution of highly specific gene expression and modification patterns (2, 33).  
 
 
Figure 1.2 Different modular structures of RNA binding proteins (RBPs). 
Examples are taken from the most common RBPs. Each RBP contains many 
domains as shown by the colored boxes. This Figure is adapted from (2, 4). 
 
1.3 Single-stranded RNA recognition 
In most cases, RNA binding proteins (RBP) recognize ssRNA as their 
target. Many ssRNA binding domains have been identified and have been shown 
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to recognize RNA by conserved RNA binding domains (RRM and KH) and by 
repeats of RNA binding domains (TRAP and Sm). The 
oligonucleotide/oligosaccharide binding protein (OB-fold) domains recognize 
structured RNAs (34). Many of ssRBPs are sequence-specific RNA binding 
proteins with a hydrophobic binding surface to maximize intermolecular contacts 
with the RNA bases. The most common ssRBPs and their structures are 
discussed in detailed. 
1.3.1 RNA recognition motifs (RRM) 
The RNA recognition motif (RRM) domain is the most abundant and the 
best characterized RNA binding domain in higher eukaryotes. It has been 
estimated that about 2% of human gene products are associated with RRM (30). 
These domains, also known as ribonucleoprotein domain (RNP) or RNA-binding 
domain (RBD), consists of 80-100 amino acid residues (30, 35) and are often 
found in multiple copies. Single RRMs recognize a minimum of two to a 
maximum of eight nucleotides in the RNA (36, 37).  RRM has four antiparallel !-
sheets packed against two "-helices with a topology of !"!!"! (Figure 1.3A and 
Figure 1.3B). An unusual fifth !-strand is present in RRM3 of polypyrimidine tract 
binding protein (PTB) (Figure 1.3C) (15, 38). Most of the studied structures of 
RRM protein in complex with RNA has led to two proposed primary conserved 
sequence stretches that contribute to the RNA binding known as RNP1 ([R/K]-G-
[F/Y]-[G/A]-[F/Y]-[I/L/V]-X-[F/Y]) and RNP2 ([I/L/V]-[F/Y]-[I/L/V]-X-N/L) (Figure 
1.3A) (35). These RNA binding sequences often rely on the surface of the central  
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Figure 1.3 Structures for common single-stranded RNA binding protein RRM and 
KH domains. (A) The secondary structure for RRM domain with conserved 
sequences RNP2 (red) and RNP1 (green). (B) The RRM for Fox-1 domains 
(PDB: 2ERR) (C) The RRM domain 3 of PTB (PDB: 2ADC) showing the extra !-
strand (red). (D) The secondary structure for type I KH domain. (E) Type I KH 
domain of Nova-1 (PDB: 1EC6) with GXXG conserved loop. (F) Type II KH 
domain in NusA (PDB: 2ATW). RNA nucleotides are represented in color and 
protein secondary structures are shown in grey. Figures were generated with 
PyMOL. 
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!-strands; !1 and !3 (15, 39-41). To form these RRM-RNA complexes, solvent-
exposed charged residues (Arg or Lys) form a salt bridge to the phosphodiester 
backbone of the RNA and two aromatic residues can form a ring stacking 
interaction or hydrogen bonds with the RNA nucleobases (7, 35). The wide range 
of RNA structures and recognition sequence elements have associated RRM 
proteins with diverse biological functions. These motifs in eukaryotes are 
implicated in post-transcriptional gene regulation, like pre-mRNA splicing, 
alternative splicing, capping, mRNA stability and export, RNA editing and poly(A) 
recognition (9, 30). During alternative splicing many ssRBPs associate with pre-
mRNA (RNPA1, U2AF65, U2AF35, PTB, Fox-1, sex-lethal) to regulate splicing 
(42). For example, SR proteins recognize exonic splicing sites to promote 
alternative splicing whereas Fox-1 does the same activity by interaction with 
intronic splicing elements (43, 44). Recent studies have shown that RRMs are 
also involved in protein-protein interactions for the recognition and interaction 
with RNA with very distinct mechanisms from protein-RNA interactions (30). 
1.3.2 KH-homology domain 
The heterogeneous nuclear ribonucleoprotein K-homology (KH) domain is 
highly expressed and most abundant in gene expression and regulatory systems 
in bacteria, archaea and eukaryotes (45). The KH domain consists of nearly 70 
amino acid residues with a signature sequence of (I/L/V)IGXXGXX(I/L/V) at the 
center of the domain (45, 46). All KH domains are composed of three !-sheets 
packed against three "-helices. KH domains are divided into two sub families: 
type I has !""!!" topology (Figure 1.3D and Figure 1.3E) (Nova) whereas type 
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II has !""!!" topology (Figure 1.3F) (NusA) (46). An important feature of the 
KH domain is the presence of a variable length loop that connects !2 and !3 in 
type I and !3 and "2 in type II (47). In both type I and II, the consensus 
sequence is formed by a GXXG loop recognized four nucleotides. Hydrophobic 
interactions between bases and non-aromatic residues, backbone contacts with 
the GXXG loop, as well as hydrogen bonding with bases are the prevalent 
interactions observed between protein and RNA (4). This ssRNA binding protein 
domain can also found in multiple copies (14 copies in chicken vigilin, three KH 
domains in hnRNP K) that can increase the RNA binding affinity and 
cooperativity of this protein (48). 
The KH domain is the most abundant RNA binding domain in eubacteria 
and eukaryotes, suggesting the evolutionary importance of this ancient RNA 
binding domain. Like RRM, KH protein domains are also involved in a myriad of 
biological processes like splicing (splicing factor 1, SF1) (49), alternative splicing 
(Nova family protein) (50), transcriptional and translational gene control (hnRNP 
K) (51) and mRNA stability, transport and localization (9). Unusual expression of 
this protein has been linked to many diseases, such as human fragile X mental 
retardation syndrome which is caused by a loss of FMR-1 expression where a 
mutation on the conserved KH motif has an RNA binding defect (52).  
1.3.3 RNA recognition by modular RNA binding repeats 
In some cases, RNA binding domains oligomerize to form modular RNA 
binding repeats. The numbers of modular repeats varies; for example, eleven 
  
11 
repeats are observed in TRAP proteins, seven in Sm core proteins and six in 
Lsm proteins Hfq (19-21, 53). 
The tryptophan RNA binding attenuation protein (TRAP) is comprised of 
70 amino acids in each of the eleven monomers that fold into four antiparallel !-
strands to form a !-sandwich-like structure. Tryptophan is inserted between the 
interfaces of two !-strands. Each monomer oligomerizes into an 11-mer 
symmetric ring as observed in the crystal structure of Bacillus subtilis TRAP 
bound with a 53-nucleotide ssRNA containing GAG triplets (Figure 1.4A) (19). 
Each monomer contains an RNA binding pocket created by two !-strands to 
allow for binding to the GAG triplet through protein-base interactions (19). 
 
Figure 1.4 RNA recognition by modular RNA binding repeats. (A) The crystal 
structure of the 11-mer TRAP (PDB: 1C9S) protein with GAUGU ssRNA repeats. 
The surface in magenta is a L-tryptophan inserted in the !-sandwich. (B) 
Structutre of Hfq (PDB: 1KQ2) showing the hexameric ring from S. aureus. The 
central core contains a bound 5’-AU5G-3’ RNA. For clarity, each protein subunit 
is colored differently and RNA is in yellow sticks. Figures were generated from 
PyMOL. 
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The outer edge of the 11-mer oligomeric structure has a symmetrical ring 
with an 80 Å diameter. TRAP regulates the expression of L-tryptophan 
biosynthesis genes in several bacilli, which is activated by bound L-tryptophan. 
For regulation, TRAP binds to the 5’ ssRNA leader sequence of an mRNA 
operon and terminates transcription by preventing the formation of the 
antiterminator stem-loop structure (9, 54).  
The classical Sm fold is characterized by an N-terminal !-helix followed by 
five "-strands with a topology of !""""" (Figure 1.4B) (55). The Sm proteins 
consist of nearly 80 residues and recognize the uridine-rich site (Sm-site) present 
in small nuclear RNAs (snRNAs). Each Sm proteins oligomerizes to form a 
heptameric ring (~70 Å diameter) structure around the poly(U) RNA (55). The 
central hole of this ring can accommodate the U small nuclear RNP (UsnRNP) 
during pre-mRNA splicing (56, 57). It has been proposed that the intersubunit 
interaction during oligomerization is manifested by hydrophobic contacts between 
adjacent "-strands and each U-rich RNA is recognized by three conserved 
residues in the loops of !2-!3 and !4-!5 (20). The interactions between Sm 
protein domains and the RNA include stacking and hydrogen bonding. Unlike Sm 
proteins, LSm proteins, such as bacterial host factor for Q-! bacteriophage (Hfq), 
form a hexameric doughnut-shape with a 12 Å central cavity in the absence of 
RNA (21, 58, 59). The crystal structure of S. aureus Hfq with a short RNA (5’- 
AU5G-3’) showed that the RNA is bound around the basic central pore (Figure 
1.4B) (21). Hfq is known to play a role in post-transcriptional gene regulation 
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where it helps small non-coding RNAs (ncRNA) to identify its target mRNA (60-
62). 
1.3.4 Other ssRNA binding proteins  
Several recent studies have shown other proteins that can bind RNA 
through different structural arrangements than the traditional RRM and KH 
domains. These protein domains include zinc fingers, pumilio homology domain 
(PUF), PAZ domain and OB-fold. Their structures, RNA recognition motifs and 
protein interactions are summarized in Table 1.1 and are mentioned in many 
research and review articles (34, 35, 63-65).  
1.4 Double-stranded RNA recognition 
Double-stranded RNA binding motifs (dsRBM) recognize perfectly duplexed 
RNA and are distributed in eukaryotes, bacteria and viral proteins (66). This motif 
adopts an !/" sandwich global fold with an !"""! topology that contains 70-90 
amino acid residues (Figure 1.5A) (4, 10, 67, 68). Previous structural studies of 
dsRBM protein-RNA complexes proposed that these proteins bind in a shape-
specific rather than sequence-specific. Many of the solved structures suggested 
that dsRBM recognizes the A-form helix of dsRNA, and intermolecular 
interactions involve the direct contact with the 2’-OH sugar and phosphate 
backbone (4, 27, 69-71). But the recent solution NMR structure of an adenosine 
deaminase (ADAR2) in complex with a stem-loop pre-mRNA encoding the R/G 
editing site of GluR-2 has revealed that dsRBM recognizes shape as well as 
sequence of the RNA (26). The minor groove of the A-form helix in the stem-loop 
is specifically recognized by the N-terminal helix (!1) and "1-"2 loop of ADAR2 
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(Figure 1.5A). The two domains of ADAR2, dsRBM1 and dsRBM2 preferentially 
recognize G-X9-A and G-X8-A RNA sequences respectively in a long stem-loop 
pre-mRNA. The sequence-specificity of ADAR2 dsRBM is important for the 
proper editing function of the enzyme (26). 
 
 
Figure 1.5 Structure of RNA (yellow sticks) bound with dsRBM and SAM proteins 
(grey). (A) USL (upper stem-loop of GluR-2 R/G) RNA recognition by dsRBM1 of 
ADAR2 (PDB: 2L3C). Shown in red is a !1-!2 loop that is important for sequence 
specific recognition of RNA (26). (B) The structure of Vts1p-SAM (PDB: 2ESE) 
domain in complex with SRE RNA. Figures were generated from PyMOL. 
 
The double-stranded RBM is involved in several biological processes from 
RNA editing to protein phosphorylation in translational control (66). For example, 
the RNaseIII domain is involved in RNA processing in the RNA interference 
(RNAi)/microRNA (miRNA) pathway (72-74). Drosophila melanogaster staufen 
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contains multiple copies of dsRBM domains that control RNP localization (74). 
Furthermore, ADAR1 and ADAR2 are RNA editing proteins that regulate gene 
expression at the RNA level (75) by converting adenosine-to-inosine (A-to-I) by 
hydrolytic deamination in many mRNA and pre-mRNA transcripts (26, 76).  
1.5 SAM binding domain 
The sterile alpha motif (SAM) domain is the most copious of the eukaryotic 
protein motifs, initially identified as a protein-protein interaction module involved 
in transcription regulation and signal-transduction (28, 77). Later, it was reported 
that the SAM domain also interacts with RNA to control post-transcriptional gene 
expression (78). The SAM domain from Saccharomyces cerevisiae (Vts1p) and 
its homolog from Drosophila melanogaster (Smaug) specifically interact with the 
RNA stem-loop (78). The RNA stem-loop recognized by Smaug contains a 
CNGGN pentaloop in the Smaug recognition element (SRE) present at the 3’ 
untranslated region (UTR) of the nos transcript (78, 79). The solution NMR 
structure of Vts1p-SAM in complex with a 23 nucleotide SRE stem-loop RNA with 
a CUGGC pentaloop was recently solved (Figure 1.5B). This study revealed that 
the SAM domain recognizes RNA in a shape-specific rather than sequence-
specific manner specifically recognizing the G in position three of the pentaloop 
(28). Two intermolecular hydrogen bonds specifically recognize the identity of the 
third G in the pentaloop, which also occupies the hydrophobic cavity formed by 
Leu465 and Ala495 (28). This protein consists of six !-helices that adopt a 
globular protein fold and recognize the major groove of the RNA pentaloop 
through contacts with the RNA sugar-phosphate backbone (28).  
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1.6 Protein-RNA interactions in the ribosome 
The ribosome is a protein-RNA complex with a catalytic role in protein 
synthesis. This complex macromolecule consists of more than 50 different 
ribosomal proteins that interact with RNA. How all of these proteins interact with 
RNA to form an active structure of the ribosome was a question that proved 
elusive. The recent X-ray crystal structures of the ribosomal subunits offered a 
clear picture to explain the interactions between ribosomal proteins and the RNA 
(80, 81). The majority of the ribosomal proteins recognize ribosomal RNA by 
shape rather than by sequence. Hydrogen bonding, stacking, hydrophobic 
interactions, as well as interactions with the phosphate backbone were observed 
among the characterized protein-RNA interactions. 
Ribosomal proteins contain globular domains with similar !/" sandwich 
folds (80, 82). The topologies of some of the ribosomal proteins are similar to 
other RNA binding proteins as described before, reflecting the similar RNA 
binding properties among them. Most of these proteins have extended structures 
like extended !-hairpin (S2), "-hairpin (S5, S10), N-terminal extension (S3) and 
C-terminal tail (S6) (81, 82). These extensions are associated with basic amino 
acid side chains and have extensive contacts with ribosomal RNA that stabilize 
the tertiary structure of the ribosome and also participate in protein-protein 
interactions (82). In the crystal structure, most of the primary binders are 
globular, surface-oriented, and have a direct interaction with RNA helices during 
assembly. For example, S15 is a primary binder with four !-helices and without 
any extensions that recognizes the junction of helices h20, h21 and h22 as well 
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as helix h23a in the 16S ribosomal RNA (83). Proteins with multiple extensions 
are buried in the RNA and are secondary or tertiary binders. Except for very few 
(h10, h14 and h33a), most of the RNA helices in the 16S RNA contact proteins 
and many proteins can recognize a single RNA helix. Most of proteins in the 
large subunit, except L12, have a direct interaction with RNA (80). Therefore, it 
can be theorized that RNA binding proteins may function in the proper folding of 
RNA. But some of the ribosomal proteins from large subunit (L1, L10 and L11) 
are directly involved in protein synthesis. Ribosomal proteins also have 
significant protein-protein interactions that influence the proper assembly of the 
ribosomal subunits (82).  
1.7 Conclusions 
RNA molecules can adopt different secondary and tertiary structures that 
not only allow it to perform structural, catalytic and regulatory roles but also 
create a platform to interact with many proteins to form protein-RNA complexes. 
These protein-RNA complexes have a wide variety of structural and functional 
roles in the cell. Most of the RNA-binding proteins are modular and their mode of 
RNA recognition is also different. Several methods including single-molecule 
techniques have been used to explore the structural and dynamics of protein-
RNA interactions. This will finally led to characterize the mechanistic importance 
of protein-RNA interactions and their roles in cellular functions. Therefore, 
understanding the molecular mechanism of protein-RNA interactions and their 
applications to function is an important aspect of structural and biological 
research. 
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CHAPTER 2  
Methods 
2.1 Methods used to study protein-RNA interactions 
RNA folding and conformational changes are important for proper RNA-
protein interactions and ribonucleoprotein (RNP) assembly and function. To 
understand the detailed mechanisms and to obtain a clear picture of RNA-protein 
interactions, several methods have been used; each method has its own 
advantages and disadvantages. For example, native gel Electrophoresis Mobility 
Shift Assay (EMSA) can show binding of protein with RNA, characterized by gel 
shift, but lacks any kind of kinetic information (84, 85). X-ray crystallography can 
provide specific structural information of a large RNP complex (86) as well as 
discrete intermediates formed during the protein-RNA interaction (87) but cannot 
provide details of conformational dynamics of the interaction. Cryo-Electron 
Microscopy (cryo-EM) is another method that can be used to determine the 
three-dimensional structure of large RNP complex (88-90), but like X-ray 
crystallography, it does not offer details of conformational dynamics. Nuclear 
Magnetic Resonance (NMR) spectroscopy can provide insight into both structure 
and conformational dynamics of RNA-protein interactions (15, 41, 91, 92); 
however, this technique has a size limit due to technical challenge (93). Chemical 
probing can capture intermediates but lacks any detailed structural information 
(94, 95). Hydroxyl radical footprinting can be used to capture the detailed 
mechanistic information of protein-RNA interactions (96, 97) because of its 
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higher time resolution but it also cannot provide structural information. Pulse-
chase mass spectrometry can provide kinetic information of protein-RNA 
interactions, such as kinetics of 30S ribosome assembly (98), but this method is 
not able to observe kinetics of transient interactions (99). 
Unlike the aforementioned techniques, fluorescence spectroscopic 
techniques have been developed to understand both the structural and dynamic 
behavior of protein-RNA interactions. This study focuses on the characterization 
of protein-RNA interactions using Fluorescence Resonance Energy Transfer 
(FRET) in combination with single-molecule FRET (smFRET).  
2.2 Fluorescence spectroscopy 
Fluorescence is defined as the ability of a molecule to emit light from its 
electronically excited singlet state upon excitation by light of a certain 
wavelength. According to the Jablonski diagram (Figure 2.1A), the electronic 
state of a molecule changes from the ground state (S0) to the vibrational levels of 
the excited states upon excitation. The relaxation of a molecule from a singlet-
excited state (S1) down to the singlet ground state results in the emission of light 
at a certain wavelength. This phenomenon has a lifetime of 10-9 s (100). A 
fluorescence spectrum can be generated by plotting fluorescence emission 
intensity as a function of wavelength. The emission spectrum can be used to 
obtain both qualitative and quantitative information from a molecule of interest. 
The nature of those spectra depends on the nature of the fluorescent compound 
(chromophore) and solvent used. 
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2.3 Fluorescence resonance energy transfer 
The phenomenon of fluorescence resonance energy transfer (FRET), also 
known as FÖrster resonance energy transfer, was discovered by Theodor FÖrster 
in the 1940s (101). FRET is a long-range non-radiative energy transfer process 
from one fluorophore called the donor to other fluorophore called the acceptor, 
when they are within 10-100 Å of each other (Figure 2.1A). FRET can be used 
as a molecular ruler to measure the distance between a fluorophore pair directly 
(102) as the rate of energy transfer (kT) and efficiency (ET) of energy transfer 
both depend on the distance between donor and acceptor (Equations 2.1 and 
2.2) 
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where, !D is the fluorescence lifetime of the donor in the absence of acceptor, R0 
is the Förster distance (103) defined as the distance at which 50 % of energy is 
transferred from the donor to the acceptor, typically 20-80 Å (Figure 2.1B). R0 
depends on the spectral overlap between donor and acceptor and the relative 
orientation of their transition dipoles (Equation 2.3) (104).  
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where, "2 is the orientation factor (2/3 in average), #D is the quantum yield of the 
donor in the absence of acceptor, n is the refractive index of the solution (1.33 for 
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aqueous solution) and J is the spectral overlap between donor emission and 
acceptor excitation calculated by Equation 2.4 (Figure 2.1C). 
 
 
Figure 2.1 A Jablonski diagram showing the simplified energy levels. (A) 
Diagram showing the possible photophysical transitions after a molecule is 
excited by a certain wavelength. S and T represent the singlet and triplet states 
respectively. The black arrow represents the fluorescence resonance energy 
transfer (FRET) from donor to acceptor fluorophores when two molecules are in 
close proximity. !EX and !EM are excitation and emission for both donor (D) and 
acceptor (A). (B) FRET efficiency as a function of distance between two 
fluorophores for a FRET pair Cy3 and Cy5. R0 is the Förster distance (60 Å) 
represented by a line where the energy transfer efficiency is 50% (C) Spectrum 
overlap for Cy3 and Cy5 fluorophores. Absorption and emission spectra are in 
blue and red for both fluorophores, respectively. The area in green represents 
the spectral overlap between donor emission and acceptor absorption (105). 
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In this equation, FD(!) is the emission spectrum of the donor and "A(!) is 
the absorption spectrum of the acceptor fluorophore normalized to the extinction 
coefficient. The value of J from Equation 2.4 is used to calculate R0 in Equation 
2.3. In general, FRET can be calculated simply by measuring the emission 
intensities of the donor (ID) and acceptor (IA) as in Equation 2.5.  
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2.4 Steady-state FRET 
For steady-state FRET experiments (ssFRET), a sample is excited with a 
continuous light source and emission intensity is recorded. A commercially 
available spectrophotometer (Carry Eclipse fluorescence spectrophotometer) is 
used to measure emission spectra throughout this study. This spectrometer uses 
a xenon lamp to generate a continuous light source to excite a sample in a quartz 
cuvette (Quartz Fluorometer Micro Cell, Starna Cells, Inc.). Fluorescein is excited 
at 490 nm (10 nm bandwidth) and fluorescein and rhodamine emissions are 
measured at 520 nm and 580 nm (5 nm bandwidth), respectively. Likewise, Cy3 
is excited at 555 nm (10 nm bandwidth) and Cy3 and Cy5 emissions are 
measured at 565 nm and 665 nm (5 nm bandwidth), respectively. Emission 
intensities from both donor and acceptor fluorophores are then used to calculate 
FRET using Equation 2.5.  
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2.5 Time-resolved FRET 
Time-resolved FRET (trFRET) has been successfully used to characterize 
the conformational dynamics of biological systems by measuring the distance 
distributions. For example, Haas and co-workers first developed trFRET to study 
the conformational dynamics of polypeptides in solution by measuring the 
distance between the two ends of the polypeptide (106). Lilley, Millar and co-
workers have used this technique to characterize the conformational isomers of 
Holiday junction (107-109). Walter, Rueda and co-workers have also successfully 
used this technique to characterize different RNA enzymes (110-112). In this 
technique, FRET is determined by measuring the intensity decay or anisotropy 
decay of the donor fluorophore in the presence and absence of the acceptor 
fluorophore (100, 104). This technique is important because it allows detection of 
two or more conformations simultaneously. Two types of measurements, a time 
domain and frequency domain have been successfully used to measure donor 
decay. In this study, time domain trFRET experiments were performed using the 
Time-Correlated Single-Photon Counting (TCSPC) technique.  
2.5.1 Time-correlated single-photon counting (TCSPC) 
A home built trFRET setup is used in combination of ISS TCSPC module 
as shown in (Figure 2.2). As previously described (110), time-correlated single 
photon counting is performed before the collection of a time-resolved emission 
profile for the donor fluorophore (Fluorescein and Cy3).  A class-4 high power 
Yb-doped fibre laser (Fianium inc.,UK) is used to excite the donor with 5 ps 
pulses at 40 MHz. Fluorescein was excited at 470 nm (30-nm band-pass dichroic  
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Figure 2.2 Schematic representation of TCSPC setup for time-resolved FRET 
data acquisition. A class-4 high power Yb-doped fibre laser was used to excite a 
sample after passing through an excitation filter and polarizers. The intensity of 
the excitation beam is controlled by a neutral density filter (NDF). Emission is 
passed through a selected filter and detected using a photo multiplier tube 
(PMT). The arrival time (“START”) relative to the excitation pulse (“STOP”) is 
determined by constant fraction discriminators (CFD) and a time-to-amplitude 
converter (TAC). The START signal is provided by photons emitted and STOP 
signals are detected by the photodiode (PD) from a fraction of excitation light 
diverted by a quartz cover glass. Those signals are electronically delayed and 
then feed to time to amplitude convertor (TAC) via CFD (104). Signals from TAC 
are then passed through the analogue to a digital convertor (ADC) to the 
computer. 
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filter) and Cy3 is excited at 520 nm (20-nm band-pass dichroic filter). Donor 
isotropic emission is collected at 520 nm (20-nm band-pass dichroic filter) for 
fluorescein and 540 nm (20-nm band-pass dichroic filter) for Cy3. The magic 
angle (54.7°) is used to detect the isotropic emission to more than 40000 counts. 
Collection of fluorescence decay was done in 4816 channels with a time 
increment of 12.2 ps/channel by using a micro-channel photomultiplier tube 
(Hamamatsu R3890U-52) feeding with a time correlated single-photon counting 
device (SPC-630, Becker & Hickl). A dilute solution of non-dairy coffee creamer 
is used to measure the instrument response function.  Time-resolved 
fluorescence decays are collected for donor only and donor-acceptor fluorophore 
pair solutions.  
2.5.2 TCSPC data analysis 
The fluorescence intensity of the donor fluorophore decays exponentially 
as shown in Equation 2.6. 
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  Where, !D is a fluorescence lifetime of the donor and I0 is the initial 
intensity, which depends on the concentration of the fluorophore. As previously 
described (104, 110, 112), this donor-only emission decay is fit to a sum of three 
exponential decays characterized by their lifetimes with fractional contributions "I 
in the presence of acceptor. The data from the doubly-labeled complex are then 
fit with the Förster model to determine distance distributions (Equation 2.7). 
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Finally, these decay data is used to measure the donor acceptor distance 
distributions. 
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Here, P(R) is the distance distribution, !i and "D,i are lifetime parameters 
for singly-labeled and R0 is Förster distance for 50% energy transfer which is 55 
Å for fluorescein and TAMRA pair. The distance distribution P(R) is modeled as a 
three-dimensional weighted Gaussian, (Equation 2.8), where N is a normalization 
constant, and ! and µ describes the shape of Gaussian (Equation 2.8 and 
Figure 2.3A). 
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Figure 2.3 Time-resolved FRET data analysis of fluorescence decay for 
fluorophore-labeled RNA. (A) The donor fluorescence decay profile shows the 
fast decay of donor only (absence of acceptor, black line) and in the presence of 
the acceptor fluorophore (blue line). The curves are then normalized to a peak 
count of 40,000 with a fitting constant (!2) value of <1.3. (B) The probability 
density profile for single distributions with the mean distance (60 Å) and the full 
width half maximum (fwhm).  
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Home written software was used to fit the data and the quality of fit was 
judged by the reduced !2 value. Failure to obtain a good fit for a single 
distribution alluded to the presence of more than a single donor-acceptor 
species. In this situation, the decay was fitted to a second distribution to obtain a 
better !2 value. 
2.5.3 Information from trFRET experiments 
trFRET experiments help to resolve the following information as shown in 
Figure 2.3B:  
I. Fractional distribution: Defined as an equilibrium constant and free 
energy difference between conformers. 
II. Mean distance: The distance separation between conformers. 
III. Full length with half maximum (FWHM): The contribution from global 
flexibility. 
2.6 Single-molecule spectroscopy 
[Some portion of this section was taken from a methods paper published in 
2010 (113).] 
Over the last two decades, single-molecule spectroscopy has provided 
valuable structural and kinetic information about complex biological systems 
(114-120). Some of the advantages that single-molecule approaches offer over 
ensemble-averaged experiments are that they directly reveal the presence of 
heterogeneous populations and allow access to kinetic information without 
synchronization. Furthermore, single-molecule experiments monitor kinetic 
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pathways in real time, thus revealing the existence of relevant kinetic 
intermediates. Single-molecule spectroscopy has been applied to elucidate the 
mechanisms of numerous systems such as RNA and DNA polymerases (121-
128) and molecular motors (129, 130) among many others. More recently, single-
molecule assays have been developed to study gene expression in vivo (131, 
132) as well as DNA and RNA sequencing (133-135).  
2.6.1 Single-molecule fluorescence microscopy 
Several types of single-molecule methodologies have been developed 
(136). These include force-pulling and fluorescence techniques. Force-pulling 
experiments employ one or two traps that can be either magnetic or optical traps 
and the change in distance is monitored as the force is varied (120, 137-139).  
These experiments have been successfully used to monitor RNA and DNA 
unwinding and RNA transcription.  Fluorescence techniques can be divided into 
several categories. The molecules can either freely diffuse or be immobilized to 
the slide and recorded on a single-molecule microscope. Freely diffusing set-ups 
are generally coupled to confocal microscopes, and total internal reflection 
(TIRF) is used for immobilized samples.  These techniques have been used to 
study small ribozymes, RNA-protein interactions, and DNA polymerase. 
Multiple approaches have been developed to study immobilized single-
molecules with fluorescence detection (136, 140-142). Fluorescence studies 
often rely on FRET, an increasingly popular approach to follow conformational 
changes of macromolecules and measure intermolecular interactions in real time. 
The combination of single-molecule spectroscopy and FRET enables real time 
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monitoring of the global structure and dynamics of isolated molecules. Thus, 
smFRET is complementary to other structural techniques, such as X-ray 
crystallography, NMR or cryo-electron microscopy, which can provide structural 
information at the atomic level but not in real time.  
2.6.2 Total internal reflection fluorescence microscopy 
Total Internal Reflection (TIRF) microscopy is particularly valuable as it 
significantly reduces the background signal so that there is a better signal to 
noise ratio for the molecules of interest. A prism-based TIRF set up was used 
with an inverted microscope (IX-71, Olympus, Center Valley, PA) as shown in 
Figure 2.4. Here, the molecules are immobilized on a quartz slide (Finkenbeiner, 
Waltham, MA) that directly contacts the prism. A quartz Pellin-Broca prism (CVI 
Melles-Griot, Albuquerque, NM) is used with immersion oil (Cargille, cedar 
Grove, NJ) in between prism and quartz slide surface. A laser beam of 532 nM (3 
mW, CrystalLaser GCL-532-L, Reno, NV) is used to excite the immobilized 
molecules. The laser hits the solution with an incidence angle greater than the 
critical angle such that the beam is totally reflected rather than entering the 
solution, but produces an evanescent wave that can excite molecules about 100-
150 nm into the solution. The donor and acceptor intensities collected by the 
objective are separated in a light tight box as shown in Figure 2.4 by using 
dichroic mirrors and passed to the CCD (charge-coupled device) camera (Ixon+, 
DV-897E, Andor, South Windsor, CT) (141, 142).  Using this technique, 
hundreds of molecules are detected in parallel.  
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Figure 2.4 Schematic diagram of excitation and single FRET pair emission for 
prism-based TIRF (141, 142). The excitation beam reaches the slide-solution 
interface and creates an evanescent wave that excites immobilized molecules in 
aqueous solution. The emission from donor and acceptors are collected through 
an inverted microscope objective and passed through a slit into a light-tight box, 
where the donor (green) and acceptor (red) emissions are physically separated 
by dichroic mirror. Finally, the two emission signals are detected side-by-side by 
an electron multiplied back illuminated CCD camera. The focal length of the lens 
L1 is represented by f1, d and h are distances and height of mirror from objective. 
The refractive indices for air, prism, and quartz slide and aqueous solutions are 
nair, nq and nsol respectively. L1-L3, lenses; M1-M6, mirrors; DM1-2, dichroic 
mirrors. This figure is reproduced from (113).  
2.6.3 Surface immobilization 
Frequently, molecules are surface-immobilized to extend observation 
times into the minute time scale (143).  Molecules of interest can be immobilized 
through a biotin-BSA, poly(ethylene glycol) (PEG) conjugated to biotin, PEG with 
Ni2+ or Cu2+ ions, or using click chemistry (143). Immobilization is relatively 
straightforward for nucleic acids alone (DNA or RNA) because their overall 
negative charge makes them less likely to interact non-specifically with the 
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microscope slide surface, which is also electronegative at neutral pH (144, 145). 
The most common immobilization strategy for such straightforward experiments 
is biotin-BSA. However, the study of RNA or DNA interacting with proteins is 
more challenging because the latter can readily interact non-specifically with the 
slide surface (Figure 2.5A) (146). One way to circumvent this issue is to 
passivate the slide surface with a polymer-coating using, for example, PEG 
(Figure 2.5B) (141, 147). Alternatively, Ni-NTA coated surfaces and PEG with 
Ni2+ or Cu2+ ions can be used to immobilize His-tagged proteins; however, this 
method is not generally applicable to all systems (148-150).  The click chemistry 
method of immobilization was recently introduced and may be useful in 
preventing interactions with the slide, but it has not yet been applied to systems 
that include protein (143). In addition, non-specific surface interactions can be 
suppressed by trapping the molecules inside of lipid vesicles immobilized on a 
PEGylated surface (151, 152). Several reviews have described both the theory 
and basic protocols for smFRET as shown in Figure 2.4 (136, 140-142); the 
basic protocols essential for studying protein-RNA interactions are explained 
here (141, 147) (adapted from (113) with modifications, Figure 2.5). 
2.6.3.1 Surface preparation 
Two holes were drilled into a quartz slide (G. Finkenbeiner Inc. 33 
Rumford Ave Waltham, MA) using a hand drill (Dremel 300-N, Racine, WI) and a 
1 mm diameter diamond drill bit (Kingsley North, Norway, MI) (142) to prepare 
the microfluidic channel for smFRET study as shown in Figure 2.6. The following 
processing steps were performed to passivate the slide and coverslip surface. 
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Figure 2.5 Stepwise representation of surface passivation and sample 
immobilization. (A) The slide surface is cleaned.  (B) The slide is aminosilanized 
and ready for PEGylation. (C) PEG and biotin-PEG molecules are conjugated to 
the amine-modified surface (D) Streptavidin is bound to the immobilized biotin-
PEG molecules. (E) The sample can be surface-tethered with an attached biotin 
molecule. After washing to remove unbound sample, the slide is ready for use. 
This figure is reproduced from (113). 
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2.6.3.1.1 Cleaning of slides and coverslips 
Cleaning the slides and coverslips is one of the most vital steps in slide 
preparation because the presence of impurities on the surface increases 
background fluorescence. First the reaction container was cleaned with distilled 
water and was dried completely by using nitrogen gas. Both the microscope 
slides and the coverslips were thoroughly cleaned (Figure 2.5A) by using slightly 
different cleaning protocol from elsewhere (140, 153, 154).  
Slides were cleaned by scrubbing with Alconox (VWR International Inc.) 
paste and then rinsed with distilled water. The slides were then thoroughly rinsed 
with ethanol (200 proof) and followed by distilled water to remove debris from 
previous experiments. After that slides were boiled for >20 min in 100 mL water, 
20 mL NH4OH (ACS grade, Mallinckrodt Chemicals, USA) and 20 mL 30 % H2O2 
(EMD Chemicals, USA) to remove organic materials and restore the silanol 
groups on the surface. Slides were then rinsed with distilled water and dried with 
a Bunsen burner flame, while avoiding formation of any dry deposits on the 
surface. Coverslips and slides were placed in separate Coplin staining jars 
(made from clear soda lime glass by Wheaton Industries Inc., USA) and rinsed 
with distilled water. The slides and coverslips were sonicated in the presence of 1 
M KOH (ACS certified, Fisher Scientific, USA) for 30 minutes, rinsed with distilled 
water followed by methanol (ACS grade, Fisher Scientific, USA), and sonicated 
for 30 minutes in presence of methanol. 
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2.6.3.1.2 Aminosilanization of slides and coverslips 
Clean slides and coverslips must be functionalized with an amino group, 
which will later react with an N-hydroxysuccinimide (NHS) ester on the PEG 
molecule (Figure 2.5B and C). This is achieved by aminosilanization with 3-
aminopropyltriethoxysilane. VECTABONDTM reagent (3-aminopropyltriethoxy-
silane Vector Laboratories, Inc., Burlingame, CA) is sensitive to oxidation and 
should be stored under inert gas. VECTABONDTM should be a colorless solution; 
yellowing is a sign that oxidation is occurring. 
100 mL methanol, 5 mL acetic acid (ACS grade, Mallinckrodt Chemicals, 
USA) and 1 mL VECTABONDTM reagent were mixed in a clean, dry beaker, and 
then poured into the Coplin jar containing the slides and coverslips.  The slides 
and coverslips were then incubated for 10 minutes with the VECTABOND 
solution, sonicated for 1 minute and further incubated for 10 minutes. The slides 
and coverslips were further rinsed with methanol, distilled water and again with 
methanol then dried with nitrogen gas. 
2.6.3.1.3 Surface PEGylation 
Poly(ethylene glycol) is typically used to passivate microscope slides and 
coverslips to prevent non-specific interactions with proteins. Adsorption of 
proteins to PEGylated surfaces depends on the size and the surface density of 
polymer used (155). For standard applications, linear PEG is often sufficient; 
however, for particularly highly adsorbent proteins, branched PEG can be used 
(155). When branched PEG is used to coat the surface, intermolecular 
crosslinking can increase the surface density and further prevent interaction 
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between the protein and the glass surface (155, 156). Regardless of the type of 
PEG used, a fraction of the PEG is biotinylated to provide an anchor for 
immobilization of biotin-labeled samples through streptavidin (Figure 2.5C). The 
biotin-avidin bridge is a convenient approach to surface immobilize nucleic acids 
(157, 158) because they are both commercially available, they remain tightly 
bound to each other (KD ~ pM) (159), and biotin can be easily incorporated at 
either the 3! or 5! end of nucleic acids during synthesis or by a labeling reaction 
(160, 161).  
Biotin Polyethylene Glycol Succinimidyl Carboxymethyl (BIO-PEG-SCM, 
MW 3400/5000, Laysan Bio. Inc, Arab, AL) and Methoxy Polyethylene Glycol 
Succinimidyl Carboxymethyl (m-PEG-SCM, MW 5000, Laysan Bio. Inc) were 
removed from storage at –20°C, 30-60 minutes before use to equilibrate to room 
temperature. A PEGylation buffer (100 mM sodium bicarbonate, pH 8.4, Fisher 
Scientific, USA) was prepared in distilled water and sterilized using a 0.2 !m 
Supor" Membrane syringe filter. For five pairs of slides and coverslips, ~80 mg of 
m-PEG-SCM and 5-8 mg BIO-PEG-SCM (which will introduce 5-10% biotinylated 
PEG) were dissolved in 320 !L PEGylation buffer. The solution was gently 
vortexed and centrifuged for one minute at ~10,000 rcf to remove bubbles. An old 
pipette tip box was about 10% filled with distilled water to maintain a humid 
environment and was used as a reaction chamber for further PEGylation. The 
slides and coverslips were then dried with nitrogen gas. 70 !L of the PEGylation 
reaction mixture was applied to the surface of each slide and one dry coverslip 
was placed on the top of each slide and solution, avoiding formation of bubbles. 
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The reaction was incubated in the humid chamber in the dark overnight. The 
coverslips were carefully removed from the slides, rinsed with distilled water and 
dried completely with nitrogen gas. 
2.6.3.1.4 Preparation of sample channel with flow tubing 
Sandwich-like ~4 mm wide and 200 !m deep flow channels (Figure 2.6) 
were prepared to immobilize molecules or exchange buffers during experiments.  
Slides were held on a micro slide staining rack (VWR International Inc.) 
with a the PEG surface side down and ~10 cm of 0.51 mm I.D. SILASTIC! 
laboratory tubing (Dow Corning, Midland, MI) was inserted through each hole, 
such that a small portion protrudes from the PEGylated side.  Tubes were fixed 
with epoxy glue (5 min epoxy, ITW Devcon, Danvers, MA) on the non-PEGylated 
surface of the slide. The protruding segment of the tube was removed from the 
PEGylated slide surface using a razor blade. Double-sided sticky tape (Scotch, 
3M) was used to prepare a microfluidic channel on the PEG surface. A piece of 
tape was applied to each side of the drilled holes approximately 4 mm away and 
parallel to the hole-centers (Figure 2.6). A second layer was added to increase 
the channel depth to ~200 !m. A coverslip was placed on the sticky tape 
centered on the slide with the PEGylated surface facing towards the slide. Epoxy 
was used to seal the coverslip’s periphery (Figure 2.6C). The assembled slides 
were stored in a 50 mL falcon tube under inert gas and protected from light in 
order to protect from possible photo degradation. 
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Figure 2.6 Diagram detailing slide specifications for single-molecule 
experiments. (A) Top view of an assembled microscope slide. (B) Slide with 22 
mm long, 8 mm wide and 200 !m deep microfluidic channel prepared using two 
layers of double-sided tape between the quartz slide and coverslip. The 
assembly is sealed with epoxy at the edges to prevent leaking from the channel. 
(C) Slide in B with attached flow tubing for injection of sample. This figure is 
reproduced from (113). 
2.6.3.2 Sample immobilization and preparation 
A biotinylated sample (DNA, RNA or protein) was prepared in a buffer of 
interest (sample buffer) and immobilized on the single-molecule slide. During the 
PEGylation process, 5-10% of biotinylated PEG was introduced to immobilize the 
sample. A streptavidin solution (Molecular Probes S888, 0.2 mg/mL in 50 mM 
Tris-HCl, pH 7.5, 50 mM NaCl) was injected and incubated for 5-10 minutes to 
allow it to interact with biotin (Figure 2.5D). The excess unbound streptavidin 
was washed out with the sample buffer, and 10-25 pM biotinylated sample was 
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injected and allowed to interact with the streptavidin for 5-10 minutes (Figure 
2.5E). The unbound sample was washed with the sample buffer and an OSS 
solution prepared in 2 mM Trolox was injected. After 5-10 minutes, the prepared 
slide was placed on the microscope stage and used to acquire data. Detailed 
protocols about sample preparation, immobilization and detection have been 
extensively reviewed (140-142, 144). After use, the slides were recycled and 
reused by boiling the slides in water for ~1 hour to soften any epoxy or tape 
residue from previous experiments which was then scraped off with a razor 
blade. 
2.6.4 Oxygen scavenging system for smFRET 
Oxygen can be removed from a solution by using a system of glucose 
oxidase and catalase in the presence of glucose (162). This two-step reaction 
mechanism is very useful in single-molecule experiments to remove the solution 
of excess oxygen. This oxygen-scavenging system (OSS) (10% wt/vol glucose, 
50 !g/ml glucose oxidase (Sigma, C2133 ! 100 kU/g) and 10 !g/ml catalase 
(Sigma, C3155 ! 35 kU/mg)) is used to deplete the solution of oxygen molecules 
in effort to decrease photobleaching of the fluorophores, which can be stimulated 
in the presence of oxygen (Figure 2.7A). In order to increase photostability and 
decrease blinking of the fluorophores, it is important to include Trolox (Figure 
2.7B) or "-mercaptoethanol ("-ME) (Figure 2.7C) in the solution (163). Trolox (6-
hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid, ACROS Organics, 
Belgium) is a vitamin E analog that can be used as an antiblinking and 
antibleaching reagent in single-molecule experiments (164, 165) (Figure 2.7B). 
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A saturated Trolox solution (~2 mM) in water is a better candidate to quench 
triplet state-related blinking than !-ME (163). !-ME increases the photodarkening 
of the fluorophore in a concentration dependent manner and may not be 
compatible with many biological systems at high concentration (163-166). A 
stock saturated solution of Trolox was prepared by dissolving 5 mg of solid 
Trolox in 10 mL distilled water. The solution was shaken at room temperature for 
20-30 minutes and filtered through a 0.2 "m syringe filter. This Trolox solution 
was used in the preparation of buffers and OSS solution used in single-molecule 
experiments in lieu of distilled water. 
 
 
Figure 2.7 Oxygen scavenging system for single-molecule study. (A) Schematic 
chemical reaction showing how glucose oxidase converts dissolved O2 in to H2O2 
in the presence of glucose and decomposition of H2O2 back to the molecular O2 
in the presence of catalase. (B and C) Chemical structures of Trolox (B) and !-
Mercaptoethanol (C) commonly used as antiblinking and antibleaching agents in 
single-molecule studies. 
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2.6.5 Single-molecule data analysis 
Single-molecule data were processed and analyzed as previously 
described (142, 158, 167, 168). Each single-molecule spot on the donor channel 
of the CCD chip corresponds to the same molecule with same frame on the 
acceptor channel as shown in Figure 2.8A. A second order, non-linear 
polynomial equation was used to match these two spots. An image from 
immobilized fluorescence beads with 0.2 !m red microspheres (Invitrogen, 
Carlsbad, CA) was used for calibration. After integrating each spot, a 
fluorescence trajectory of each fluorophore was obtained, which is characterized 
by a certain donor intensity (ID) and acceptor intensity (IA). Each trajectory was 
analyzed using MATLAB to select real single-molecules from other unwanted 
data. Molecules with stable fluorescence emission, anti-correlated donor-
acceptor emission intensities and single step photobleaching are indicators of 
real single-molecules (Figure 2.8B). FRET is calculated by using Equation 2.5 
and each FRET trajectory is binned to a FRET histogram. FRET histograms of 
many molecules are combined and can used to calculate thermodynamic 
information, which depends on temperature, ionic strength, pH, protein nature 
and RNA sequences. The number of peaks in the histogram characterizes the 
number of conformations present and the ratio of those peaks is consistent 
(Figure 2.8C) with the dynamic equilibrium between a number of conformations 
(169). The peak width is a contribution from conformational fluctuations in a 
single species. Along with peak width, a peak area and peak position 
characterizes the equilibrium population and distance between donor and 
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acceptor fluorophores respectively. The position of the peak is related to the 
structure (169).  
Kinetic information is calculated from the single-molecule measurements 
by dwell time analysis of individual states. Each transition is selected and a 
dwell-time histogram is calculated as shown in Figure 2.8D. Each bar in the 
histogram represents the number of dwell times that correspond to a particular 
time. Each cumulative histogram is fitted to get lifetimes (!) and transition rates.  
 
Figure 2.8 Single-molecule data analysis. (A) Overlaid images of two-color 
emission for donor (green) and acceptor (red) (113, 170). (B) A fluorescence 
emission trajectory (top) for donor (blue) and acceptor (red) fluorophores 
attached to the sample showing the anti-correlated behavior. A calculated FRET 
time trajectory (bottom) shows the on and off states. (C) FRET histogram 
obtained from more than 100 molecules reveals the probability of two states in B. 
(D) Dwell time distributions in the on state (!on) and off state (!off) used to 
calculate the on and off rate constants. Data points are processed with five points 
average after collecting them every 33 ms. 
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2.7 Fluorophores 
Fluorophores are molecules that have the ability to fluoresce. The 
delocalized electrons present in certain molecules have a tendency to absorb 
photons of a specific wavelength and emit light of a different wavelength. The 
wavelength of emission depends on the nature and chemical environment of the 
fluorophore. For a dye to be useful, it should be photostable, so that it can emit 
many photons before photobleaching, and exhibit a high quantum yield.  The 
quantum yield (defined as the ratio of number of emitted photons to the number 
of absorbed photons) is a measure of the brightness of a fluorophore. The small 
size, commercial availability, and ease of conjugation to biomolecules are other 
important factors to consider when choosing a good fluorophore for fluorescence 
experiments. 
A good FRET dye pair requires a good spectral overlap between donor 
emission and acceptor absorption, as well as, a large spectral separation 
between donor and acceptor emission to reduce donor emission leakage into the 
acceptor emission range. As mentioned before, both donor and acceptor 
fluorophores should be photostable and have a good quantum yield (168, 169). 
Fluorescein and Tetra-methyl rhodamine (TAMRA) have been used successfully 
for steady-state FRET experiments and cyanine dyes (Cy3 and Cy5 pair) are 
recognized as a good dye pair for smFRET experiments. The photophysical 
properties of some common dyes used in this study are summarized in Table 2.1 
with their chemical structures in Figure 2.9. 
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Table 2.1 Photophysical properties of some common fluorophores. 
Fluorophore Excitation 
!max (nm) 
Emission 
!max (nm) 
Extinction coefficient 
(") (cm-1M-1) 
Quantum yield 
Fluorescein (169) 490 520 83,000 0.7 
TAMRA (169) 554 580 95,000 0.2-0.5 
Cy3 (105) 550 570 150,000 > 0.15 
Cy5 (105) 649 670 250,000 > 0.28 
 
 
 
Figure 2.9 Common fluorophores used for FRET measurement. Fluorescein and 
TAMRA were used as donor and acceptor in the steady-state and trFRET 
measurement. Cy3 and Cy5 is a common donor-acceptor pair for single-
molecule study. The detailed photophysical properties are described in Table 
2.1. 
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2.8 Sample preparation 
2.8.1 RNA purification 
RNA samples were purified and labeled as previously described (110, 
171). Briefly, an RNA with 2’-protection groups was purchased from the Keck 
Foundation Biotechnology Resource Laboratory at Yale University School of 
Medicine (New Haven, CT). The deprotection reaction was carried out according 
the manufacturer’s protocol (172). In detail, solid RNA sample was dissolved in 
200 !l N,N-dimethylformamide (DMF, EMD Chemicals, Belgium) and 850 !l 
triethylamine trihydrofluoride (New Jersey, USA) and shaken overnight at room 
temperature. The deprotected RNA was butanol precipitated and dried under 
vacuum. The RNA was dissolved in water and purified by denaturing gel 
electrophoresis (20% polyacrylamide and 8M urea). The RNA band was crushed 
and soaked in elution buffer (0.4 M NH4OAc, 0.1% SDS, and 0.1 mM EDTA) at 4 
°C overnight. The purification continued with chloroform extraction, ethanol 
precipitation, and C8 reverse-phase HPLC with a linear acetonitrile gradient with 
0.1 M triethylammonium acetate (TEAA, pH 7.4).  RNA concentration was 
measured by UV-Vis from the absorbance at 260 nm after background 
substraction.   
2.8.2 Fluorophore labeling 
To perform FRET experiments, the samples must have fluorophore labels 
at appropriate positions.  Fluorophores can be attached to DNA, RNA or proteins 
and can thus be used to monitor conformational changes including changes in 
nucleic acid structure, nucleic acid binding, and protein binding. After optimal 
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positions based on the Förster radius have been determined, fluorophores can 
be attached to oligonucleotides using a labeling reaction.  
Oligonucleotides were synthesized with desired fluorophores at different 
positions using phosphoramidite chemistry or with an amino linker at the 5’ end, 
the 3’ end, or internally on a dT residue. Fluorophores conjugated with a 
succinimidyl ester was reacted with the amino group during the labeling reaction. 
The deprotected RNA sample was chloroform extracted, ethanol precipitated and 
dried under vacuum. The RNA was resuspended in 66 µL water and 20 µL 
labeling buffer (100 mM sodium carbonate, pH8.5 for Cy3 and Cy5; 100 mM 
sodium tetraborate, pH 8.3 for TAMRA). The fluorophore solution (200 µg in 
14µL DMSO) was added and the mixture was shaken at 650 rpm overnight at 
room temperature. 
After the labeling reaction was complete, the excess fluorophore was 
removed and the labeled and unlabeled nucleic acids were separated.  As a first 
step, the reaction was ethanol precipitated with 100 nmol GTP (as carrier ion), 
and resuspended in 100µL HPLC Buffer (0.1 M TEAA, pH 7.4 & 5% acetonitrile). 
The labeled and unlabeled fractions were separated via HPLC and the labeled 
fractions were dried under vacuum and resuspended in 100 µL distilled water. 
The RNA concentration was measured by UV-Vis and stored at -20°C.  
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CHAPTER 3  
Alternative splicing regulation through RNA looping 
3.1 Gene splicing 
RNA transcription in eukaryotes produces precursor mRNA (pre-mRNA) 
that contains coding sequences (exons) and non-coding sequences (introns) in 
the nucleus. This pre-mRNA undergoes three processing steps: 5’ end capping, 
3’ polyadenylation and splicing. Splicing is a eukaryotic phenomenon that 
generates a mature mRNA from pre-mRNA by removing introns and ligating 
exons together. The mRNA is then exported into the cytoplasm to be translated 
into protein by the ribosome. The splicing machinery recognizes cis-acting 
elements within the pre-mRNA to facilitate the splicing reaction. These elements 
are more highly conserved in yeast than in mammals (173, 174). The 5’ end of 
the intron contains the 5’ splice site (SS), a conserved GU dinucleotide; the 3’ SS 
(3’ end) is a conserved AG dinucleotide; and the branch point sequence (BPS) A, 
which lies before a pyrimidine tract ahead of the 3’ splice site (Figure 3.1A). All 
these elements are recognized by the spliceosomes during assembly and 
catalysis. 
3.2 Spliceosome assembly 
The spliceosome is a megaDalton (~ 3 MDa) (175) molecular assembly 
composed of five small nuclear ribonucleoproteins (snRNPs) and more than 200 
different accessory proteins (176, 177). The assembly of these trans-acting 
factors is important for the folding of pre-mRNA and for the active splicing 
reaction.  
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Figure 3.1 Spliceosome assembly. (A) Pre-mRNA sequence elements of 
metazoa and yeast conserved splice sites and sequences. Exons are in light blue 
and intron is in grey. (B) The spliceosome assembly cycle showing different 
complexes formed after assembly. Different snRNPs and other protein factors 
are assembled to activate splicing reaction. Reprinted from (174), copyright 
(2009), with permission from Elsevier. 
 
 
 
 
  
48 
There are five major uridine rich RNA sequences (UsnRNAs), U1, U2, U4, 
U5 and U6. These UsnRNAs combine with serine/arginine (SR) and other 
specific RNA binding proteins for splicing. During spliceosome assembly, first U1 
snRNP recognizes the 5’ SS of the pre-mRNA intron through RNA-RNA 
interactions. At the same time, splicing factor 1 (SF1) recognizes the BPS and 
U2 auxiliary factor binds the polypyrimidine tracts at the 3’ splice site to form an 
early spliceosome complex (E complex). Then U2 snRNP base pairs at the 3’ 
splice site and change the E complex to the A complex. The binding of 
preassembled U4/U6.U5 tri-snRNP to the A complex leads to the formation of B 
complex. Conformational rearrangement of the B complex releases U1 and U4 
snRNPs to form a catalytically activated spliceosome complex, the B* complex. 
This activated complex performs the first splicing reaction to form the C complex. 
The C complex undergoes the second splicing reaction and generates the mRNA 
and post-spliceosomal complex. This post spliceosomal complex later 
dissociates to release and recycle the snRNPS for next round of splicing (Figure 
3.1 B). 
3.3 Splicing reaction 
The intron excision and exon ligation is a two-step transesterification 
reaction performed by the B* and C complexes respectively. In the first step, 
nucleophilic attack of the 2’-OH of A at the BPS to the phosphate at the 5’ splice 
site to form a lariat structure linked by 2’-5’ phosphodiester bond. In the second 
step, the free 3’-OH of 5’ exon attacks the phosphate at the 3’ splice site, 
releasing intron lariate structure and ligating the two exons together (Figure 3.2).  
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Figure 3.2 Two step trans esterification splicing reaction. In the first step, 2’-OH 
of adenisine of the BPS attack the 5’ splice site generate a free 5’ exon and 
intron lariate. In the second step, 3’-OH of the 5’ exon attacks the phosphodiester 
bond at the 3’ splice site and generates a free mRNA and lariate structure.  
3.4 Alternative splicing 
First discovered by Walter Gilbert in 1978, alternative splicing changed the 
one gene one protein hypothesis of the central dogma of molecular biology (178) 
to the new paradigm of “one gene many protein” in higher eukaryotes. In which 
two or more than two protein isoforms from a single gene (179). Alternative 
splicing (AS) is a highly regulated biological process that plays a crucial role in 
generating high proteomic diversity. Factors that regulate AS can impede the 
early stages of spliceosome assembly (180).  
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Figure 3.3 Different modes of alternative splicing responsible for generating 
different spliced products. (A) The cassette exon. (B) Mutually exclusive 
alternative exons. (C) Alternative 5’ SSs. (D) Alternative 3’ SSs. (E) Alternative 
promoters. (F) Alternative poly (A) sites. (G) Intron retention.  
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Alternative splicing occurs frequently in cells, and most RNA binding 
proteins that influence alternative splicing were found to be non-spliceosomal 
(181) It has been estimated that >90% of human genes are alternatively spliced 
(182). Because of AS, the number of protein coding genes doesn’t correlate with 
the number of protein and the overall cellular complexity of the organism (183). 
For example, the number of protein coding genes in human is ~25,000, similar to 
the ~20,000 genes present in the small flowering plant Arabidopsis thaliana 
(183). A single gene can give rise to multiple protein isoforms as in the Down 
syndrome cell adhesion molecule (Dscam) gene in Drosophila Melanogaster 
(fruit flies) that can give rise to as many as 38,000 unique proteins by alternative 
splicing of 95 different exons (184). A particular exon can be expressed or 
repressed in a cell depending on different factors including the cell or tissue type, 
sex, developmental stage and sometimes external stimuli (185).  
The variation in spliced products is due to the selection of splice sites in 
the pre-mRNA. Several modes of alternative splicing have been observed. In 
some cases, most of the exons are constitutive and are always included, 
however, the cassette exons can be either included or excluded from final mRNA 
(Figure 3.3A). In contrast only one out of several alternative cassette exons is 
included in the case of mutually exclusive exon types (Figure 3.3B). In addition, 
selection of alternative 5’ or 3’ SS sites can increase or decrease the length of 
particular exon (Figure 3.3C and D).  Alternative selection of promoters and poly 
(A) sites influences the pattern of exons due to 5’ and 3’ switch (Figure 3.3E and 
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F). Finally, particular introns may be retained in mRNA when splicing does not 
occur (Figure 3.3G) (180, 183, 186). 
3.4.1 Alternative splicing regulation 
Alternative splicing is a highly regulated biological process characterized 
by the splicing control mechanism. Splicing regulation depends on different key 
players such as cis-acting sequence elements (generally, 4 to 18 nucleotides 
(186)) present in pre-mRNA and tras-acting factors (snRNPs and other protein 
factors) that bind to the cis-acting elements. Cis-acting elements are critical in the 
selection of splice sites. In animals, these sequence elements are classified as 
intronic/exonic splicing enhancers or silencers. Furthermore, the binding context 
of the regulatory elements can control the positive and negative regulation of 
alternative splicing (180).  
Exonic splicing enhancers (ESEs) are RNA sequences within exons that 
promote splicing after binding with some regulator, commonly an SR family 
proteins (43, 187). These SR proteins have N-terminal RNA recognition motifs 
(RRMs) and a C-terminal RS domain. In general, RRMs confer sequence 
specificity for particular exonic enhancers (Figure 3.4A). The RS domain 
enriched with serine and arginine repeats can act as a protein- protein interaction 
domain during spliceosome assembly (187, 188). It has been also proposed that 
the RS domain also binds to the splicing signals in pre-mRNA (189). The RS 
domain of SR proteins can be phosphorylated by several kinases. This 
phosphorylation is important for protein-protein interactions between RS domains 
and overall splicing activity of SR proteins (190, 191). The most studied SR 
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protein, SF2/ASF, recognizes (GAR)n sequences in pre-mRNA, where R is either 
G or A, and initiates spliceosome assembly (192, 193).  
 
 
Figure 3.4 Alternative splicing regulatory elements. (A) Pre-mRNA showing 
conserved splicing sites and other factors that can influence alternative splicing 
regulation. Exon and intron splicing enhancers (ESE and ISE) can enhance the 
splicing where as silencers (ESS and ISS) repress splice sites. Fate of 
alternative splicing regulation depends on binding of trans-acting elements like 
SR proteins, hnRNP, U1 and U2 to the cis-acting elements on pre-mRNA. (B) 
Intron definition. After binding U1 and U2AF to the 5’ and 3’ splice site, SR 
proteins starts to communicate with both splice sites to define intron. (C) Exon 
definition. Binding to U1 snRNP to 5’ splice site enhances the recruiting of U2AF 
at the 3’ end. This process needs SR protein to interact with both U1 and U2AF 
to define exon. 
 
Exonic splicing silencers are the RNA sequences present in exons of pre-
mRNA recognized by several heterogeneous nuclear ribonucleoprotein (hnRNP) 
families of proteins that inhibit recognition of the adjacent splice site during 
spliceosome assembly (180, 194). Members of this family are recognized by their 
interaction with unspliced pre-mRNA and hence they are not a part of only one 
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family protein (195, 196). One example of such protein is hnRNP A1, which 
contains two RRM domains and one glycine rich auxiliary domain (180, 197). The 
RRM recognizes the UUAGGG consensus sequence and controls splicing by 
interacting with SR proteins (198). Other examples of hnRNP family proteins are 
hnRNP H and F, with three RRMs recognizes G-tracts and binds to exonic 
splicing silencer elements (199). 
Intronic splicing enhancers are splicing regulatory elements in introns that 
can enhance exon expression. Proteins that recognize these enhancers and 
activate splicing include GUGBP and ETR-like factors (CELF). Some of this 
family protein can compete with other splicing factors like polypyrimidine tract 
binding protein (PTB) to enhance the exon inclusion. Most of neuron specific 
splicing factors like NOVA-1 (neuro-oncological ventral antigen 1), a K homology 
(KH) type RNA binding domains binds to the intronic enhancer sequences and 
stimulate the inclusion of glycine receptor GlyR!2 exon 3. Likewise, a sequence 
element present in intronic splicing element UGCAUG is recognized by RNA 
binding protein Fox (Feminizing locus on X) and enhances splicing (44, 200). 
These sequence elements are often expressed on downstream of the tissue- and 
muscle-specific exons (201). The classical example of Fox dependent alternative 
splicing is observed in neuron-specific N1 cassette exon in the c-src pre-mRNA. 
Fox stimulates the inclusion of this exon after binding to the downstream 
UGCAUG element (200, 202, 203). This mechanism will be examined in greater 
detail in Chapter 4. 
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Sequence elements of introns in pre-mRNA that repress the splicing of 
associated exons are called intronic splicing silencers. Both SR and hnRNP 
family proteins bind intronic splicing silencers (204). HnRNP A1, which 
multimerizes both upstream and downstream of the exon can form a loop to 
block the access of splicing factors. The most studied protein; PTB (hnRNP I) 
binds to intronic splicing silencers and represses many tissue-specific exons. 
This protein recognizes the CU rich elements and binds to block the access of 
splicing factors as observed in c-src pre-mRNA (205, 206). This protein 
repressed the N1 exon after binding CUCUCU elements in the pre-mRNA. The 
mechanism of PTB mediated splicing regulation will be discussed in section 3.6. 
3.4.2 Alternative splicing regulation and diseases 
Splicing regulation is tightly controlled by trans-acting factors that bind to 
cis-acting elements. Misregulation is linked to many diseases and disorders. Any 
mutation of the cis- or trans-acting factors can disrupt the splicing code, 
unbalancing the splicing regulatory mechanisms. Addition or removal of a single 
nucleotide from cis-acting site may disrupt the open reading frame can express 
aberrant mRNAs that can cause disease, if the mRNA bypasses the quality 
control mechanism (nonsence-mediated mRNA decay; NMD) and is translated 
into an abnormal protein (207). Several studies have shown that mutation of a 
cis-acting element that affects a single gene can cause disease through 
deleterious effects of a single gene product (8, 185, 208). On the other hand, 
mutation of the trans-acting factors can effect the splicing of multiple genes that 
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can disrupt the components of splicing machinery or regulatory mechanism 
(209).  
Previous studies have characterized several cancers (185, 210-213) and 
neurological disorders (207, 214, 215) linked to misregulation of alternative 
splicing mechanism. Diseases caused from mutation in cis-acting elements are 
Fraiser syndrome (FS) (207, 216), cystics fibrosis (217), frontotemporal dementia 
and parkinsonism (218) and many more. Diseases including spinal muscular 
attropy (SMA) (219), retinitis pigmentosa (220), Prader-Willi syndrome (PWS) 
(221), Huntington disease, (222) Myotonic dystropy (208, 214) arise from 
mutations in trans-acting factors. 
3.5 Splicing regulation of the c-src N1 exon 
The mouse c-src transcript is a model system to study alternative splicing 
regulation. This pre-mRNA encodes a receptor tyrosine kinase with an 18- 
nucleotide long cassette exon (N1) between two consecutive exons 3 and 4 
(Figure 3.5A). This exon is expressed in neuronal cells and skipped in other cells 
(223, 224). There are two intronic regulatory elements present in this pre-mRNA 
that are important for the regulation of N1 splicing (200, 202, 225). A CU reach 
sequences (CUCUCU) present at the upstream of 3’ splice site of N1 is 
recognized by PTB and is essential for N1 repression (226). Paradoxically, there 
are additional CU rich elements present downstream of the N1 exon (nucleotides 
17 to 142) that is required for both splicing repression and splicing enhancement 
(227). The region from nucleotides 37 to 70 are highly conserved enhancer 
region that contain a core sequence elements called downstream control 
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sequences (DCS). This DCS has two regulatory sequence elements that are 
important for splicing enhancement; a G-tract followed by CUG (GGGGGCUG) 
and a UGCAUG element. Several RNA binding proteins have been characterized 
to bind around DCS (228). PTB and its neuronal homolog (nPTB) bind to the CU 
 
 
Figure 3.5 Splicing regulation of c-src N1 exon through multiple regulators. (A) 
The c-src pre-mRNA with alternative exon N1 and two consecutive exons 3, and 
4. Important regulatory elements are represented as PPT and DCS (sequence at 
the top of pre-mRNA). PPT is an important for repression and located on both 
upstream and downstream of N1 exon. DCS is present at the downstream of N1 
exon and is important for splicing activation. DCS contains G-tract, PPT and Fox 
binding site (UGCAUG). (B) Repression of the splicing of the N1 exon in non-
neuronal cell. PTB binding block the assembly of spliceosomal complex at 5’ 
splice site and the downstream exon’s 3’ splice. (C) Activation of the N1 splicing 
in neuronal cells due to splicing activators. PTB is replaced by nPTB while Fox 
protein is also expressed in high level. Other RNA binding proteins like hnRNP 
and KSRP are also expressed and binds at the downstream intron. Figure A is 
adapted from reference (16) and Figures B and C are adapted from (229). 
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rich elements (227, 230), hnRNP F and hnRNP H, recognize the G-tract (230-
232), while KH-type splicing regulatory protein (KSRP) and Fox bind to UCGAUG 
element (230, 232, 233). 
Although there are many splicing factors associated with DCS, the 
detailed mechanism of assembly and their roles in splicing regulation is poorly 
understood. The most important splicing repressor of N1 exon is PTB, which 
binds to the upstream and downstream polypyrimidine tracts (PPTs). Another 
factor Fox binds the UGCAUG enhancer element to activate N1 expression but it 
is not clear how Fox binding antagonizes action of PTB for splicing of N1 exon in 
neurons. It seems that there is a communication between Fox and PTB to 
regulate N1 exon, but the detailed mechanism is not well understood. Other 
factor for high-level expression of c-src N1 exon in neurons is PTB paralog 
nPTB. Even though, nPTB have similar sequence with PTB, this protein functions 
as weaker splicing repressor in neurons than PTB (230). This study focuses on 
both PTB and Fox proteins and their role in splicing regulation of c-src N1 exon 
to elucidate this highly complex mechanism. 
3.6 The polypyrimidine-tract-binding protein 
The Polypyrimidine-Tract-Binding protein (PTB) is an important trans-
acting factor involved in splicing regulation. PTB is ubiquitously expressed and 
most often associated with its role as a splicing repressor (180, 234, 235), but it 
is also involved in other aspects of mRNA processing including 3' end 
processing, (236, 237) mRNA localization and stability (238) and internal 
ribosome entry site- mediated translation initiation of both cellular and viral 
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mRNAs (239). PTB plays an important role in the splicing regulation of different 
genes, including c-src, ! tropomycinin, ! actinin, Calcitonin/CGRP, GABA "2 and 
its own mRNA (PTB mRNA) (13, 240, 241). 
3.6.1 Structure of PTB 
PTB is a 58 kDa member of the hnRNP family consisting of four RNA 
recognition motifs (RRMs 1, 2, 3 and 4) connected by three inter-domain linkers 
(30, 242). Humans have 3 variants of PTB (PTB1, PTB2 and PTB4) with similar 
structures (Figure 3.6A). These variants differ only in the sequence of the 
interdomain linker between RRM2 and RRM3 (240, 243). NMR studies of 
individual domains showed that all domains have nearly 90 amino acid residues 
that fold into a typical #!##!# topology where a four-stranded #-sheet packs 
against two-! helices (38, 244) (Figure 3.6 B-E). An additional fifth # strand was 
also observed in case of RRM2 and RRM3. PTB recognizes polypyrimidine-
tracts in the RNA target containing CU rich elements with a preference for 
sequences within a longer PPT (92, 205, 206). Recently, the structures of all four 
RRMs complexed with short CUCUCU RNA have been characterized in solution 
(15). These results showed that all domains bind to RNA through the #-sheet 
surface. Domains 1, 2 and 4 interact with 3 nucleotides but domain 3 interacts 
with 5 nucleotides of RNA sequence. Furthermore, all RRMs have similar binding 
affinity in the micromolar range that depends on sequence and the length of the 
PPT. The binding affinity is higher for a longer PPT and sequence of PPT with 
cytosine (15). 
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Figure 3.6 The structure of PTB. (A) The domain organization of PTB1 (13). 
NLS; N-terminal nuclear localization signal. RRM; RNA recognition motiffs. (B-E) 
The structure of RNA (CUCUCU) bound to RRM1, RRM2, RRM3 and RRM4. (F) 
Intermolecular interactions in RNA bound PTB34. RRM3-blue, RRM4-green, 
interdomain linker-red and interacting residues-black. (G) PTB34 interdomain 
interaction between helix 2 of RRM4 (green) and helix 1 of RRM3 (blue). (H) 
Interactions between helix 2 of RRM3 with the interdomain linker (red). Sticks 
represent side chains of amino acids in different color according to their domain. 
Figures B-F are from reference (15). Reprinted with permission from AAAS. 
Figures G and H are adapted with permission from Macmillan Publishers Ltd: 
[EMBO] (242), copyright (2006). 
 
3.6.2 Interdomain interaction between PTB domain 3 and 4 (PTB34) 
All four PTB domains 1, 2, 3 and 4 bind RNA independently but the two C-
terminal domains, 3 and 4, have extensive interactions (15) (Figure 3.6F-H). 
Segmental isotope labeling experiments further characterized the interactions 
between domain 3 and 4 that positioned the bound RNA in an antiparallel 
orientation (242). Nearly 27 amino acids side chains from both helices of domain 
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3, helix 2 of domain 4 and the inderdomain linker form a hydrophobic core that 
place the RNA binding surface of the two domains in opposite orientation (242). 
These inderdomain interactions are highly conserved in PTB paralogs (13, 230, 
245). This interaction is also stabilized by a salt bridge between K398 and E502 
(242). The most important interactions that observed in PTB34 are direct inter-
RRM contacts that is mediated by interdomain linker. In order to further 
characterize these PTB34 interactions, a mutational study have been done. Two 
sets of mutants have been made to disrupt the interface by replacing 
hydrophobic residues by charged residues and disrupting the salt bridge. One 
mutant, PTB 3Mut was prepared with three mutations in RRM 4 !-helix 2 
(E502K, V505E and I509K). A second mutant, PTB34-m was expressed with six 
mutations; three mutations as in PTB 3Mut, one in RRM3 (I356K) and two in 
linker (I446E and I449K). The interdomain interaction between domain 3 and 4 is 
disrupted after mutation and they bind RNA independently (242). None of these 
mutations affect the protein surfaces interacting with RNA. 
3.6.3 PTB as a splicing regulator  
PTB is involved in splicing repression of several alternative exons but the 
mechanism by which PTB promotes exon exclusion is poorly understood (240). 
The RNA map from the study of genome-wide analysis of PTB-RNA interactions 
has revealed a positional effect of PTB binding on splicing regulation (246, 247). 
In other word, splicing activity of PTB depends upon the location of the binding 
site on the pre-mRNA with respect to the target exons (248). PTB binding near 
alternative exon promotes exon skipping whereas it’s binding near consecutive 
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distal sites facilitates exon inclusion (246, 247). The NMR structure of RNA-
bound PTB has suggested a potential mechanism of PTB action in splicing 
whereby RRMs 3 and 4 bind the polypyrimidine-tracts flanking an alternative 
exon and loop out the intervening RNA, thus repressing the exon (Figure 3.7) 
(15). 
 
Figure 3.7 Structural models for the RNA looping mechanism of PTB. (A) Full 
length PTB1 bound to a long pre-mRNA-orange. (B) Models represent the 
formation of RNA loop after binding full length PTB. This model is based on the 
GABA-!2 exon 9 repression. (C) Repression of a short exon by one PTB 
molecule. (D-F) Models showing how multiple PTB binding loop out a short exon. 
(G) A hypothecal model showing how PTB loops out branch point A when it binds 
to the 3’ SS. Figures A-G are from reference (15). Reprinted with permission 
from AAAS.  
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The two RRM-bound polypyrimidine-tracts appear in opposite directions 
as if forming a loop to exclude the intervening exon or the branched adenosine 
from the spliceosomal machinery. Other mechanistic models for PTB repression 
have proposed a direct (235) and an indirect (235, 249) competition between 
PTB and other splicing factors like U2AF65, co-repression with Raver-1 (250) 
and PTB preventing exon (249) or intron definition (251).  However, all proposed 
mechanisms are consistent with RNA looping between RRMs 3 and 4. The NMR 
structure also revealed that the RNA sequences with a 15-nucleotide spacer 
between two CUCUCU elements have the highest binding affinity for PTB34 (15). 
PTB binds cytosine-rich PPT more tightly than poly (U). On the other hand, 
splicing factor U2AF is happier with poly (U) sites for binding. These findings 
leads to the controlled mechanism of splicing frequency on the basis of cytosine 
contents at the 3’ SS. High cytosine contents favors PTB binding and, hence, 
increases exon repression (92, 206, 252).  
The aim of this work is to test and characterize the suggested looping 
mechanism of PTB34 using different biophysical and in vivo experiments. 
Fluorescence Resonance Energy Transfer (FRET), NMR spectroscopy and in 
vivo splicing assays were carried out to characterize the overall looping 
mechanism and splicing repression. 
3.6.4 Results 
[This portion is adapted from reference (170).] 
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3.6.4.1 PTB34 binds polypyrimidine-tracts and brings their 5’ and 3’ ends 
into close proximity.  
First, we tested the binding of RRMs 3 and 4 of PTB (PTB34,Figure 3.8A) 
to several model RNAs using a FRET-based gel shift assay (110). We prepared 
a series of single-stranded polypyrimidine-tracts (PPTs) separated by a variable 
size loop (5’-CUCUCU(A)NCUCUCU-3’, N = 5-30, named PPT-N), and labeled 
their 5’ and 3’ ends with fluorescein and tetramethylrhodamine (TAMRA), 
respectively. FRET measures the distance between the fluorophores (110, 112), 
and it enables monitoring of RNA conformational changes during the binding 
reaction: if PTB34 loops the RNA, it should bring the RNA 5’ and 3’ ends into 
close proximity resulting in a FRET increase. With this assay, we could detect 
both the gel shift of our labeled RNAs upon PTB34 binding and the RNA 
conformation by measuring the fluorescence intensity of the FRET pair. Distant 
fluorophores yield green bands, while close ones appear red (110). Figure 3.8B 
shows the results for PPT-5, 10, 15, 20 and 30 in the absence and presence of 
PTB34. The free RNAs migrate as single bands, demonstrating the labeled RNA 
purity. As the RNA size increases, the corresponding bands migrate more slowly 
and change color from red (PPT-5) to yellow (PPT-30), as expected.  Bound to 
PTB34, the bands become red and migrate slower indicating the formation of the 
protein-RNA complex.  For PPT-5 and 10, a second super-shifted band is also 
visible (80% and 30% intensity, respectively), but for PPT-15, 20 and 30, it does 
not exceed 10% intensity. Based on the gel mobilities, we assigned the first band 
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to a monomeric complex and the second band to a dimeric complex with two 
RNAs and two PTB34 (Figure 3.8B). 
 
 
Figure 3.8 Structure of RNA bound PTB34 and native gel. (A) Schematic 
representation of the RNA looping mechanism by PTB34. The Figure shows two 
possible looped conformations: with the intervening RNA on the same side of the 
PTB34 interdomain linker (left) or the opposite (right). (B) FRET based non-
denaturing gel electrophoresis of the fluorophore labeled PPTs in presence and 
absence of PTB34, as shown. Donor emission is represented as green and 
acceptor emission as red. RNA and RNA-protein complexes are assigned as 
shown. 
3.6.4.2 Steady-state experiment 
We further studied binding of RNA to protein in solution with steady-state 
FRET (ssFRET). Figure 3.9A shows the fluorescence spectrum of PPT-15 in the 
absence (in blue) and presence (in red) of PTB34. In the free RNA, the donor 
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intensity (520 nm) is larger than the acceptor (580 nm), indicating that the 
fluorophores, and therefore the 5’ and 3’ ends, are distant. Bound to PTB34, the 
donor intensity decreases while the acceptor increases, indicating that the 5’ and 
3’ ends are brought into close proximity in the complex. The calculated FRET 
ratio for PPT-15 increases from 0.38 to 0.66 (Figure 3.9B), in agreement with the 
gel shift assay. Similar results were obtained for all PPTs except PPT-5, which 
did not show a significant FRET increase.  The initial FRET ratio in absence of 
PTB34 decreases with increasing RNA length from 0.61 to 0.27. Bound to 
PTB34, all FRET ratios increase to ~0.65. Small differences in the final FRET 
ratios are likely caused by differences in the binding affinities of each RNA.  
We tested for the specificity of the PPT-PTB34 interaction using a 
fluorophore-labeled RNA lacking a polypyrimidine-tract, which did not show any 
FRET increase upon addition of PTB34. We also tested whether non-specific 
RNA binding proteins could loop the PPTs using the small protein B (SmpB), a 
basic protein that binds tmRNA in bacteria (253). Although SmpB can bind PPT-
15 non-specifically, we did not observe any appreciable FRET change upon 
addition of 1µM SmpB, confirming that the observed FRET increase is specific to 
PTB34 binding  
3.6.5 PTB34 looping efficiency depends on RNA loop size  
We have used the observed FRET increases to quantify the binding 
affinity of PTB34 to polypyrimidine-tracts (Figure 3.9B). A fit of the PPT-15 
titration to a modified Hill equation yields a dissociation constant KD = 11 ± 5 nM 
and a cooperativity coefficient n = 0.7 ± 0.2 (Figure 3.9C). The KD is expected to 
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decrease in vivo because of the presence of two additional RRMs (1and 2) in the 
full length PTB (92, 243). The cooperativity coefficient near unity confirms that 
PTB34 binds stoichiometrically.  
 
Figure 3.9 Evidence of RNA looping by PTB34. (A) Fluorescence emission 
spectra of labeled PPT-15 RNA in the absence (blue) and presence of 100 nM 
PTB34 (red). (B) FRET ratios for PPT-5-30 in the absence (blue) and presence 
of 100 nM PTB34 (red). (C) FRET ratio of PPT-15 as a function of [PTB34]. The 
black line is a fit to a modified Hill equation (Methods). Error bars stem from three 
independent assays. (D) Apparent KD as a function of the intervening loop size. 
Error bars stem from the standard deviation to the fit as shown in (C). 
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Similarly, we determined the KD for all six PPTs (Figure 3.9D and Figure 
3.10). The resulting KD’s decrease with increasing loop size and plateau for 
PPT15 and higher, indicating that PTB34 requires a !15 nt long intervening 
sequence to loop the RNA effectively (15). The KD obtained for PPT-5 and 10 are 
global average constants for the monomer and dimer. The cooperativity 
coefficients of all PPTs !15 are near unity, confirming the stoichiometric nature of 
these complexes.  
 
Figure 3.10 PTB34 binding of RNA with varying linkers. A 25 nM double-labeled 
RNA samples were titrated with different PTB34 concentration. Protein 
concentration was plotted with FRET values and fitted for KD values with the 
modified Hill equation (Equation 3.1). Error bars are the standard deviation of the 
three independent experiments. KD values are reported in nM for all PPTs. The 
dissociation constants obtained for PPT-5 and 10 are global average constants 
for the monomer and dimer. The cooperativity coefficients of all PPTs larger than 
10 are near unity, supporting a 1:1 stoichiometry, while the cooperativity 
coefficients for PPT-5 and 10 are higher, suggesting the presence of higher order 
complexes in solution.  
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3.6.6 All RNA-protein complexes have similar conformations  
To characterize the global structure of all the PTB-RNA complexes, we 
used time-resolved FRET (trFRET) to accurately measure the distances between 
the two fluorophores (104, 144). trFRET consists of measuring the fluorescence 
lifetime of the donor fluorophore in the presence and absence of the acceptor. 
Figure 3.11A shows the donor fluorescence decays for PPT-20. In the absence 
of PTB34 (compare black and blue curves), the donor lifetime decreases more 
rapidly in the presence of the acceptor, which is indicative of FRET. This 
difference is used to fit a distribution of distances between the dye pair (254).  
The resulting distribution reveals a bimodal distribution (Figure 3.11A inset, 
blue). We assign the major distribution (85%, 71 Å) to unfolded molecules where 
the 5’ and 3’ ends are distant.  The minor distribution (15%, 31 Å) is attributed to 
a minor population of molecules transiently folding into hairpins or duplexes 
where the pyrimidines and adenosines from the linker form base-pairs resulting 
in closer 5’ and 3’ ends of the RNA. In the presence of PTB34, the donor lifetime 
decreases dramatically, indicating a large increase in FRET (Figure 3.11A, 
compare red and blue curves).  The calculated distribution collapses to a single 
distribution centered at 35 Å (Figure 3.11A, inset, red), confirming the shorter 
distance between the 5’ and 3’ ends in the protein-RNA complexes observed in 
previous experiments.  
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Figure 3.11 Time-resolved FRET analysis. (A) Donor fluorescence decay (PPT-
20) in the absence (black) and presence of the FRET acceptor (blue), and in the 
presence of PTB34 (red). Inset: Donor-acceptor distance distribution in the 
absence (blue) and presence (red) of PTB34. (B) Average donor-acceptor 
distance as a function of the intervening RNA length. 
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We measured the donor-acceptor distance for all PPTs in the presence 
and absence of PTB34 and found similar results. Figure 3B shows the mean 
distance of the major distribution in the absence of PTB34 as a function of loop 
size (blue). The distance between the two dyes increases linearly between 51 
and 85 Å for PPT-5 and 30, respectively, with a slope of 1.4 ± 0.1 Å/nt. Upon 
PTB34 binding, all PPTs have a mean distance ranging 32 to 38 Å. For PPT-5 
and 10, the observed mean distance corresponds to a weighted average 
between the monomer and the dimer (Figure 3.8B). 
3.6.7 RRMs 3 and 4 bind the 5’ and 3’ polypyrimidine tracts, respectively  
[These data were collected in Dr. Allain’s lab at ETH Zürich.] 
We next used NMR spectroscopy to investigate the complex between 
PTB34 and two pyrimidine tracts separated by 15 adenosines. Although the 
FRET data showed unambiguously that PTB34 forms RNA loops, the FRET data 
did not provide information on the directionality of binding: two binding modes are 
possible with either RRM3 and RRM4 binding the 5’- and 3’-tracts, respectively, 
or the opposite (Figure 3.8A). Complex formation with CUCUCU(A)15CUCUCU, 
GGUCUCU(A)15CUCU and  GGCUCU(A)15UCUCU resulted in almost identical 
spectra, indicating that all three RNAs bind PTB34 in the same orientation even if 
the pyrimidine-tract is shorter at the 5’end or the 3’end (5’-GG was used for in 
vitro transcription). By comparing the spectra of PTB34 in complex with 
GGUCUCU(A)15CUCU (1:1 stochiometry) and in complex with CUCUCU (1:2 
stochiometry), we could observe clear differences indicating contacts between 
the 15 adenine linker and the protein. 
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Figure 3.12 Chemical shift mapping and structure of RNA bound PTB34. (A) Plot 
of the chemical shift differences (in parts per million, plotted against the residue 
numbers) between PTB34 bound to two 5’CUCUCU3’ and PTB34 bound to 
GGUCUCU(A)15CUCU. Chemical shift differences are calculated as !" = [!"HN
2 
+ (!"N/6.51)
2]1/2. (B) Structure of PTB34 bound to short pyrimidine-tract (15) 
(RNA-orange, protein-grey). The nitrogen shown in blue are the residues which 
chemical shift different is greater than 0.1 ppm and the nitrogen shown in cyan 
indicate resonances that are broadened or disappeared upon binding of 
GGUCUCU(A)15CUCU. 
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Major chemical shift changes and line broadening are observed within the 
interdomain linker (Q421, Q424 and N432, Figure 3.12) and in the loop between 
!-helix 2 and "-strand 4 in RRM4 (H514 and D515, Figure 3.12). This indicates 
that the adenine linker interacts with this region of PTB34. Hence, the RNA takes 
the shortest path of the two possibilities (Figure 3.8A), where RRM3 and RRM4 
are binding the 5’ and 3’ tracts, respectively (Figure 3.12B). The distance 
measured in the structure between the 5’ nucleotide (nt) bound to RRM3 and the 
3’ nt bound to RRM4 is 41 Å, which is in good agreement with the estimated 
FRET distance of 32 to 38 Å between the two dyes. The spectra of PTB34 bound 
with PPT-10 to -30 are very similar, indicating that the RNA is bound with this 
same orientation independently of the linker length up to 30 nt.  
3.6.8 A mutant reveals a synergistic role between RRMs 3 and 4 for 
efficient RNA looping  
The NMR structure of PTB34 free (242) and bound (15) has revealed 
interactions between RRMs 3 and 4 involving 27 amino acids.  We sought to test 
the function of these interactions in the looping of RNA by PTB34.  To this aim, 
we used the FRET-based gel shift assay with a six-fold mutant of PTB34 that 
was shown to prevent the interaction between RRM 3 and 4 (I356K, F446E, 
I449K, E502K, V505E and I509K) (242).  It is noteworthy that none of these 
mutations affect the protein surfaces interacting with RNA. Figure 3.13A shows 
that PTB34 mutant does not form the RNA-protein complex with PPTs as readily 
as the wild type PTB34 (Figure 3.8B). This result suggests an active role for the 
inter-domain interactions between RRMs 3 and 4 in PTB for looping, and  
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Figure 3.13 Mutant PTB34 exhibits a different conformation than the WT. (A) 
Non-denaturing gel electrophoresis of PPTs in the presence and absence of 
PTB34-m. (B) Time-resolved FRET analysis for PPT-30. Donor fluorescence 
decay in the absence (black) or presence of the FRET acceptor (green), and in 
the presence of PTB34-m (red). Inset: Donor-acceptor distance distribution in the 
absence (green) and presence (red) of PTB34-m. (C) Distance distributions for 
PPT-30 in presence and absence of PTB34-m and comparison to the wild type. 
Top panel: PPT-30 alone (blue). The average donor-acceptor mean distance is 
87 Å. Middle panel: In the presence of PTB34 (red) a single distribution is 
observed with an average distance of 36 Å corresponding to the loop RNA 
Bottom Panel: In the presence of PTB34-m two distributions are observed. We 
assign the short one (86%, 29 Å mean distance) to the dimer and the long one 
(14%, 63 Å mean distance) to the 1:1 complex. This result indicates that the 
PTB34-m can bind polypyrimide tracts but cannot loop the RNA as the WT. 
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Figure 3.14 PTB34-m titration with different looped size RNA (PPTs). 25 nM 
double-labeled RNA samples (as indicated in Figure) were titrated with different 
PTB34-m concentrations. Data were fit with the modified Hill equation (Equation 
3.1). Error bars are the standard deviation of the three independent experiments.  
KD values are reported in nM for all PPTs. The resulting KD for PPT-30 (38 ± 6 
nM) and n (1.6 ± 0.4) are four- and two-fold higher than WT PTB34 (Figure 3.9 
and Figure 3.10), respectively, indicating the presence of higher order 
complexes in solution, contrary to the WT. 
 
implicates a synergistic effect between the two domains for efficient looping in 
vivo.  The resulting dissociation constant for PPT-15 (KD = 105 ± 4 nM) is ~10-
fold higher than the WT, and the large cooperativity coefficient (n = 7 ± 1) 
indicates the presence of higher order oligomers, which result in the observed 
high FRET value, similarly to PPT-5 and 10 (Figure 3.9). The formation of 
stoichiometric complex is expected to occur at much lower concentrations than 
the dimer, but almost no FRET increase is observed below 100 nM (compare 
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Figure 3.10 and Figure 3.14), indicating that the FRET ratio of the stoichiometric 
mutant complex is similar to that of the free RNA, also supporting the idea that 
the mutant does not loop the RNA. The observed KD is, therefore, an average 
value of multiple species in solution, and likely to be an upper estimate for the 
stoichiometric complex. When the linker length increases (PPT-30), the affinity 
for the mutant protein increases (KD = 38 ± 6 nM, Figure 3.14) due to an 
increase of negative charges, while it remains almost the same for the WT PTB 
(KD = 10 ± 3 nM, Figure 3.10). The cooperativity coefficient decreases too (n = 
1.6 ± 0.4) indicating the presence of fewer higher order complexes. However, a 
FRET gel shift assay reveals no specific looped complex as the WT (Figure 
3.13A). These results indicate that the inter-domain interactions between RRMs 
3 and 4 provide RNA looping and only slightly higher affinity. 
3.6.9 Single-molecule FRET 
Single-molecule FRET is a powerful tool to study the conformational 
dynamics of protein-RNA complexes (114). We used this technique to study the 
differences in binding of PTB34 and the six-fold mutant with PPT-15 Figure 3.15. 
A biotinylated RNA and fluorophore labeled PPT-15 was surface-immobilized on 
a PEG-passivated quartz slide via a biotin-streptavidin bridge. FRET histograms 
are built from the observed FRET ratio of hundreds of individual molecules.  In 
the absence of PTB34 (Figure 3.15C, top panel), the majority of molecules 
exhibit low FRET (0.2 - 0.4) and only few molecules transiently reach the high 
FRET range. Such a broad FRET distribution is expected for a single-stranded 
RNA without a well-defined secondary structure, consistent with our trFRET data 
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(Figure 3.11). Addition of 10 nM PTB34 results in the appearance of a major 
peak at 0.55 FRET (Figure 3.15C, center panel). We assign this major peak to 
the PTB34-RNA complex, consistent with the bulk FRET experiments. In the 
presence of 10 nM six-fold PTB34 mutant, the observed FRET distribution 
resembles the RNA only distribution. A minor broad distribution ranging from 0.4 
- 0.8 FRET and centered at higher FRET than the WT is also present. We assign  
 
 
Figure 3.15 Single-molecule study of PTB-RNA interaction. (A) Schematic 
diagram of the single-molecule experiment. (B) Single-molecule time trace for 
RNA only sample. Top panel: donor intensity is in blue and acceptor intensity is 
red. Bottom panel: A FRET trajectory calculated from donor and acceptor 
intensities in top panel. (C) Single-molecule FRET histograms for RNA only (top), 
the WT protein (middle) and the six-fold mutant (bottom). Histograms are built 
from the observed FRET ratios of hundreds of single-molecules. The 0-FRET 
peak corresponds to molecules without an acceptor. The fits to a Gaussian 
distribution (red lines) are only intended to guide the eye.  
 
  
78 
this distribution to the formation of the mutant PTB34-RNA complex. This result is 
consistent with both the weaker binding of the mutant PTB34 and the lack of 
interactions between RRMs 3 and 4. The observed FRET differences between 
the WT and the mutant distributions suggest that in the absence of interactions at 
the interface between RRMs 3 and 4, the mutant binds in a different 
conformation. 
3.6.10 RNA looping by PTB34 is essential for efficient splicing regulation 
in vivo.  
[These data were collected in Dr. Allain’s lab at ETH Zürich.] 
To test the functionally importance of the interface between RRMs 3 and 
4, we used a splicing reporter assay (200) in HeLa cells with a reporter gene 
containing 2 separate polypyrimidine-tracts separated by a long linker (DS9-175) 
(255). In a control experiment without protein over expression, the alternative 
exon is 80% included, while only 34% is included when PTB is transfected and 
overexpressed. This assay illustrates the repressive role of PTB in the regulation 
of this alternative exon (Figure 3.16).  
We then transfected the cells with a PTB mutant (PTB 3Mut) with three 
mutations in helix 2 of RRM4 (E502K, V505E and I509K) that we know are 
sufficient to prevent the interaction between RRMs 3 and 4 (17). Here, 74% of 
the exon is included, indicating that PTB 3Mut is much less repressive than PTB 
WT (Figure 3.16). To confirm that the loss of repression is not due to a lower 
expression of PTB 3Mut, we performed a Western-Blot for the same splicing 
assay (Figure 3.16C). PTB 3Mut shows an even higher expression (10%) than  
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Figure 3.16 In vivo splicing assay showing the importance of the interaction of 
RRM3 and RRM4 of PTB on splicing repression. (A) The previously 
characterized splicing reporter gene (255). (B) In vivo splicing of the reporter 
gene containing two polypyrimidine-tracts separated by a long linker. nPTB, PTB 
WT and PTB 3 mut were over expressed in HeLa-cells and after RT-PCR 
developed on a Typhoon PhosphorImager. (C) Western Blot corresponds to the 
same splicing-assay shown on the left and verifies similar expression-levels of 
  
80 
proteins. Consistent with published data (256) the expression-level of nPTB in 
HeLa-cells was very low and near detection-limit. (D) Histogram of the splicing-
assay. Each RT-PCR product was quantified with the ImageQuant software and 
the exon-inclusion ratio calculated (exon included product/ (exon excluded 
product + exon included product)). Standard deviation was computed from three 
independent experiments. (E) Quantification of the relative protein-levels of PTB 
WT and PTB 3Mut to GAPDH from Western-Blot using ImageQuant software. 
PTB WT, confirming that the loss of repression is not due to a lower expression 
level. As a control, overexpression of neuronal PTB (nPTB) under the same 
condition confirms earlier reports (230) that nPTB is less repressive than PTB 
(56% exon inclusion), but still more repressive than PTB 3Mut. However, in the 
case of nPTB loss of repression is due to a much lower expression level, as 
reported (256). Since the interaction between RRMs 3 and 4 is essential for RNA 
looping, these in vivo data support the idea that splicing repression by PTB 
depends on the interface between RRM3 and RRM4 and consequently on the 
ability of PTB to mediate RNA looping. 
3.7 Discussion 
Despite the diverse and crucial roles PTB plays in many processes, its 
molecular mechanism of action remains elusive. We have used FRET, NMR 
spectroscopy and in vivo splicing assays to study the ability of PTB to remodel 
RNA structure. The FRET data unambiguously show the ability of PTB34 to bring 
together (<40 Å) the RNA 5’ and 3’ ends, forming RNA loops as suggested (15). 
However, the spacer between the two polypyrimidine-tracts must be !15 nt. The 
FRET data also provide the affinity of these RNAs for PTB34, which is <50 nM 
when the linker is !15 adenosines. Compared to the affinity obtained for each 
domain separately (KD " 1 µM) (92), this indicates that the two pyrimidine-tracts 
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bind synergistically even with a 30 nt long linker. These results prompted us to 
look further into how PTB34 could favor RNA looping. Our NMR investigation of 
PTB34 bound to pyrimidine-tracts linked by 15 adenines showed that the RNA is 
bound to PTB34 with a specific directionality, with the 5’ and the 3’ pyrimidine-
tracts bound to RRM3 and 4, respectively. These data support earlier footprinting 
experiments of the intron upstream of the alternative-exon 9 of GABA-!2 that 
showed the binding of RRM4 to the 3’ pyrimidine-tracts and of the rest of the 
protein to the 5’ pyrimidine-tract (257). This RNA binding directionality might be 
due to the presence of several positively charged residues (R366, R418, R437, 
K439, K440 and K444) in a region of the protein that interacts with the RNA linker 
without sequence specificity.  
Finally, we showed that the interaction between RRM3 and 4 is essential 
for efficient RNA binding, looping and for splicing repression in vivo. However, 
the question remains whether the differences in splicing repression between the 
mutant and the WT arise from defective RNA looping or from its lower binding 
affinity. The mutant binds PPT-15 with 10-fold lower affinity than the WT, while 
the decrease for PPT-30 was only 3-4 fold (Figure 3.14). These KD are average 
values of different species in solution, and likely to be an upper estimate for the 
stoichiometric complex. Additionally, the tr-FRET and single-molecule 
measurements (Figure 3.13 and Figure 3.15) confirm that the structure of the 
mutant PTB34-RNA complex is different from the WT. Therefore, the observed 
FRET increases in Figure 3.13 and Figure 3.15 are not due to the formation of 
looped RNA, even if the apparent average FRET ratios are similar to the wild 
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type. This is further supported by the much higher cooperativity coefficients 
observed in the mutant titrations, which indicate the presence of higher order 
complexes. The stoichiometric RNA-protein complexes, which should be formed 
at lower concentrations than the higher order complexes, yield no apparent 
FRET increase, indicating the lack of RNA looping. Based on these results, we 
expect that the mutant will bind pyrimidine-tracts with longer spacers, such as 
DS9-175 used in the splicing assay, with an affinity similar to the WT. Therefore, 
the defective RNA looping, and not its weaker binding affinity, is the most likely 
reason for the lower splicing repression of the mutant compared to the WT. 
Altogether, this study confirms the unique ability of PTB34 to bring distant 
pyrimidine-tracts into close proximity. These findings strongly support the model 
that PTB could repress alternative exons by looping out the exon or the 
associated branch point (13, 240). It also explains the RNA-remodeling role 
proposed for PTB in IRES-mediated translation regulation, since PTB34 could 
bring distant pyrimidine-tracts into close proximity, and therefore, influence the 
IRES structure (13). 
3.8 Conclusions 
Preliminary work from a gel shift assay confirmed that PTB34 binds RNA. 
This result is consistent with a previous electrophoretic mobility shift assay, which 
already proved that RNAs with CUCUCU elements showed gel shift upon 
addition of PTB34 (15). Steady-state FRET experiments showed an increased in 
emission intensity for acceptor fluorophore (higher FRET efficiency) after the 
addition of PTB34 in a solution containing labeled RNA. This increase in FRET 
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value implies a decrease in the distance between the two fluorophores, which 
supports the looping mechanism. PTB34 titration experiments with various size 
RNAs revealed different binding affinities, leading to the conclusion that the 
PTB34 binding depends on the length of the intervening sequence, which is 
optimal for 15 nucleotides or longer. Time-resolved FRET was used to correlate 
the distance and flexibility of labeled RNA. This experiment showed a decrease 
in distance between the two fluorophores after adding PTB34 as compared with 
RNA only. For all the set of RNA constructs, trFRET experiments showed nearly 
the same distance between fluorophores after PTB34 binding, which is a key 
point to propose looping of RNA by PTB34. These results clearly showed that the 
binding of RRM3 and 4 of PTB34 brings the 5’ and 3’ ends of the ssRNA to a 
close proximity, supporting a mechanism where PTB loops out the intervening 
sequence and regulates the splicing of alternative exon. NMR investigation of 
PTB34 bound to the several RNAs containing two polypyrimidine-tracts 
separated by adenine linkers showed that the RNA is bound to PTB34 with 
precise directionality, the 5’ and the 3’ pyrimidine-tracts being bound to RRM3 
and RRM4, respectively. Single-molecule FRET experiment showed different 
distributions for PTB34 and six-fold mutant. 
3.9 Materials and methods 
3.9.1 RNA purification and labeling 
RNA samples with 5’ fluorescein and 2’-OH protection groups were 
purchased from Keck Foundation Biotechnology Resource Laboratory at Yale 
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University School of Medicine, deprotected, purified and labeled, as described in 
Chapter 2 (110, 258).  
3.9.2 Protein expression and purification 
PTB34 and mutant proteins were over-expressed in E. coli and purified, as 
described (15, 242). DNA encoding RNA binding domains 3 and 4 of PTB was 
amplified from PTB1 (Acc. NO X62006) and cloned into pET28a (+) (Novagen) 
with an N-terminal His-tag. The protein was expressed in BL21 (DE3) E. coli at 
37 °C in LB containing 50 mg l-1 kanamycin. When the cells grew to OD600 ! 
0.7, they were induced with 1 mM IPTG (Isopropyl !-D-1 thiogalactopyranoside) 
for 4 h, harvested by centrifugation (~ 4000 x g), and kept at -20°C overnight. 
Cells were resuspended in 20 ml lysis buffer (300 mM NaCl, 50 mM Na2HPO4, 
pH 8.0, 0.002% (v/v) SUPERase RNase inhibitor (Ambion Inc.) containing 10 mM 
Imidazole and lysed using a French press. The cell lysate was centrifuged at 
20000 x g and the supernatant was incubated with NiNTA beads (Bio-RAD 
Laboratories Inc.) for > 1h. The beads were loaded in a column and after an 
extensive washing with lysis buffer containing 10 mM Imidazole, the protein was 
eluted with a step gradient of imidazole (20 – 500 mM) in a lysis buffer. The 
purest fractions as judged by 15% SDS-PAGE (Figure 3.17) were dialyzed 
against lysis buffer without imidazole and subjected to a second identical NiNTA 
affinity column to reduce residual RNase activity. Pure fractions were dialyzed 
against 5 liters NMR buffer (20 mM NaCl, 10 mM NaH2PO4, pH 6.5). The protein 
was concentrated by centrifugation in an Amicon concentrator at 4 °C and ~3000 
x g using a 5 kDa molecular mass cut-off membrane. RNase activity of the 
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protein sample was tested for using a commercial RNase activity test (Ambion 
Inc.). 
 
 
Figure 3.17 SDS-PAGEs showing fractions of the NiNTA purification of PTB34. 
M: molecular weight marker (Fisher’s EZ-Run Pre-Stained Rec Protein Ladder), 
CL: soluble fraction of the cell lysate, FT: fraction of the cell lysate that did not 
bind to the NiNTA resin, W: wash fraction (10 mM imidazole), E: eluted fractions 
represented by fraction numbers. Gels were stained by comassie blue dye for 
visualization. 
 
3.9.3 FRET gel shift assays 
15% non-denaturing polyacrylamide (29:1acrylamide: bisacrylamide ratio) 
gel electrophoresis was performed in 20 mM NaOAc (sodium acetate) and 10 
mM sodium phosphate (pH 6.5) using low-fluorescence glass plates, as 
described (110). 10 pmol doubly labeled RNA samples were heated at 90°C for 
45 s, annealed to room temperature and allowed to equilibrate with 40 pmol 
PTB34 or PTB34-m for 5 minutes before loading. Acrylamide gel was 
equilibrated for 15 minutes at room temperature before loading.  Samples were 
loaded on the gel, and constant electric field of 6 V/min was applied immediately. 
After electrophoresis at 4°C, the gel was scanned with in glass plate in a 
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Typhoon Imager by exciting the donor with a 532 nm laser. The fluorescence 
emission of the donor (526 nm, fluorescein) and acceptor (580 nm, TAMRA) 
were analyzed with Fluorsep program (Amershan Bioscience).  
3.9.4 Steady-state FRET  
Steady-state FRET measurements of doubly labeled RNA samples were 
carried out in a spectrofluorometer as described in Chapter 2. A 25 nM RNA 
sample was annealed in standard buffer, and fluorescence was measured in the 
absence and presence of protein. Relative FRET efficiencies were calculated 
Equation 2.5. The global dissociation constant (KD) and cooperativity coefficients 
were obtained by plotting FRET as a function of protein concentration, and fitting 
to the modified binding Equation 3.1. 
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3.9.5 Time-resolved FRET for distance measurements  
The distance between the two fluorophores was measured using time-
resolved FRET (trFRET), as described in Chapter 2 (110). A 250 nM RNA 
sample (donor only or doubly labeled) was heated for 2 minutes at 90°C and 
annealed in standard buffer (20 mM NaCl, 10 mM sodium phosphate, pH 6.5). 
After collection of photons from RNA only sample, 1 !M protein was added and 
allowed to equilibrate for five minutes in room temperature. Photons were 
collected from protein-RNA complex for both donor only and doubly labeled 
sample. Data analysis was done as described in Chapter 2. Experiments were 
repeated until to get a best fit characterized by a better !2 value. 
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3.9.6 Single-molecule FRET experiments 
PPT-15 [5’-CUC UCU (A)15 CUC UCU dTAA-3’] was labeled with 5’ Cy3 
and 3’ biotin and purified as discussed in Chapter 2. Cy5 was attached to an 
amino linker on dT following labeling protocol. The biotinylated single-stranded 
RNA was annealed in standard buffer and surface-immobilized on a PEG-
passivated quartz slide, as described (142, 147). The donor and acceptor 
intensities (ID, IA) from single-molecules were used to calculate apparent FRET 
efficiencies in the presence and absence of 10 nM PTB34 or PTB34-m. 
3.9.7 NMR spectroscopy  
[These experiments were performed in Dr. Allain’s lab at ETH Zürich.] 
Complex formation for NMR spectroscopic measurement was carried out 
as described (15). Resonance assignments for the 15N-13C labelled PTB34 in 
complex with GGU CUC U(A)15C UCU where obtained with the TROSY-HNCA 
experiment at 313K. 
3.9.8 In vivo splicing assay  
[These experiments were performed in Dr. Allain’s lab at ETH Zürich.] 
3.9.8.1 DNA constructs 
PTB1, nPTB and reporter plasmid DS9-175 were prepared as described 
(255). The 3 mutations in PTB1 (PTB 3Mut) were made with 2 consecutive PCR-
reactions using the primers 2Mut-F, 2Mut-R, 1Mut-F and 1Mut-R (Table 3.1). 
The PCR-protocol included 20 cycles: 95°C for 30 s, 55°C for 1 min and 72°C for 
7.5 min. The PCR followed a digestion with Dpn1 for 1 h at 37°C. 
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3.9.8.2 Transfections  
HeLa cells were cultured in EMEM (Eagle’s Minimum Growth Medium)-
growth-medium supplemented with 10% FBS (Fetal Bovine Serum) on six-well-
plates and grown to a 90% confluence approx. DNA-Lipofectamine 2000 
complexes were assembled according to the manufacturer’s protocol. The 
complexes were added to the cells and incubated for 5 h. After, medium was 
changed and cells grown for 19 h.  
3.9.8.3 RNA-isolation and RT-PCR  
Both were carried out following the instructions of the Cells-to-cDNA™ II 
Kit. After RT-PCR, 5 µl of the resulting cDNA were used in a 50 µl PCR-reaction 
with 10 µM of the: !-32P-labeled forward primer Dup1a and reverse-primer Dup8 
(Table 3.1). The PCR-protocol included 35 cycles: 94°C for 30 s, 50°C for 30 s 
and 72°C for 30 s. Samples of the PCR-reaction were then loaded on a 6% 
denaturing acrylamide-gel. The gel was exposed to a PhosphorImager and the 
bands quantified using ImageQuant software. 
3.9.8.4 Western blot 
Cells were lysed in RIPA-buffer containing a protease inhibitor cocktail. 
Protein-lysate (30!g) was used for Western Blot, and chemiluminescent 
detection of the Flag-Tag protein was carried out by using the Immun-Star 
Western C Kit. PTB 3Mut and PTB34 concentrations were normalized to GAPDH 
concentration and quantified from the Western Blot using ImageQuant software. 
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Table 3.1 List of primers used to study in vivo splicing assay. 
Name DNA sequence (5’-3’) 
2Mut-F 
CAG ATG GGC TCC GTG AAG GAG GCG GAG CAG GCC CTC 
ATT GAC GTC 
2Mut-R AAT GAG GGC CTG CTC CGC CTC CTT CAC GGA GCC CAT CTG 
1Mut-F GCG GAG CAG GCC CCA AGG ACC TGC ACA ACC ACG AC 
1Mut-R 
GTC GTG GTT GTG CAG GTC CTT GAG GGC CTG CTC CGC 
CTC 
Dup1a CTC AAA GAA CCT CTG GGT CCA AGG 
Dup8 GAC ACC ATG CAT GGT GCA CCT G 
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CHAPTER 4  
Fox-1 antagonizes PTB to activate N1 splicing 
4.1 Introduction 
The Feminizing locus on X (Fox) protein is an important tissue specific 
splicing enhancer that binds to intronic enhancers and regulates alternative 
splicing. In mammals there are three Fox-1 paralogs: Fox-1, Fox-2 and Fox-3. 
Among these, Fox-1 and Fox-2 are well characterized and expressed in neurons 
and muscle cells, where as Fox-3 has only been observed in neurons and has 
not been characterized in detailed (203, 259). Fox-1 is a small protein (~100 
amino-acid) with only one RRM, which is highly conserved among its paralogs. It 
has a typical RBD fold with a four stranded antiparallel !-sheet packed against 
two "-helices that can form a !"!!"! topology (41) (Figure 1.3B). The !-sheet is 
a primary RNA binding site that can bind three to four nucleotides present is a 
single-stranded RNA (30) The NMR structure of UGCAUGU bound Fox-1 
showed that Fox-1 interacts with all seven nucleotides of the RNA (Figure 1.3B) 
(41). Fox-1 specifically recognizes UGCAUG RNA sequences in pre-mRNAs with 
a high preference for U (200). Fox-1 has an unusual binding mode to single-
stranded RNA with intra-RNA interactions that form a curvature in the RNA and 
change the conformation of RNA as observed in the NMR structure of the 
protein-UGCAUGU complex (Figure 1.3B) (41). The binding affinity of Fox-1 to 
UGCAUGU is 0.49 nM at 150 mM NaCl and decreases with increasing ionic 
strength (41). The binding affinity for this protein is very high compared to other 
single-stranded RNA binding proteins.  
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Previous studies have shown that UGCAUG sequence elements are 
enriched in the downstream introns of many neuronal and muscle cassette exons 
(44, 201, 202, 260). Fox-1 can act as either a splicing activator or repressor 
depending on the location of UGCAUG elements in pre-mRNA. It has been 
proposed that Fox-1 binds a UGCAUG element in the c-src gene downstream of 
the N1 exon and activates exon inclusion (Figure 3.5 A and C) (203, 261). C-src 
pre-mRNA has two regions that are important to regulate N1 splicing (200, 202, 
225). The CUCUCU element at the 3’ splice site is important for the repression of 
the N1 exon. Downstream of the N1 exon is a second regulatory element mainly 
responsible for splicing enhancement. This highly conserved region of the gene 
sequence, consisting of 37 to 70 nucleotides in this enhancer region, is called the 
Downstream Control Sequence (DCS) (200). The DCS contains multi-protein 
binding sites specific to the neural extracts, which are important for splicing 
regulation. The UGCAUG element recognized by Fox protein also lies in the DCS 
region. Two PTB binding sites are located on either side of the Fox binding 
sequence and are important for splicing repression. There is an activator and a 
repressor element in the DCS region that most likely regulate N1 splicing (227).  
PTB represses splicing of the N1 exon in all cells; however, in neuronal 
cells, Fox has been hypothesized to antagonize the effect of PTB by competing 
with overlapping binding sites as observed in DCS sequence and helps to 
activate N1 splicing. The high binding affinity of Fox-1 (0.49 nM at 150 mM NaCl) 
and its sequence specificity might help to find the correct binding sites and could 
be an efficient competitor for binding sites in the pre-mRNA (16, 41). Fox-1 
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binding to the UGCAUGU element could break the RNA loop that was induced 
by PTB34 (170) upon binding to the CU rich elements presents on either side of 
Fox binding sequence. However, the mechanism of this process and its 
implications for alternative splicing regulation is still poorly understood.  
4.2 Results 
4.2.1 Designing RNA samples 
To understand how Fox-1 competes with PTB34 for binding and ultimately 
aids in the regulation of N1 splicing, binding and competition experiments were 
performed using a single-stranded RNA with a 15 nucleotide loop containing both 
PTB and Fox-1 binding sites (Figure 4.1). As a control, adenine nucleotides were 
added in between PTB and Fox binding sites (Table 4.1). Here, the 5’ end of the 
RNA was labeled with fluorescein and TAMRA was positioned at either the 3’ 
end (PPT-15F) or an internal dT modification (PPT-15F-dT). The change in 
FRET was used to monitor the conformation of the RNA in the presence and 
absence of PTB34 and Fox-1. 
 
Figure 4.1 RNA constructs and position of labeled fluorophores.  
To measure the true binding affinity of Fox-1 to the ssRNA with 
UGCAUGU element, a small RNA oligonucleotide, CUCWT, was prepared 
without a poly-A tract as an optimal Fox substrate. This RNA, along with PPT-
15P (contains both PTB and Fox binding sites without fluorophores), was labeled 
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at 5’ end with 32P to allow accurate measurement of the binding affinity of Fox-1 
and PTB34 (Table 4.1). 
Table 4.1 List of RNA oligonucleotides used 
Name RNA sequence (5’-3’) 
CUCWT CUC UGCAUGU  
PPT-15P 32P CUCUCU (A)15 CUCUCUGCAUGU 
PPT-15F CUCUCU (A)15 CUCUCUGCAUGU 
PPT-15F-A CUCUCU (A)15 CUCUCU (A)N UGCAUGU, (N = 1, 3 and 5) 
PPT-15F-dT CUCUCU (A)15 CUCUCdTGCAUGU 
PPT-15F-dTA 
CUCUCU (A)15 CUCUCdT (A)N UGCAUGU (N = 3, 5, 10, 20 
and 30) 
 
4.2.2 Gel shift assay 
A FRET based gel shift assay was performed in the presence of Fox-1 
and PTB34 separately for doubly labeled PPT-15F RNA sample as described in 
Chapter 3. The band shift in native gel suggested that both proteins bind 
individually to their respective binding sites on RNA. For Fox-1 (Figure 4.2A), 
these band shifts were observed only in the presence of higher protein 
concentrations. Quantification of each gel bands was performed to calculate the 
fraction of RNA bound to Fox-1. The fraction bound was plotted as a function of 
Fox-1 concentrations that gave a binding affinity of 2 !M after fitting with the Hill 
equation (Figure 4.2A, right). This KD is not able to reflect a true binding affinity 
of protein-RNA complex because the RNA concentration used in FRET gel was 
relatively high (0.5 !M).  
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Figure 4.2 Gel shift assay shows Fox-1 bind to RNA. (A) FRET gel shift for 
doubly labeled PPT-15F RNA (0.5 !M) in the presence of increasing Fox-1 
concentrations (0.1 !M to 7 !M). 5’ 32P-labeled PPT-15P (B) and CUCWT (C) 
(~1 nM) in the presence of different Fox-1 concentrations as indicated. Graphs 
on right are quantitative analysis of the gel shift data of each gel. Quantification 
of each gel bands and analysis were performed as described in the Materials and 
Methods section.  
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To further quantify the binding affinity of Fox-1 to the UGCAUGU 
sequence elements present on RNA, CUCWT and PPT-15P RNAs (Table 4.1) 
were 32P-labeled at the 5’ end. Gel shift experiments were performed for both 
RNAs (~1 nM) in the presence of Fox-1 and a clear band shift was appeared only 
in the presence of higher Fox-1 concentrations (Figure 4.2B and C). At low 
concentrations, bands were diffuse and less prominent. Quantification of PPT-
15P was performed and the calculated binding affinity was 94 nM with higher 
cooperativity value (Figure 4.2B, right) after fitting with the Hill equation. Similar 
trends were observed for CUCWT RNA in the presence of Fox-1 (Figure 4.2C). 
These experiments clearly showed the formation of RNA-protein complexes but 
the quantification did not provide a true binding affinity of Fox-1 to the RNA. 
4.2.3 Fox-1 binds with high affinity to Fox binding site 
A steady-state FRET experiment was performed in the presence of 25 nM 
doubly labeled RNA at different Fox-1 concentrations. The calculated FRET for 
PPT15-F RNA in the absence of protein was 0.21 and increased to 0.3 in the 
presence of 100 nM Fox-1 (Figure 4.3A). This increase in FRET is due to the 
formation of a curvature in the RNA upon binding of Fox-1, bringing its 5’ and 3’ 
ends closer. This result is consistent with a previous study of protein-RNA 
complex from NMR spectroscopy (41). A titration was performed using different 
Fox-1 concentrations and the observed FRET increase was used to quantify the 
binding affinity of Fox-1 to PPT-15F. A fit to a modified binding equation 
(Equation 3.1) indicates stoichiometric binding with high binding affinity of Fox-1 
to PPT-15F (n=1, KD = 8 ± 1 nM) (Figure 4.3A). Fox-1 titration was repeated for 
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other RNA constructs as well (Table 4.2). The calculated KD (10 ± 1 nM) for PPT-
15F-dT is not significantly different from PPT-15F, indicating that the labeling 
position in the RNA does not alter protein binding. 
 
 
Figure 4.3 Steady-state FRET to measure the change in FRET for PPT-15F 
RNA. (A) FRET as a function of Fox-1 concentration. (B) FRET as a function of 
PTB34 concentration. (C) A Fox-1 competition experiment in the presence of 50 
nM PTB34. Normalized fluorescence was plotted as a function of wavelength; 
RNA only (blue), RNA-PTB34 complex (green) and RNA-PTB34-Fox-1 complex 
(red). (D) FRET as a function of Fox-1 concentration to measure the K1/2 in the 
presence of 50 nM PTB34. Data were fitted with the binding Equation 3.1. 
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Similarly, a PTB34 titration was performed for PPT-15F (Figure 4.3B) and 
other RNA constructs and the calculated dissociation constant were slightly 
higher than previously characterized for PPT-15-PTB34 complex (170). The 
cooperativity and increased KD of PTB34 for PPT-15F RNA suggest the 
formation of different secondary structure in the presence of extra UGACUGU 
sequence elements at the 3’ end of the RNA. This change in secondary structure 
eventually prevented PTB34 binding to the binding site that leads to increase in 
KD. Similar binding affinities and cooperativity constants were observed for all the 
tested RNA samples and are summarized in Table 4.2. 
Table 4.2 Binding affinities and inhibition constants for different RNA samples 
Name KD (Fox) nM KD (PTB34) nM K1/2 (nM)
a 
PPT-15F 8 ± 1 38 ± 1 (n = 2) 2 ± 1 
PPT-15F-1A 8 ± 1 70 ± 2 (n = 3) 2 ± 1 
PPT-15F-3A 4 ± 1 58 ± 3 (n = 3) 5 ± 1 
PPT-15F-5A 3 ± 1 57 ± 3 (n = 3) 7 ± 1 
PPT-15F-dT 10 ± 1 58 ± 3 (n = 3) 2 ± 1 
PPT-15F-dT3A n/a 42 ± 1 (n = 3) 15 ± 2 
PPT-15F-dT5A n/a n/a 7 ± 1 
PPT-15F-dT10A n/a n/a 6 ± 1 
PPT-15F-dT20A n/a 42 ± 1 (n = 3) 11 ± 1 
PPT-15F-dT30A n/a n/a 36 ± 5 
a measured in the presence of 50 nM PTB34; n/a = experiments have not 
performed at those conditions.; n = 1, otherwise it was mentioned 
 
4.2.4 Fox-1 competes with PTB34 for binding 
Competition experiments were performed by titrating Fox-1 in the 
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presence of PTB34 bound PPT-15F. A Fluorometer was used to monitor change 
in fluorescence intensities of the donor and acceptor fluorophores. As shown in 
Figure 4.3C, donor intensity in the absence of protein is higher than acceptor 
intensity (blue) resulting in a 0.21 FRET value. In the presence of 50 nM PTB34, 
donor intensity decreased and acceptor intensity increased (green) 
simultaneously, yielding a 0.49 FRET value (Figure 4.3C). This increase in 
FRET implies a decrease in the distance between the donor and acceptor 
fluorophores. This is possibly due to looping of PPT-15F RNA when PTB34 binds 
to form a RNA-PTB34 complex. This result is consistent with our previous results 
where binding PTB34 loops out RNA (170). In the presence of 100 nM Fox-1, 
donor intensity then increased and acceptor intensity decreased (red), thus 
decreasing the FRET value to 0.34 (Figure 4.3C). This decrease in FRET is only 
possible when the distance between donor (5’) and acceptor (3’) fluorophores of 
PPT-15F is increased. For this to happen, domain 4 of PTB34 may dissociate 
from the RNA-PTB34 complex. Fox-1 protein then binds to this free RNA binding 
site to form a RNA-PTB34-Fox-1 complex or vice versa. The final FRET state of 
0.34 is equivalent to the final FRET value in the presence of 100 nM Fox-1 alone 
as shown in Figure 4.3D. Here, the inhibition constant (K1/2 = 2 ± 1 nM) (Figure 
4.3D) is slightly lower than Fox-1 dissociation constant after fitting with binding 
equation (Equation 3.1). Further experiment with PPT-15F-dT yielded a similar 
value for K1/2 (2 ± 1 nM). These dada suggest that Fox-1 competes with PTB34 
for overlapping binding site and release domain 4 of PTB34 from the RNA-
PTB34 complex. 
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4.2.5 Competition depends on PTB34 concentration 
We attempted to perform the competition at different PTB34 
concentrations. However, 25 nM PTB34 did not cause a large enough initial 
FRET change to allow us to monitor competition by Fox-1. On the other hand, 
100 nM PTB34 causes a large increase in overall FRET, but the addition of Fox-
1 did not cause a change in FRET. This indicates that at the saturating 
concentrations of PTB34, Fox-1 cannot compete with PTB34 for RNA binding. 
These experiments clearly show that Fox-1 causes a release of PTB domain 4 
from the PTB34-RNA complex and competes for the RNA binding site in a 
concentration dependent manner. A reverse competition experiment was also 
performed and showed that PTB34 still binds in the presence of 25 nM as well as 
50 nM Fox-1 with a high dissociation constant and higher stoichiometry. 
4.2.6 Effect of intervening sequences between PTB and Fox binding sites  
Competition experiments were performed in the presence of different 
lengths of intervening sequences (adenines; As) between PTB and Fox-1 binding 
sites. RNA samples; PPT-15F-A(N) and PPT-15F-dTA(N) were prepared with 
incorporation of adenine nucleotide in between two binding sites as shown in 
Table 4.1. The PTB34-RNA complex was prepared in the beginning by 
equilibrating 50 nM PTB34 with 25 nM RNA in a standard buffer (10 mM 
NaH2PO4 and 20 mM NaCl, pH 6.5).  
After scanning this complex in a Fluorometer, Fox-1 titration was 
performed with different Fox-1 concentrations and the FRET ratio was calculated. 
The observed FRET was plotted as a function of Fox-1 concentration and fitted  
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Figure 4.4 Competition experiment performed for different PPT-15F-dT RNA 
samples in the presence of 50 nM PTB34.  
using Equation 3.1 to calculate K1/2 (Table 4.2 and Figure 4.4). For PPT-15F 
samples (3A and 5A), K1/2 increases slightly with linker length. This indicates that 
when the separation between binding sites are increased, both PTB34 and Fox-1 
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can bind to their respective binding sites so that Fox-1 cannot replace PTB34 
efficiently from RNA-PTB34 complex. 
In the same way, competition experiments were performed for PPT-15F-
dT RNAs with variable intervening sequences (Table 4.2 and Figure 4.4) and 
the K1/2 was measured. The resulting K1/2’s were plotted as a function of a linker 
length as shown in Figure 4.5. The observed K1/2’s for 3 to 20 nucleotide linkers 
are slightly higher as compared to RNA with overlapping sequence. The smaller 
K1/2 for 5 and 10 than 3 might be due to the greater flexibility or secondary 
structure of RNA, but still small size of the five and ten nucleotide linkers that 
could allow the two binding sites to be closer in space. These surprising results 
suggest that Fox-1 can compete with PTB34 for binding even when the binding 
sites are separated by 20 nucleotides, but efficiency is smaller than for an 
overlapping binding site. A very long linker results in a K1/2 of 36 ± 5 nM for 30A 
RNA; this construct significantly abrogates the inhibitory effect of adding Fox-1.  
Presumably the protein binding sites are too distant for the proteins to compete. 
Taken together, Fox-1 replaces domain 4 from the PTB34-RNA complex with 
smaller affinity for distant binding sites, but when the separation is 30 nucleotides 
or more, Fox-1 is a less efficient competitor. Direct competition at binding sites 
that are separated by significant lengths could be a result of secondary structure 
of the RNA that brings binding sites in close proximity, or there may be an 
interaction between the two proteins that allow Fox-1 to replace PTB even when 
two binding sites are separated in space. 
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Figure 4.5 Inhibition constant as a function of linker length. Error bars are from 
the standard deviation to the fit as shown in Figure 4.4. 
4.2.7 Time-resolved FRET for distance distributions 
To characterize the global structure of the PTB34-RNA and PTB34-RNA-
Fox-1 complexes, we used time-resolved FRET to measure the distances 
between the two fluorophores for PPT-15F RNA sample (104, 144). Experiments 
and data analysis were performed as described in Chapter 2 and summarized in 
Table 4.3 and Figure 4.6. For RNA only (PPT15-F), the distance between two 
ends was 72 Å, which is comparable to the distance for PPT-20 from our 
previous experiment (170). The measured distance for 1!M Fox-1 and 250 nM 
RNA complex is calculated as 68 Å. This suggests that Fox-1 binding to the RNA 
slightly decreases the distance between the two ends of the RNA that was 
consistent with the previous study where a curvature was observed on Fox-RNA 
complex (Figure 4.6C) (41). 
In the presence of 0.5 !M PTB34, the calculated distance distribution was 
44 Å, confirming the shorter distance between the 5’ and 3’ ends for PTB34-RNA  
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Figure 4.6 Distance distributions for PPT-15F in the presence of Fox-1 and 
PTB34. (A) Donor fluorescence decay in the presence of acceptor (black), in the 
presence of 1!M Fox-1 (blue), and in the presence of 0.5 !M PTB34 (green). (B) 
Distance distributions for RNA alone with a mean distance of 72 Å (middle). The 
average donor-acceptor mean distance is 68 Å in the presence of 1 !M Fox-1 
(left). In the presence of 0.5 !M PTB34 an average distance of 44 Å was 
observed, which corresponds to the loop RNA. (C) Schematic representation of 
distance distributions from B with respect to protein binding and change in the 
RNA conformation. 
complex that is consistent with an RNA-looping mechanism (Figure 4.6C) (170). 
Upon addition of 1 !M Fox-1, the calculated distance was 45 Å for PTB34-RNA-
Fox-1 complex (Table 4.3). This distance was not changed even in the presence 
of 2 !M Fox-1. These distance distributions are according to our expectations at 
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higher PTB34 concentrations. At this moment we believe that in the presence of 
higher RNA (250 nM) and PTB34 (0.5 !M) concentrations, Fox-1 is not able to 
replace PTB34. This is consistent with what was observed in steady-state 
experiment, where in the presence of 100 nM PTB34, increase in FRET after 
titrating Fox-1 didn’t occur. As a control, we calculated the distance for PTB34-
RNA complex in the presence of 1!M PTB34 which was 36 Å and is similar to a 
previously measured distance of PTB34-PPT-20 complex (170).  
Table 4.3 Distance distributions measured from trFRET  
SN Sample Distance (Å) 
1 RNA Only (PPT-15F) 72 ± 1 
2 RNA + 1.0 !M Fox-1 68 ± 1 
3 RNA + 0.5 !M PTB34 44 ± 2 
4 RNA + 0.5 !M PTB34 + 1!M Fox-1 45 ± 1 
5 RNA + 0.5 !M PTB34 + 2!M Fox-1 45 ± 1 
6 RNA + 1.0 !M PTB34 36 ± 2 
 
4.3 Discussion 
It has been known form a long that UGCAUG sequence elements are 
shown to control many alternative exons including c-src N1 exon (203, 262, 263). 
These sequence elements are recognized by an RRM in Fox-1 and they regulate 
splicing of many tissue-specific alternative exons (260, 264, 265). The c-src N1 
exon is one of the most studied alternative exons that can be regulated through 
both positive and negative control mechanisms (203, 266). PTB binding to the 
intronic splicing silencer of c-src pre-mRNA elements can repress N1 expression 
in non-neuronal cells. The downstream of this exon is a complex and flanked by 
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binding sites for several proteins including hnRNPs and KH-types (230, 232, 
233). Specifically, highly conserved hexanucleotide sequence is located 
downstream of neuron-specific-exons (201). Recent studies been proposed and 
characterized the RNA looping mechanism for splicing regulation of the N1 exon 
in non-neuronal cells (15, 170). It has been proposed that Fox-1 and PTB 
compete for overlapping binding sequences and Fox-1 replaces domain of PTB 
from the PTB-RNA complex to regulate the N1 expression (16). However, the 
exact mechanism by which Fox-1 up-regulates the N1 expression on neuronal 
cells is yet to be explored. We have used a FRET assay to study the binding and 
competition of Fox-1 to the ssRNA with UGCAUGU sequence and 15 nucleotide 
spacer in between two poly-pyrimidine tracts. It has been previously shown that 
PTB efficiently loop out RNA with !15 nucleotide spacer (170). Our results show  
 
Figure 4.7 The proposed model for splicing regulation of c-src N1 exon. PTB34 
loops out the N1 exon that blocks N1 inclusion (left). Fox-1 competes with 
overlapping binding sites and displaces domain 4 of PTB34 from complex and 
disrupt the RNA loop induced by PTB34 (right) (16). 
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that both PTB34 and Fox-1 bind to their respective binding sites where Fox-1 has 
high affinity (~8 nM) for the Fox binding sequence. Competition experiments 
revealed that Fox-1 replaces domain 4 of PTB34 from protein-RNA complex. 
Here, Fox-1 competes with PTB34 for overlapping binding sequence U present 
as in downstream control sequence (DCS) (Figure 4.7). This is consistent with 
the previous NMR study of the PTB34-RNA complex (16). The calculated K1/2 is 
slightly lower than the Fox-1 dissociation constant. This is possibly due to the 
formation of secondary structure that allowed Fox-1 binding more efficiently in 
PTB-RNA complex. Another explanation for this is the possible protein-protein 
interaction between PTB34 and Fox-1 that helps to find UGCAUGU elements 
more efficiently in a PTB34-complex rather than RNA alone. These experiments 
also revealed that Fox-1 replaces PTB34 in a concentration dependent manner 
such that it is only an efficient competitor at PTB concentrations !50 nM. 
The same experiment with ssRNA was also performed in which the 
downstream pyrimidine tracts were separated by additional adenine nucleotides 
from Fox-1 binding sequence. All these RNAs bound with PTB34 with similar 
binding affinities (Table 3.2). The competition experiments were performed for 
these RNAs and the K1/2 was measured to be largest for 30 nucleotides 
separation. This data suggests that the secondary structure formed under these 
conditions keeps the two binding sites close in proximity so that Fox-1 is able to 
replace PTB4 from the complex. Another explanation for this might be that from 
the protein-protein interactions, rather than direct competition for an RNA binding 
site or steric clashes, actually allow Fox-1 to displace PTB34. These findings are 
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related to the splicing regulation by Fox-1 that helps to express N1 exon of c-src 
pre-mRNA in neuronal cells. 
4.4 Conclusions 
The designed RNA substrate can bind PTB34; upon binding, it decreases 
the distance between two fluorophores, which supports the looping mechanism 
of splicing repression. However, when Fox-1 is added as a competitor, the 
fluorophores become further apart, suggesting that Fox-1 inhibits RNA looping.  
The tight binding affinity of Fox-1 observed here indicates that it could be an 
efficient competitor for binding pre-mRNA in the DCS of the c-src N1 exon. The 
competition experiments showed that Fox-1 competes with PTB34 for same 
binding site in a concentration dependent manner at concentrations that are likely 
to be physiologically relevant. Since the binding affinity of Fox-1 is higher than 
PTB domain 4, we propose that Fox-1 replaces domain 4 from PTB-RNA 
complex. Together, these data support the hypothesis that Fox-1 counteracts the 
splicing repression by displacing PTB34 and thereby disrupting the RNA loop to 
enhance the splicing of the N1 exon.  
4.5 Materials and methods 
4.5.1 RNA purification and fluorophore labeling 
RNA samples with or without 5’ fluorescein and 2’-OH protection groups 
were purchased from Keck Foundation Biotechnology Resource Laboratory at 
Yale University School of Medicine and were deprotected, purified and labeled as 
described in Chapter 2 (110, 258).  
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4.5.2 Radioactive 5’ labeling of RNA 
Both CUCWT and PPT-15P RNA (20 pmole) were labeled at the 5' end in 
T4 PNK buffer (50 mM Tris·HCl, pH 7.6, 5 mM DTT, 10 mM MgCl2, 0.1 mM 
EDTA and 0.1 mM spermidine) with 10 !Ci [! -
32P]-ATP and 10 units of T4 
polynucleotide kinase (PNK) enzyme in a volume of 50 !l at 37 °C. The reaction 
mixture was centrifuged through a spin column at 3000 rpm for one minute. The 
labeled RNA samples were used in gel shift assays for protein binding. 
4.5.3 Protein expression and purification 
Fox-1 was over-expressed in E. coli and purified as described previously 
(41). In brief, DNA encoding the RNA binding domain of Fox-1 (residues 109-
208, Swissport Q9NWB1) was PCR amplified from a full length Fox-1 cDNA and 
cloned into pET28a (+) (Novagen) with an N-terminal His-tag. The protein was 
expressed in BL21 (DE3) E. coli at 37 °C in LB containing 50 mg l-1 kanamycin.  
 
Figure 4.8 SDS-PAGEs showing fractions of the NiNTA purification of Fox-1. M: 
molecular weight marker (Fisher’s EZ-Run Pre-Stained Rec Protein Ladder), CL: 
soluble fraction of the cell lysate, FT: fraction of the cell lysate that did not bind to 
the NiNTA resin, W: wash fraction (10 mM imidazole), E: eluted fractions 
represented by fraction numbers. Gels were stained by comassie blue dye for 
visualization. 
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After this, induction and purification was performed as described in Chapter 3 for 
PTB34. Figure 4.8 shows the SDS-PAGEs of the purification of Fox-1 protein. 
4.5.4 Gel shift assays 
Non-denaturing polyacrylamide gel electrophoresis was performed as 
described in Chapter 3 to observe the protein binding to the purified RNA. For the 
competition experiment, RNA was allowed to bind first protein (PTB34 or Fox-1) 
and equilibrated for five minutes in room temperature. Next, the second protein 
was allowed to bind and loaded on a pre-equilibrated native gel. Similarly, 32P-
labeled RNA samples were heat denatured in standard buffer and allowed to cool 
down to room temperature. Protein was allowed to bind with RNA and loaded on 
a pre-equilibrated native gel. After running (0.5x TBE) for 6 hours at 4 °C, the gel 
was exposed on a phosphoimager and was scanned using typhoon. 
Quantification of each gel bands was performed using ImageQuant software 
(Molecular dynamics). The fraction bound were plotted as a function of Fox-1 
concentration and fitted using Hill equation. 
4.5.5 Steady-state FRET 
Steady-state FRET measurements of doubly labeled RNA samples were 
carried out in a spectrofluorometer as described in Chapter 2. A 25 nM RNA 
sample was annealed in standard buffer, and fluorescence was measured in the 
absence and presence of protein (PTB34 and Fox-1). Relative FRET efficiencies 
were calculated by using Equation 2.5. The global dissociation constant (KD) and 
cooperativity coefficients were obtained by plotting FRET as a function of protein 
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concentration, and fitting to the modified binding Equation 3.1. For the 
competition experiment, after scanning RNA only sample, different PTB34 
proteins (25, 50 and 100 nM) were added to the solution and scanned to 
measured FRET. After that, protein titration was performed as described before 
and K1/2 was calculated by plotting FRET as a function of protein concentration 
after fitting with Equation 3.1. 
4.5.6 Time-resolved FRET for distance measurements 
The distance between the two fluorophores was measured using time-
resolved FRET (tr-FRET), as described in Chapter 2 (110). A 250 nM PPT-15F 
RNA sample (donor only or doubly labeled) was heated for 2 minutes at 90 °C 
and annealed in standard buffer. After collection of photons from the RNA only 
sample, 0.5 !M PTB34 protein was added and allowed to equilibrate for five 
minutes at room temperature. Photons were collected from PTB34-RNA complex 
for both donor only and doubly labeled sample. 1 !M Fox-1 was added to the 
solution and photons were collected after equilibrating for five minutes. Data 
analysis was done as described in Chapter 2. 
4.6 Acknowledgements 
This work was done in collaboration with Prof. Frédéric Allain’s lab in ETH, 
Zurich. I would like to thank Prof. Allain and Markus Blatter for providing Fox-1 
protein, plasmid and finally for their help and suggestions. 
 
 
 
  
111 
CHAPTER 5  
Protein-RNA dynamics in the 30S ribosome assembly 
5.1 Introduction to the ribosome 
The ribosome is a macromolecular machine, responsible for synthesizing 
proteins during a process called translation. Ribosomes utilize messenger RNA 
(mRNA) as a template and aminoacyl-transfer RNAs (tRNA) as substrate during 
translation. Ribosomes is a ribonucleoprotein complex, composed of ribosomal 
RNAs (rRNAs) and ribosomal proteins (rproteins). The 70S bacterial ribosome 
has a mass of 2.6-0.28 MDa and a diameter of about 20 nm (267-269). Each 70S 
ribosome is composed of a small (30S) and a large (50S) subunits (86). The 
small subunit is composed of one rRNA, 16S (1642 nucleotides) and 21 rproteins 
(S1-S21), whereas the large subunit is composed of two rRNAs, 23S (2900 
nucleotides) and 5S (120 nucleotides), and 34 rproteins (L1-L34) (86, 94) 
(Figure 5.1). The intermolecular bridges between 30S and 50S help to associate 
the two subunits during the formation of a complete 70S (270).  
Both subunits have different roles in protein synthesis (271). The 30S 
subunit is the location of the decoding center and is responsible for the selection 
of the correct tRNA on the basis of mRNA codons. This subunit also helps in the 
formation of the initiation complex. On the other hand, the 50S subunit is 
responsible for the formation of the peptide bond since the peptidyltransferase 
center (PTC) is located in this subunit. The 50S subunit also helps to release 
nascent polypeptide and tRNA (267). Both subunits have three tRNA binding 
sites during translation: the A, P and E sites. 
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Figure 5.1 Composition of bacterial ribosome. 70S is composed of 30S and 50S 
subunits. 30S subunit consists of 16S rRNA and 21 rproteins where as 50S 
subunit consists of 23S rRNA, 5S rRNA and 34 rproteins. Figures are generated 
from PDB IDs: 2aw4 (50S) and 2avy (30S) (272). 
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5.2 Ribosomal RNA 
Ribosomal RNA of both subunits are transcribed from the same 
transcriptional unit called the rrn operon. The native transcript undergoes 
enzymatic processing with the help of different enzymes in order to form a 
functional rRNA (273, 274). This mature RNA is the catalytic part of the 
ribosome. The overall folding of the nucleotide sequences have been 
characterized by different biophysical studies such as chemical modification 
assays, evaluation of nucleotide susceptibility to nucleases, co-variation analysis 
and so on. These studies have ultimately generated the secondary structure of 
rRNA and determined the conserved nucleotides for ribosome function in all 
forms of life (275, 276). The secondary structure of 16S rRNA is divided into the 
5’ domain (1-556), the central domain (557-918), and the 3’ domain (919-1542). 
The 3’ domain is further divided into 3’ major and 3’ minor (decoding region) 
domains (82, 276) (Figure 5.3). The 23S rRNA is divided into six domains 
(domains I-VI) with the peptidyltransferase center located in domain V.  
The folding of the secondary structure of rRNA is stabilized by the 
formation of different secondary structure motifs. The important secondary 
structure motifs involved in rRNA are hairpin loop, bulge loop, internal loop and a 
junction loop (Figure 5.4). Hairpin loops consists of a double-stranded stem 
formed by complementary sequences with a single-stranded loop. Hairpin loops 
are prevalent building blocks of RNA secondary structures. About 70% of the16S 
rRNA nucleotides are associated with hairpin structures (277). On the other hand  
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Figure 5.3 Secondary structure of E. coli rRNA with major domains. 5’ is a 5’ 
domain, C is a central domain, M is 3’ major and m is 3’ minor domains. This 
Figure is adapted from reference (278).  
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for bulge loops and internal loops, an unpaired region is present either on one 
side or on both sides, respectively of a helical region (279). 
The stability of these loops depends on the loop closing base pairs, loop 
complementarity with other loops in the structure, the sequence of the stems 
adjacent to the loops, and the number of nucleotides in the loop(s) region (277, 
280, 281). Junction loops are formed when three or more than three helices 
intersect. All these secondary structural motifs are the sites for folding nucleation, 
protein interactions, and drugs or other small molecules (metal) binding (279).  
 
 
Figure 5.4 Secondary structural motifs of rRNA. (A) Hairpin loops (B) Bulge loop 
(C) Internal loop (D) Junction loop. 
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5.3 Ribosomal proteins 
The original hypothesis for protein synthesis stated that it was carried out 
by rproteins while rRNA only acted as the structural scaffold for the rproteins. 
Later on different studies suggested that the ribosome is not a multi-enzyme 
complex, but instead it is a ribozyme, where rRNA carries out the catalytic activity 
(282, 283). Ribosomal proteins bind to rRNA to assist in its folding in order to 
maintain the correct structure for catalytic activity. E. coli has fifty-five rproteins 
that are globular with extended N- and C-terminal domains. The globular 
domains are mainly located on the surface (81). The remaining portion of the 
rproteins extends into the core of the ribosome to help reduce the steric 
hindrance between phosphate backbone (80, 82, 284). Although rproteins are 
distributed through out the surface of the ribosome, none are present near the 
decoding region and PTC (80, 82). The peptidyltransferase activity of 50S is still 
possible even after depletion of many rproteins (285), which demonstrate that the 
catalytic activity of ribosome is carried out by rRNA. Besides providing the folding 
platform for rRNA and its catalytic activity, many rproteins have several other 
roles in the cell. For example, S15 and S4 have autoregulatory activity for the 
translation of the rprotein operon genes (286). 
5.4 Ribosomal assembly 
The biogenesis of ribosomes takes place in a well-defined manner. The 
several steps of biogenesis are rRNA transcription, rprotein synthesis, RNA 
processing and folding, protein binding and modification. All these steps are not 
sequential; some of them might be parallel or cotranscriptional (287). After 
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transcription, all rRNA undergoes processing events and at the same time 
rproteins are synthesized and undergo assembly in a hierarchical manner. For 
example 30S subunit assembly occurs simultaneously with transcription in a 5’ to 
3’ direction (287). Several in vitro reconstitution experiments were performed in 
order to determine the binding orders of rprotein to the rRNA (288, 289). 
 
Figure 5.5 Assembly map of 30S ribosomal subunit. Primary binding proteins are 
in red, secondary binding proteins are in blue, tertiary binding proteins are in 
purple and quaternary binding proteins are in orange. Black arrows indicate the 
binding order and dependencies (288-290).  
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Very few modifications have been made to the first proposed model by 
Nomura (290, 291) (Figure 5.5). Out of 21, six of the rproteins (S4, S7. S8, S15, 
S17, and S20) of the 30S subunit are capable of binding directly to the naked 
16S rRNA and are known as primary binding proteins. The binding of these 
rproteins changes the conformation of rRNA and allows binding of the second set 
of proteins, called secondary binding proteins (S6, S9, S12, S13, S16, S18 and 
S19). The tertiary binding proteins (S5, S10, S11 and S14) bind only after the 
binding of primary and secondary rproteins. Finally, the last set of rproteins; 
quaternary binding proteins (S2, S3 and S21), bind resulting in a fully assembled 
30S subunit. Assembly of 50S occurs in a similar manner to 30S subunit (292). 
After complete assembly of 30S and 50S, the two subunits associate with the 
help of interacting bridges to form a complete 70S subunit. There are twelve 
intersubunit bridges characterized in the 70S crystal structure (293). 
5.5 Protein synthesis 
Ribosome with the help of several factors can translate mRNA into protein. 
There are three steps in protein synthesis: initiation, elongation and termination.  
Initiation is the first step of protein synthesis that starts with binding of 30S 
subunit to the mRNA (294). In bacteria, the Shine-Dalgarno sequence (SD) of 
mRNA recognizes the anti-Shine-Dalgarno (ASD) sequence of 16S rRNA, which 
positions the AUG start codon in the P-site of 30S subunit (295-297). The 
positioning of the start codon allows the binding of tRNAfMet to the P-site (298). 
This initiation complex then associates with 50S subunit through several 
intersubunit bridges. Initiation factors (IF1, IF2 and IF3) help to prevent 
  
120 
premature binding of the initiation complex with 50S and non-initiator tRNA from 
entering the P-site (299). 
The elongation of protein synthesis takes place after binding of an 
incoming aminoacyl-tRNA incomplex with elongation factor (EF)-Tu and GTP to 
the A site (299). After this, GTP hydrolysis takes place that releases the 
aminoacyl end of the tRNA from EF-Tu (294). The conformational changes in 
rRNA orient the peptydyl-tRNA and aminoacyl-tRNA to allow peptide bond 
formation that forms the polypeptide at A-site and leaves the deacylated-tRNA at 
P-site creating the pre-translocation complex (300). The rotation of the ribosome 
after the pre-translocation stage moves the deacylated-tRNA to a P/E hybrid 
state and the aminoacylated-tRNA to the A/P state (301). This is recognized by a 
complex of EF-G and GTP and another translocation takes place upon GTP 
hydrolysis where the tRNAs moves from the hybrid state to their final position in 
the P-site and E-site, which moves the mRNA ahead by one codon (294, 300, 
302). After this the next round of elongation starts. 
The final stage of protein synthesis occurs when the A-site encounters a 
termination codon (UAA, UAG or UGA) in the mRNA. At this stage, release 
factors interact with both the decoding site as well as the PTC and then protein 
release is catalyzed by the PTC (303). After hydrolysis of the peptide bond, 
ribosome-recycling factors (RRF) break the intersubunit bridges between the two 
subunits and dissociate 30S and 50S for another round of protein synthesis. 
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5.6 Ribosome and antibiotic resistance 
Ribosomes of the three domains of life (bacteria, archaea and eukaryotes) 
have significantly different structures and nucleotide sequences on their RNA. 
These structural differences permit some compounds (antibiotics) to bind and 
inhibit ribosome function without affecting human protein synthesis. Antibiotics 
are chemical compounds produced by some organisms or chemically 
synthesized, which are used to kill other organisms. Almost half of the clinically 
used antibiotics target ribosomes and protein synthesis. Figure 5.6 shows the 
possible antibiotic targets of the elongation cycle. Antibiotics have different 
binding sites in the ribosome, for example, the aminoglycoside family of 
antibiotics bind to the decoding region of 16S rRNA (A-site) and cause 
mistranslation (269, 304, 305). On the other hand, the macrolides, 
chloramphenicol, lincosamides, oxazolidines and so on target the PTC and block 
the peptide bond formation (306, 307).  
The emergence of resistance to antibiotics has been a major challenge of 
the medical field since its discovery in 1940’s (308, 309). Bacteria utilize several 
different mechanisms like target modification, inductive expression of latent 
chromosomal genes, plasmids or transposons, degradation of the antibiotic, 
inactivation by modification of functional groups, efflux of the antibiotic and so on 
(309). Among these, target modification is the greatest concern because most 
synthetic antibiotics become resistant due to mutation of the target-binding site in 
rRNA (310-312).  
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Figure 5.6 Schematic representation of translation elongation cycle and sites for 
antibiotic action. Reprinted from (307), 2010 with permission from Elsevier. 
Due to the slowing down in development of antibiotics and an increase in 
resistance rate by bacteria, it is necessary to explore new possible drug leads 
and targets. Several approaches are being employed to develop new antibiotics. 
Ribosomes could be a good drug target to study from both a structural and a 
genetic point of view. Recent high-resolution crystal structure with and without 
bound antibiotic (313-315) increases our understanding of the interactions of 
rRNA with small molecules. These structural constraints are being used by 
different computational scientists in their structural based drug discovery to 
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predict small molecule binding to the ribosome. The predicted compounds are 
synthesized, assayed for its function and binding to its particular target as a drug 
lead (316). Other approaches to study drug development are genetic-based 
study. These allow studying target modifications in the ribosome caused by 
mutations. According to this approach, mutational studies are performed to 
determine the critical structural nucleotides in the target. Since there are multiple 
rRNA operons, the phenotype of a mutation in one operon will be overshadowed 
by the wild-type (WT) operons. This along with the lethal phenotype of other 
mutations has made it difficult to do mutational studies. To study the rRNA 
structure and function, the Cunningham lab has developed a pRNA123 plasmid 
system (317, 318). The plasmid allows mutational studies in vivo without 
affecting normal cellular function (317, 318). This system has two-reporter genes, 
the green fluorescence protein (GFP) and chloramphenicol acetyltransferase 
(CAT) along with ampicillin (bla) gene and a complete rRNA operon, rrnB (Figure 
5.7). This rRNA operon is under the control of the IPTG inducible lac (lacUV5) 
promotor. The Shine-Dalgarno (SD) sequence of the reporter genes has been 
modified in a way that recognizes the complementary anti-Shine-Dalgarno 
sequence (ASD) of the plasmid 16S rRNA. This allows only plasmid-derived 
ribosomes to translate GFP and CAT mRNA and is suitable to study the function 
of any mutation in the plasmid rRNA by determining the level of GFP production 
(317). After finding the functional target sequences, potential drug leads (small 
molecules or peptides) can be identified and a phase display can be used to 
select the possible peptides that bind to the target. 
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Figure 5.7 Genetic system for studying the functional analysis of the 16S rRNA. 
CAT and GFP are two reporter genes can only translated by plasmid ribosome 
but not translate by chromosomal transcripts (317). 
5.7 Protein-RNA dynamics in the central junction control 30S ribosomal 
subunit assembly 
The interactions between ribosomal proteins and ribosomal RNA (rRNA) 
facilitate and stabilize the folding of rRNA into its active conformation. The central 
domain of 16S rRNA contains several protein-binding sites. S15 is a central 
domain primary binding protein that has been shown to trigger a conformational 
change in the rRNA (83). This conformational change allows other central 
domain binding proteins to bind to the central domain causing a cascade of 
changes resulting in the functional structure of the central domain. Previous 
biochemical and structural studies have revealed two regions that are minimally 
required for binding S15 in vitro. One of these regions is the junction of helices 
20, 21, and 22 in 16S rRNA (Figure 5.8).  
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Figure 5.8 Location of the junction loop in the central domain and S15 
interaction. (A) The central domain secondary structure showing the important 
helices and junction loop (square box) (276). (B) 30S subunit with position of 
central domain and junction loop. A magnification of the junction loop and S15; 
rproteins are colored light orange and 16S rRNA is in light grey; S15 is red 
(Lys64, Tyr68, and Lys72 are within 2-3 Å of side B and interact with the 
backbone of side B); S8 is in light blue, 652:753 in green; 654:752:754 in blue; 
653 in orange. In both 16S and 30S, helix 20 is in pink, helix 21 is in purple, and 
helix 22 is in cyan. Part of this Figure is taken from reference (286). 
This junction includes nucleotides 652-654 and 752-754 plus two or three 
base pairs in each helix to maintain the junction structure. All junction nucleotides 
except 653 are highly conserved in bacteria, implying that these nucleotides are 
functionally important. Saturated mutagenesis and S15 over-expression studies 
identified the functionally important sequence and structural elements within the 
junction loops complemented by S15. Nonfunctional mutants were not 
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complemented by over-expression of S15. Here, we present the results of 
comprehensive in vivo genetic and in vitro single-molecule fluorescence studies 
that identify the key sequence, structural motifs and structural dynamics of the 
central junction are responsible for its role in proper ribosome assembly and 
function.  
5.8 The central domain 
The 16S rRNA is divided into 4 domains as indicated above. Each domain 
plays an important role in rRNA folding and protein synthesis. The central domain 
consists of nucleotides 557-918 (Figure 5.8A) that make helices 19 through 27. 
Some of the universally conserved sequences like the 690 loop and the 790 
loops are within the central domain (94, 267). Both of these loops are important 
for 30S and 50S subunit association during protein synthesis (293, 319). Another 
important part of this central domain is the junction region of helices 20, 21 and 
22, which plays a role in assembly of the central domain (83, 320, 321). Besides 
these rRNA, there are multiple proteins associated with the central domain. 
These proteins are S6, S8, S11, S15, S18 and S21 (Figure 5.8B) (83). 
5.9 S15 and junction loop interaction 
The interactions between ribosomal proteins and ribosomal RNA facilitate 
and stabilize the folding of rRNA into its active conformation. The central domain 
of the 16S rRNA contains several protein-binding sites. S15 is a central domain 
primary binding protein (288, 289) that has been shown to trigger a 
conformational change in the rRNA (321). This conformational change allows 
other central domain binding proteins to bind to the central domain causing a 
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cascade of changes resulting in the functional structure of the central domain. 
Previous biochemical and structural studies have revealed two regions that are 
minimally required for S15 binding in vitro. One of these regions is the junction of 
helices 20, 21, and 22 in 16S rRNA (Figure 5.8). This junction includes 
nucleotides 652-654 and 752-754 with two to three base pairs in each helix to 
maintain the junction structure. All junction nucleotides except 653 are highly 
conserved in bacteria, implying that these nucleotides are functionally important 
(276). 
S15 is a small protein with 89 amino acids that has only one domain and 
folds into four ! helices. This protein doesn’t recognize any specific base in 16S 
rRNA but interacts with the backbone of junction nucleotides 752-754 (81, 83). 
The nucleotide interactions in the junction region 652-654 and 752-754 create 
the backbone conformation to bind S15 and proper folding of the junction. S15 
binding promotes the cooperative binding of S6 and S18 and then S11 and S21 
(83). So, the formation of correct junction structure is very important for S15 
binding and assembly of other central domain proteins.  
5.10 Results 
This project is divided into two parts. In the first part, regions of importance 
in S15 binding to the central domain were genetically analyzed. This study 
characterizes the different sequence elements that are important for S15 binding 
and proper folding of central domain. In the second part, those mutants were 
used to characterize the dynamics of junction-S15 interaction by using a 
biophysical method. Here we chose to use single-molecule fluorescence 
  
128 
resonance energy transfer (smFRET), which allows protein-RNA interactions to 
be studied at a molecular level. In this section, I have summarized some of the 
most exciting results that were obtained from the genetic study and have 
described the single-molecule data. 
5.10.1 Genetic analysis of important regions for S15 binding to the central 
junction 
[Kris Ann Baker performed this work in Prof. Cunningham’s lab. All results 
in this section are adapted from her dissertation submitted to the graduate school 
in 2008 (286).] 
5.10.1.1 Mutational study 
To identify functionally important sequence and structural elements within 
the central junction, three nucleotides 652-654 (side A), and 752-754 (side B) of 
the E. coli 16S rRNA junction loop were subjected to saturation mutagenesis 
using PCR (318, 322). The mutations were cloned in the ribosome expression 
vector pRNA228 (317, 318, 323), expressed in E. coli DH5 cells (324) and 
functionally active mutants were isolated by selecting with 100 !g/ml of ampicillin, 
50 !g/ml of chloramphenicol, and 1 mM IPTG (LBCm50).  
Side A mutations: A total of 48 side A mutants were analyzed (318).  
Among these, only 15 unique sequences that produce ribosomes with in vivo 
activities >10% of WT ribosomes were identified indicating that transformants 
expressing other mutant sequences produced inactive ribosomes (318).  
Analysis of the 15 survivors revealed a random distribution at positions 652 (!2, 
"=0.98) and 653 (!2, " = 0.87), however; only the WT G654 was isolated in 14 of 
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the 15 mutants (!2, " = 3.6x10-8). The other mutation, U654, produced ribosomes 
with only 12 % activity.  
Side B mutations: We analyzed 45 side B mutants but only six unique 
sequences with >10% activity in vivo were identified. Though the sample size is 
insufficient for statistical analysis, it is interesting to note that each of the six 
mutants contained only a single mutation and that mutations were isolated at 
each of the randomized positions. The lowest activities observed among the 
mutants were C754U (16%) and C754A (11%). 
Side A and B mutations: Out of 735 chloramphenicol-resistant 
transformants, only 64 unique mutants with >10% functions were analyzed. Non-
random distributions were observed at all positions in the junction loop (!2, " ! 
5.1 x 10-5). The WT nucleotide was preferred at every position except 653, at 
which 32 of the 64 mutations were U653A. All of the mutations isolated in the 
side A only and side B only selections were present in the combined mutant pool. 
If interactions between the two sides of the junction are important for ribosome 
function, functional sequences excluded during the side A only and side B only 
selection should be presented among the sequences isolated when all six 
nucleotides were mutated. Fifteen mutations that were absent among the side A 
survivors and 17 mutations that were absent among the side B survivors, were 
isolated when all six nucleotides were mutated. In each clone, the excluded 
single-side sequence was accompanied by additional mutations on the opposite 
side. 
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Figure 5.9 Covariation analysis of selected junction mutants. Helix 20 is in red, 
helix 21 is in pink and helix 22 is in cyan. Colored nucleotide indicates the 
interaction observed in the crystal structure. Font size corresponds to the 
frequency of the nucleotide identity in the selected mutants. Boxes lines with p-
values indicate the position of significant correlation between nucleotide identity 
and function. Lines with p-values are covariation positions.  
To determine if the occurrence of these mutations was due to 
complementation between the sides of the junction, each of the 32 mutants was 
subcloned in the absence of mutated nucleotides on the opposite side of the 
junction and assayed. All but four of the 32 subclones produced inactive 
ribosomes (<10% of WT) indicating that interactions between the nucleotides on 
each side of the junction are important for ribosome function. The four single- 
side mutants with >10% activities were added to the pool of selected mutants for 
further analyses. 
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5.10.1.2 Identification of functionally important sequence and structural 
motifs  
Position 654 and 754: A covariation analysis was performed to understand 
the requirement for interaction between the nucleotides on either side of the 
junction (318) (Figure 5.9). A weak covariation was observed between positions 
652 and 753 (!2, " = 1.9 x 10-2), 654 and 752 (!2, " = 7.8 x 10-4), and 752 and 
754 (!2, " = 4.4 x 10-3). However, a highly significant covariation was observed 
between positions 654 and 754 (!2, "=6.4 X 10-26). Of the 64 junction mutants, 23 
were able to form Watson-Crick (WC) base-pairs at this position. The mean 
activity of mutants, which can form WC base-pairs, is 32%. This activity assay 
confirmed that a WC base-pair between positions 654 and 754 is an important 
component for functionally active ribosomes (Table 5.1). A base-triple between 
G654, G752, and C754 in the crystal structure also correlates the importance of 
this interaction for ribosome function (Figure 5.10A and C) (83, 272). The 
observed weaker covariations between positions 654 and 752, and 752 and 754 
may be due to the selection of nucleotide combinations that could facilitate the 
formation of strong interaction between 654 and 754. Thus, 34 out 64 functional 
mutants had mutations at 654 and/or 752 and only 3 of the 34 contained 
nucleotide combinations that can form WC base pairs between 654 and 752. 
These findings support the importance of nucleotides in positions 654 and 754 in 
ribosome function.  
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Table 5.1 Nucleotide distribution of selected junction mutants (286) 
Nucleotide 652 653 654 752 753 754 
A. Nucleotide distribution among functional mutantsa 
A 11 (6)b 32 (18) 5 (2) 11 (5) 48 (27) 11 (3) 
C 6 (4) 10 (6) 9 (3) 4 (1) 2 (0) 36 (23) 
G 9 (4) 8 (4) 39 (24) 41 (24) 7 (3) 9 (3) 
U 38 (18)a 14 (4) 11 (3) 8 (2) 7 (2) 8 (3) 
pc 6.2 x 10-9 5.1 x 10-5 8.2 x 10-10 1.3 x 10-11 1.3 x 10-18 2.4 x 10-7 
 (7.1 x 10-4) (7.1 x 10-4) (2.8 x 10-9) (1.7 x 10-9) (4.1 x 10-13) (3.6 x 10-8) 
B. Nucleotide distribution among bacteriad 
A 6 6345 13 17 12915 10 
C 11 476 10 4 5 12910 
G 3 803 12900 12904 9 7 
U 12913 5309 10 8 4 6 
aNucleotide distribution in 64 selected mutants with the WT sequence in bold. 
bNumbers indicate the distribution of selected mutants with >40% function. 
cProbability of random distribution based on Chi-square analysis. 
dNucleotide distribution in all bacterial sequences obtained from the Ribosomal 
Database Project from Michigan State University (Cole et al. 2003).  
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Figure 5.10 Junction loop structure with important interactions. (A) A position of 
RNA backbone after the formation of a base triple between G654:C754:G752. 
(B) Base stack observed in crystal structure; G588, A753, G654 and A 655. 
These two Figures are adapted from (286). Helix 20 is in pink, helix 21 is in 
purple and helix 22 is in cyan. (C) A schematic representation of triple base pair 
between G654:C754:G752. (D) A reverse-Hoogsteen interaction observed 
between U652:A753. 
 Position 652 and 753: A small but significant covariation (Figure 5.9) 
between 753 and 652, support the importance of this interaction for ribosome 
function. This interaction is observed in the crystal structure where, A753 stacks 
with A655, G654, and G588 (Figure 5.10B). The stacking interaction of A753 is 
stabilized by the formation of a reverse-Hoogsteen pair with U652 (272, 325) 
(Figure 5.10D). Out of 30 mutants isolated, 22 (73%) had the ability to form a 
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reverse-Hoogsteen pair (326), which is not much higher than the number of 
potential reverse-Hoogsteen pairs that would be expected by random chance 
(62%). So, the nucleotide interaction at 652 and 753 is important for ribosome 
function but there is no requirement for a reverse-Hoogsteen pair to be formed. 
Fifty-five mutants out of 64 contained purines at position 753 suggesting that the 
ability of the residue at position 753 to participate in the 655/654/753/588 stack is 
more important for ribosome function than its ability to form a reverse-Hoogsteen 
pair with the nucleotide at position 652 (Figure 5.10B and D). From the crystal 
structure, a hydrogen bond between the O4 of U652 and the 2’-OH of G752 was 
observed (272). Out of selected nucleotides at position 652, only U652 was 
capable of forming both the H-bond with G752 and the reverse-Hoogsteen 
interaction with A753. Disturbance of this interaction could have a small impact 
on 655/654/753/588 stack, which is important for S15 binding. 
 Position 653:  This position is the least conserved in the junction region 
with nucleotide U653 acting as a spacer nucleotide, which was determined from 
the crystal structure and in vitro studies (321, 325, 327, 328). The single deletion 
mutant, U653! was only 3% as active as WT, but all the single substitution 
mutations had near-WT function. These findings are consistent with the role of 
U653 as a spacer nucleotide. The amount of GFP produced and the growth rate 
was observed to be the same for all single mutations at 653 except U653! 
mutant. Out of several mutants, U653A significantly produced ribosomes with 
higher function. This suggests that the presence of U653A in combination with 
other mutations increases ribosome function in the junction. 
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5.10.1.3 Mutation on junction affects S15 binding 
 S15 over-expression assays were performed to test whether the loss in 
function for some mutants was due to decreased S15 binding. For over-
expression, the S15 gene was cloned into the pKan5 expression vector and all 
mutants were assayed in the presence of over-expressed S15. Out of 94 
selected mutants, 78 junction mutants were complemented by over-expression of 
S15 with an increase in ribosome function from 4% to 91% (Figure 5.11). The 
remaining 16 mutants that were not complemented by over-expression of S15 
did not contain WC pairs at positions 654 and 754. 
5.10.1.4 S15 binding affects 30S subunit assembly  
Two mutants J12 and U653! were selected for further analysis in order to 
understand the effect of mutation on ribosome function. Since S15 is a primary 
binding protein, the loss in function might correlate with failure of the mutant 
ribosomes to assemble into active 30S subunits. Ribosomes from each mutant 
and the WT were prepared and ribosomal RNA was extracted from the 30S and 
and 70S peaks. A primer extension was performed to determine the percentage 
of plasmid-derived 16S rRNA in each peak (Figure 5.12) (318). Out of the total 
ribosome pool, approximately, 37% of the plasmid-derived ribosome is present in 
the WT cells. In each mutant, the percentages of mutant ribosomes in the 30S 
peaks and in the 70S peaks are approximately equal (Figure 5.12) but loss of 
activity in the mutants is accompanied by a decrease in the percentage of mutant 
ribosomes in each peak relative to the WT. Interestingly, in each mutant the 
decrease in the number of mutant ribosomes was less than the decrease in 
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protein synthesis activity, indicating that not all of the mutant ribosomes were 
equally active.  
 
 
Figure 5.11 S15 over-expression and its effect on ribosome function. The 
production of GFP correlates the function of ribosome. Blue bars are GFP 
production levels in the absence of over-expression and green bars are with 
over-expression. Letter J is for complemented mutant and letter C is for non- 
complemented mutants. 
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Over-expression of S15 in the mutants (Figure 5.12 B and C) significantly 
increased the activity of the mutant ribosomes and also increased the proportion 
of mutant ribosomes in the 30S and 70S peaks. The increase in activity, 
however, was disproportionately greater than the increase in the ribosome in 
each peak, indicating that S15 over-expression increases the total number of 
mutant ribosomes in each peak while also increasing the proportion of mutant 
ribosomes that are active. These data together support the hypothesis that loss 
in function of mutants is due to the decrease in assembly of the functional 30S 
subunit.  
5.10.2 Junction dynamics 
Previous studies have shown that the helices comprising the central 
junction undergo a significant conformational change during ribosome assembly 
involving the ribosomal protein S15 (321, 329, 330). Three helices - h20, h21 and 
h22, are in an open conformation with equivalent interhelical angles. In the 
presence of S15 and Mg2+, h21 and h22 stack coaxially and h20 adopts acute 
angle with h22 (329, 331). Ha et al. have previously utilized smFRET to examine 
the dynamics of these three helices with WT sequence in the presence of S15 
and Mg2+ (332).  
Potentially the loss of function observed with the junction mutants may be 
partially due to a change in the dynamics of the three helices. To investigate this 
possibility, a series of smFRET experiments with the WT junction loop and 
several selected mutants, J58, J12, and C12 (Tables 5.2) were performed in the 
presence of S15 and divalent metal ions, such as, Mg2+ (83, 332, 333). The 
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mutants were chosen for further study because they have a range of function and 
ability to be complemented by S15 over-expression. J58 with 3 mutations and 
J12 with 6 mutations have high (74%) and low (18%) levels of function, 
respectively, yet both were complemented by over-expressed S15 (Table 5.2). 
C12, however, despite only having a single G654C mutation, has only 1% 
function and was unable to be complemented by over-expressed S15 (Table 
5.2). Comparison of the structural dynamics of these mutants to that of the WT 
sequence in the presence and absence of S15 revealed specific sequence and 
structural motifs in the junction loop that are important in ribosome function.  
Table 5.2 Summary of junction mutants from saturation mutagenesis 
Junction nucleotides % Function  
Type 
 
Sample 652 653 654 752 753 754   
 WT 
U U G G A C 100 100 
1 J58 
U A U G A A 74 102 
2 J12 G A C A U G 18 83 
3 C12 
U U C G A C 1 1 
 
5.10.2.1 Native gel to observe the formation of the junction and S15 
binding  
The construct utilized for the FRET experiments consisted of the E. coli 
junction loop region from the central domain of the 16S rRNA that was truncated 
as shown in Figure 5.13A. Minor modifications at the bulge near helix 20 were  
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Figure 5.13 Single-molecule study of the central domain junction loop of E. coli 
16S rRNA. (A) The truncated junction region showing three helixes h20, h21 and 
h22 labeled according to the E. coli 16S secondary structure. Donor Cy3 and 
acceptor Cy5 fluorophores are attached at 5’ and 3’ ends respectively to the 
RNA1 strand where as biotin is attached to second strand. The nucleotides in 
bold on helix 20 were modified from WT (ACG) sequence (RNA3) to increase the 
efficiency of annealing during the formation of the junction. (B) Schematic 
representation of a slide preparation for single-molecule experiment. Quartz slide 
is covered with PEG-biotin and RNA sample is immobilized through biotin-
streptavidin interaction. In the slide, the junction loop shows the conformation 
change in the presence of S15. (C) Typical single-molecule time trajectory in the 
presence of 10 nm S15 and 1 mM Mg2+ for the WT junction loop; upper is the 
donor intensity in blue and acceptor intensity in red, which are anti-correlated. 
Lower panel is the FRET trajectory calculated from the fluorescence intensities of 
the donor (ID) and acceptor (IA) from upper panel by using Equation 2.5. 
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made in order to increase the efficiency of annealing during sample preparation. 
The modifications here are feasible since the bulge was previously shown not to 
be critical for S15 binding (332, 333).  
The three RNA strands of the FRET construct (Figure 5.13A) were 
annealed as described in the Materials and Methods. The complete formation of 
the junction construct and binding of S15 was then verified on a native gel as 
shown in Figure 5.14. The gel shift was observed and positions of bands were 
found significantly different for RNA1, RNA1+RNA2 and for a complete junction 
loop with three strands. The formation of the junction loop was observed for WT 
and all mutant samples with or without modification. The modified RNA sample 
increased the efficiency of the formation of junction loop as compared to the 
unmodified sample.  
Gel shift assays were also performed in the presence of S15. Here, 20 
pmoles of S15 was allowed to equilibrate with 10 pmoles of RNA sample for five 
minutes at room temperature. Mobility of the RNA with and without S15 bound 
was compared by gel electrophoresis. In the presence of S15, the color of bands 
became red and the RNA migrated slower than in the sample without protein, 
which indicated the formation of protein-RNA complex (Figure 5.14B). S15 
binding was observed for both modified and unmodified junction loop, which 
showed that the modification near the helix did not affect S15 binding to the 
junction. The formation of a protein-RNA complex was clearly observed for WT, 
J12 and J58 mutant loops but not for mutant C12.  
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Figure 5.14 FRET based non-denaturing gel electrophoresis of the fluorophore 
labeled junction RNAs in presence and absence of S15. RNA and RNA-protein 
complexes are assigned as shown. R1 is RNA1, R2 is RNA2 and junction has all 
three RNA strands. (A) Gel showing no effect of modification on S15 binding. 
This also showed that modification helped to anneal three RNA strands and form 
a complete junction. (B) Comparison of S15 binding with WT and three other 
modified mutant loops. WT and J59 mutant bind S15 on similar manner than J12 
and C12 mutants. 
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5.10.2.2 The WT junction loop is highly dynamic 
In the absence of S15 and under near-physiological conditions (1 mM 
Mg2+), smFRET trajectories reveal that the WT junction adopts an open 
conformation with FRET values ranging 0.4-0.6. A time-binned FRET histogram 
built from >100 trajectories reveals the presence of two major conformations 
centered at ~0.4 and ~0.6 FRET (Figure 5.15). Based on the time trajectories, 
however, these two conformers interchanged more rapidly than our time 
resolution (33 ms). Increasing [Mg2+] to 10 mM results in a FRET increase to 
~0.8 (Figure 5.15), indicating that h20 and 22 are brought in close proximity 
forming a closed conformation. The corresponding smFRET trajectories reveal 
that the junction can still transiently explore the open conformation, which results 
in a second minor and broad distribution below 0.8 FRET (Figure 5.15). Dwell 
time analysis of >100 time trajectories (Figure 5.16A) show that the closing rate 
constant (kclose = 9 ± 1 s
-1) is ~5-fold larger than the opening rate constant (kopen = 
1.8 ± 0.1 s-1), in agreement with the FRET histogram (Figure 5.15B). In the 
presence of S15 and under near-physiological conditions (1 mM Mg2+), a similar 
effect was observed. The junction resides primarily in the closed conformation 
with brief transitions to the open conformation. The opening and closing rate 
constants (Figure 5.16B) were similar to those measured in 10 mM Mg2+, 
suggesting that S15 and Mg2+ ions may play similar roles in stabilizing the closed 
conformation, as proposed previously (332). 
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Figure 5.15 FRET time trajectories and histograms calculated for WT junction 
loop at different conditions. Data points are processed with three point average 
after collecting them every 33 ms. (A) FRET trajectories at 0.5 mM [Mg2+] (top), 
most of the time WT loop is in low (0.4) FRET state. Second panel, WT loop is in 
the presence of 1 mM [Mg2+], here WT loop is in medium (0.6) FRET. When the 
magnesium concentration is increased to 10 mM (third from top), WT loop is in 
high FRET (closed) state i.e. 0.8 FRET state and frequently goes to a lower 
FRET (open) states. In presence of 10 nM S15 with 1 mM [Mg2+] (Bottom), WT 
loop is stabilized to high FRET (0.8). (B) FRET histograms obtained from number 
of events at different magnesium concentrations in presence and absence of 
S15. Gaussian fit of histograms provides the distributions of molecules at each 
FRET state. Histograms are built with 100 molecules at each case unless 
otherwise mentioned. At 0.5 mM [Mg2+] (top) WT loop has predominantly (~93%) 
0.4 FRET state and ~ 7 % in higher FRET state. When [Mg2+] is 1 mM (second) 
WT loop has higher events (~66%) at 0.6 and (~34%) at 0.4 states. When the 
magnesium concentration is increased to 10 mM (third from top), the distribution 
in the FRET histogram for WT junction loop is high (~92%) at 0.8 FRET state and 
8% at lower FRET state. The distribution in the histogram in the presence of 10 
nM S15 and 1 mM magnesium (bottom), WT junction (50 molecules) shows 
similar results as 10 mM magnesium (~94% at 0.8 and 6% at lower FRET 
states). 
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Figure 5.16 Histograms of the number of events observed from dwell time 
analysis in docked (closed,right) and undocked (open, left) states. Histograms 
are fitted with a single exponential equation to calculate the dwell time of the 
open and closed states. (A) Dwell time for the WT junction loop at 10 mM [Mg2+], 
the opening rate is 1.8 ± 0.1 s-1 and the closing rate is faster than 9 ± 1 s-1. (B) In 
the presence of 10 nM S15 and 1 mM [Mg2+], the opening rate is (1.4 ± 0.1 s-1) 
and the closing rate is (14 ± 1 s-1), which is similar to rate at 10 mM magnesium. 
These results show that the junction loop is stabilized to a closed conformation in 
the presence of high magnesium concentration or S15. (C) Dwell time of the type 
3 mutant junction loop in the presence of 10 nM S15 and 1 mM [Mg2+]. The 
opening rate is 8 ± 1 s-1 where as the closing rate is 2.8 ± 0.2 s-1. Type 3 mutant 
loop is not stabilized to a closed state in the presence of S15 as compare to the 
WT. 
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5.10.2.3 Type 1 mutant (J58) junction requires S15 for proper dynamics  
The clone J58 has near-WT function (74%) and is complemented to WT 
levels in the presence of over-expressed S15. This suggests that J58 would have 
similar junction dynamics to the WT. However, single-molecule trajectories of 
clone J58 reveal that this mutant cannot fold like the WT. In the absence of S15 
and under 1 mM Mg2+, this mutant exhibits a single conformation at FRET ~0.4 
and the fast dynamics that were observed for the WT under these conditions 
disappeared (Figure 5.17). Increasing the [Mg2+] to 10 mM recovered the 
partially open ~0.6 FRET state observed for the WT, but not the closed 
conformation (0.8 FRET). This indicates that the junction mutations in J58 may 
have disrupted an important Mg2+ binding site thus preventing folding of the 
junction into the closed conformation. Interestingly, in the presence of S15 and 
only 1 mM Mg2+, folding in the closed conformation was restored. This result 
shows that S15 alone can stabilize the closed conformation even when Mg2+ 
cannot, suggesting that S15 and Mg2+ stabilize the closed conformation by 
different mechanisms. It appears that direct contacts between S15 and the 
central junction rather than electrostatic interactions are mostly responsible for 
the stabilization of the closed conformation in near-physiological conditions.  
5.10.2.4 Type 2 mutant (J12) juncyion dynamics can be restored with 
higher S15 concentrations 
The clone J12 is a low functional mutant (18%) that can be rescued by 
over-expression of S15 in vivo (Table 5.2). In the absence of S15 and 1 mM 
Mg2+, J12 smFRET time trajectories exhibit only a low FRET state (0.4) indicating  
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Figure 5.17 FRET time trajectories and histograms calculated for type 1 mutant 
(J58) junction loop at different conditions. (A) FRET trajectories at 1 mM [Mg2+] 
(top), most of the time this mutant loop is in low (0.4) FRET state. Second panel, 
is in the presence of 10 mM [Mg2+], here this mutant loop is in medium (~0.6) 
FRET. When the magnesium concentration is increased to 20 mM (third from 
top), still ~0.6 FRET state. In presence of 10 nM S15 with 1 mM [Mg2+] (bottom), 
type 1 mutant is stabilized to high FRET (0.8) as WT. (B) FRET histograms 
obtained from number of events at different magnesium concentrations, and in 
presence and absence of S15. Gaussian fit of histograms provides the 
distributions of molecules at each FRET state. Histograms are built with 100 
molecules at each case unless otherwise mentioned. When [Mg2+] is 1 mM (top) 
type 1 mutant loop has only one distribution at ~0.4 FRET state. When the 
magnesium concentration is increased to 10 mM (second) peak is shifted to ~0.6 
state (58%) from 0.4 state (38%) and remaining 4% are in lower FRET state 
which is observed from the 3 distributions in the histogram. Similarly, three FRET 
distributions are observed in the presence of 20 mM (third from top) [Mg2+]. In the 
presence of 10 nM S15 and 1 mM magnesium (bottom), this mutant has only one 
distribution at 0.8 FRET state.  
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that this mutant adopts primarily the open conformation, as observed with J58. 
Increasing the [Mg2+] to 10 or 20 mM does not result in the appearance of higher 
FRET species (Figure 5.18). Therefore, Mg2+ alone cannot stabilize the 0.6 
FRET or the closed conformations. However unlike J58, time traces of J12 in the 
presence of 10 nM S15 and 1 mM Mg2+ showed a few rapid transitions to the 0.6 
FRET state or the closed state. The corresponding time-binned histogram of 35 
trajectories shows that the 0.6 and 0.8 FRET states are only reached 21% and 
4% of the time, respectively.  Because these excursions were never observed in 
the absence of S15, this result shows that S15 is still capable of transiently 
binding the junction with lower binding affinity, but fails to stabilize the higher 
FRET conformations. To estimate the binding affinity of S15 for J12, we 
increased the S15 concentration to 25 nM (1 mM Mg2+) (Figure 5.18). 
Unfortunately, at this concentration S15 precipitated on the PEG coated quartz 
surface and only few molecules behaved well. Among greater than 50 well 
behaved molecules, 10 exhibited the closed conformation (0.8 FRET) indicating 
that under higher concentrations S15 binds and closes the junction, in agreement 
with the in vivo data. 
5.10.2.5 S15 is not sufficient to restore type 3 mutant (C12) junction 
dynamics 
Clone C12 is a low functioning mutant in vivo, which cannot be rescued 
even when S15 is over-expressed. Time trajectory traces of C12 in 1 mM Mg2+ 
and in the absence of S15 reveal the presence of a new static low FRET 
conformation (0.2) (Figure 5.19A). Increasing [Mg2+] to 10 or 20 mM reveals no 
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Figure 5.18 FRET time trajectories and histograms calculated for type 2 mutant 
(J12) at different conditions. (A) FRET trajectories at 1 mM [Mg2+] (top), most of 
the time this mutant loop is in low (~0.4) FRET state. There is no significant 
change in FRET sate when the magnesium concentration is increased to 10 
(second) or even 20 mM (third from top). In presence of 10 nM S15 with 1 mM 
[Mg2+] (fourth from top), type 2 mutant have some events in 0.6 FRET with a 
dominant 0.4 FRET state. In presence of 25 nM S15, most events are in higher 
FRET (0.8) state. (B) FRET histograms obtained from number of events at 
different magnesium concentrations, and in presence and absence of S15. When 
[Mg2+] is 1 mM (top) this mutant loop has only one distribution at ~0.4 FRET 
state. When the magnesium concentration is increased to 10 mM (second) or 
even of 20 mM (third from top) [Mg2+], type 2 mutant have only one distribution at 
~0.4 FRET state. In the presence of 10 nM S15 and 1 mM magnesium (fourth 
from top), the type 2 mutant (35 molecules) shows three distributions 75% at 0.4, 
21% at 0.6 and 4% at 0.8 FRET states. These distributions point out a 
proceeding of traces from lower to higher FRET states for the mutants in this 
condition. In the presence of higher S15 (25 nM), only one (0.8) FRET state is 
observed (10 molecules). Due to the protein crashing and accumulation on the 
slide surface, we were not able to collect many molecules at this protein 
concentration. 
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conformational changes showing that Mg2+ ions alone cannot fold the junction 
even into the 0.4-FRET state. 
Time-binned histograms of >100 time trajectories at 1, 10 and 20 mM 
Mg2+ show no discernable folding of the C12 clone junction loop (Figure 5.19B).  
A possible explanation for this observation is that the G654C mutation prevents 
the formation of the 654-754 base pair, in favor of a 654-752 base pair. In turn 
this allows A753 to base pair with either U653 or U652, and C754 with G587 
from h20. These three base pairs are then capable of stacking between h22 and 
h20, thus generating a long extended helix which would result in ~0.2 FRET, as 
observed. This multi-stack structure would be expected to stabilize the 0.2-FRET 
conformation. 
Since over-expression of S15 does not rescue the C12 clone, the 
expectation is that S15 cannot bind at all to this mutant. However, time 
trajectories in 1 mM Mg2+ and in the presence of S15, revealed an unexpected 
behavior. The junction adopted the extended 0.2-FRET conformation but briefly 
transitioned to FRET states ranging between 0.4 and 0.6 (Figure 5.19).  
Because these excursions are never observed in the absence of S15, these 
dynamics indicate that S15 is still capable of binding the extended helix 
conformation and attempts to fold it, however, 0.4-0.6 FRET conformations are 
destabilized by the presence of the extended stack between h20 and h22. Time 
traces were completely different than those in absence of S15. Dwell time 
analysis of these transient excursions yield a kclose = 2.8 ± 0.1 s
-1 and kopen = 8 ± 
1 s-1 (Figure 5.16C). These rates are the opposite of what was observed for the  
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Figure 5.19 FRET time trajectories and histograms calculated for type 3 mutant 
(C12) at different conditions. (A) FRET trajectories at 1 mM [Mg2+] (top), most of 
the time this mutant loop is in low (0.2) FRET state. There is no significant 
change in FRET state when the magnesium concentration is increased to 10 
(second) or even 20 mM (third from top). In presence of 10 nM S15 with 1 mM 
[Mg2+] (bottom), this mutant show different behaviors, most of the time traces are 
in low FRET (~0.2, open) state and frequently jumps to a higher FRET (closed) 
state. (B) FRET histograms obtained from number of events at different 
magnesium concentrations, and in presence and absence of S15. Histograms 
are built with 100 molecules at each case unless otherwise mentioned. When 
[Mg2+] is 1 mM (top) type3 mutant is in 0.2 FRET state. When the magnesium 
concentration is increased to 10 mM (second) and 20 mM (third from top) the 
distribution in the FRET histogram for type 3 mutants do not have significant 
differences on these [Mg2+] as compared to 1 mM [Mg2+]. The distribution in the 
histogram in the presence of 10 nM S15 and 1 mM magnesium  (bottom), type 3 
mutant (49 molecules) also has two distributions at ~0.2 (~94%) and ~6% at 
higher FRET states. 
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WT junction loop under the same conditions (Figure 5.16B). It is impossible to 
distinguish whether each excursion to the high FRET conformation corresponds 
to sequential protein binding events or to one S15 molecule bound for an 
extended period of time. However, the large magnitude of kclose and the high 
frequency of excursions suggest that each bound S15 makes multiple, 
unsuccessful, attempts at closing the junction indicating that the protein remains 
bound to the extended junction for long periods of time (>10 s) contrary to our 
initial expectations. This result raises the interesting possibility that the structure 
and dynamics of the S15-junction complex, and not protein binding alone, are 
important for the assembly of functional 30S ribosomes. 
5.10.3 Discussion 
Previous studies have shown that the central junction is involved in 
ribosomal protein S15 binding. S15 is a primary binding protein that is important 
for proper assembly of the 30S ribosomal subunit. In the crystal structure of 30S, 
the junction loop structure is stabilized by a base triple between nucleotides 
G654-G752-C754 and a non-canonical base-pair (reverse-Hoogsteen) between 
U652-A753 (83) (Figure 5.10). This structural arrangement allowed the 
backbone to be positioned for recognition by S15. 
A saturated mutagenesis study performed in the Cunningham lab has 
demonstrated a significant covariation and correlation of base identity with 
ribosome function between the G654:C754 WC pair. This indicates the 
importance of this interaction for ribosome function. The WC base pairing 
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between G654 and C754 twists the backbone from its standard helical position, 
becoming perpendicular to A753 and creating a localized parallel strand (272). 
This backbone conformation is recognized by S15 and this interaction is critical 
for ribosome function in vivo. On the other hand, nucleotide G752 forms a base-
triple with G654:C754 through its sugar edge (Figure 5.10B) (272, 325, 326), 
which also provides additional stabilization to the G654:C754 base-pair (325). All 
these interactions correspond with the mutational study, where loss of a 
hydrogen bond between the N2 of G752 and O6 of C754 in the single G752A 
mutant reduces protein synthesis by 29% in vivo. This also decreased the KD for 
S15 binding by 50 fold in vitro. (328). 
The reverse-Hoogsteen interaction between 652 and 753 in the crystal is 
not observed as critical as base pair for ribosome function. The reverse-
Hoogsteen interaction allows A753 to stack with 588, 654, and 655 as observed 
in crystal structure (Figure 5.10B and D) (272, 325). This positioning of 753 
contributes to the formation of the right conformation of the side B backbone, 
which is important for S15 binding. The importance of this identity and interaction 
is also observed in vitro, where A753G mutation reduced the S15 binding by 60 
fold. (328). 
It has been thought that 653 might act as a spacer (327, 329). This is 
consistent with the mutational study from the Cunningham lab that showed the 
single-site mutations at 653, all those mutants had WT and near-WT function. 
While the deletion mutant U653! was only 3% active and also had a defect on 
ribosome assembly (Figure 5.12). Interestingly, the U653! mutant was 
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previously demonstrated to have no effect on S15 binding in vitro, which is in 
contrast to its effect on assembly. It is possible that the U653! is able to bind 
S15 but is unable to fold into the structure required for full 30S assembly as was 
observed in the smFRET results for junction mutant C12. 
Previous studies have shown that the disruption of the above interactions 
by site-directed mutagenesis or any chemical modifications have a defect on S15 
binding (83, 272, 328, 334). Over-expression of S15 was revealed to restore the 
function of all 64 junction mutants to near WT. This indicates that the junction 
mutants have defects in S15 binding. This defect is also observed in a primer 
extension experiment of a selected functional mutant (J12) that demonstrated the 
decreased S15 binding affinity causing an assembly defect for 30S subunit.  
 The conformational change in the junction region after S15 binding is 
important for proper folding of the central domain into its active conformation. 
S15 binding allows h21 and h22 to coaxially stack and h20 forms an acute angle 
with h22 (83, 329). Previous studies have also characterized that a similar role of 
S15 can be played by divalent metal ion Mg2+ (329, 331).  
Mutations in the junction region affect its ability to bind S15 and to 
assemble into an active conformation. This allowed us to put forth a hypothesis 
that mutations in the junction region affect its dynamics. Ha et al. previously used 
smFRET and the labeled three-strand construct of helices h20, h21 and h22, 
respectively, to study the conformational dynamics of the WT junction in the 
presence of S15 and Mg2+ (332). In the current study, we have used a similar 
method to study the dynamics of the WT and selected mutants (Table 5.2). 
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Mutants were selected according to their function and ability to be complemented 
by S15 over-expression.  
For the WT loop, single-molecule trajectories showed that, as the 
magnesium concentration is increased, the junction shifts from an open 
conformation (~0.4 FRET state) to the closed conformation (FRET: ~0.8). The 
dynamics of molecules observed at 10 mM [Mg2+] (kclose 9 ± 1 s
-1 and kopen 1.8 ± 
0.1 s-1) is similar to 10 nM S15 plus 1 mM [Mg2+] (kclose 14 ± 1 s
-1 and kopen 1.4 ± 
0.1 s-1) (Figure 5.16A and B). These results are comparable with previous data 
that suggest the similar conformational change in junction with [Mg2+] and S15 
(329, 331, 332).  
Since S15 is a primary binding protein, the conformational change after 
binding this protein is an important for binding S6 and S18, in vitro.  For S6 and 
S18 to bind the central domain, h23b and h22 must coaxially stacked where 
h23a can interact with h22 and h20 (83). Since the binding affinities of S15 (3.5 
nM) and Mg2+ (240 !M) (332) to the junction are different, only magnesium 
binding is not sufficient to allow binding of S6 and S8 in the absence of S15. 
The type 1 mutant (J58) has 74% of WT function in vivo that increases to 
WT levels when S15 is over-expressed. This allowed comparison of the 
dynamics for this mutant to WT. But in contrast, this mutant exhibits significantly 
different behavior with Mg2+. Most of the time, molecules were in the low FRET 
state (~0.6) even in the presence of higher [Mg2+]. This FRET value is 
comparable with WT in the presence of 1 !M Mg2+. According to the crystal 
structure of the S15-rRNA complex, Mg2+ has been shown to bind to positions 
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653, 752, and 753 in the central junction (333). The U653A mutation, might 
affects the binding affinity of Mg2+, which is a cause for the instability of junction 
in the presence of Mg2+ for J58 mutant. Unlike the dynamics of J58 with Mg2+, 
presence of 10 nM S15 with 1 mM Mg2+ shifted the junction to a more closed 
state similar to WT. Most of the time, molecules are in a high (~0.8) FRET state 
(Figure 5.17) with a very few transitions to the low FRET state. This suggests 
that the binding affinity of S15 is higher for J58 than WT. The different dynamics 
for Mg2+ and S15 indicate that S15 and Mg2+ stabilize the junction by two 
separate mechanisms as suggested by previous studies (329). It is possible in 
vivo that binding of Mg2+ and S15 are both critical for junction folding as indicated 
by the loss of function in the J58 mutant. 
 The type 2 mutant has mutation in all positions in the junction region. This 
position includes the three Mg2+ binding nucleotides (653, 752. and 753) (333). In 
the smFRET experiments, most of the time J12 mutant loop is in low (~0.4) 
FRET state for all three different (1, 10, and 20 mM) [Mg2+] concentrations 
(Figure 5.18). This result indicates that the junction remained in the open 
conformation at all times. A predominant FRET state of ~0.4 was also observed 
in the presence of 10 nM S15 plus 1 mM Mg2+ with some excursions to the 
higher FRET states (~0.6 and 0.8) (Figure 5.18). This indicates that, at low S15 
concentrations, the J12 junction remains in the open conformation for most of the 
time due to a decreased affinity for S15. These smFRET results are consistent 
with the functional assays and the primer extension experiments that show 
mutant J12 has 18% function in vivo with a decrease of 30S assembly (Figure 
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5.12B). In vivo functional assays show the complementation of J12 to 83% of WT 
levels by over-expressed S15. The single-molecule study in the presence of 25 
nM S15 with 1 mM [Mg2+] showed that molecules for this mutant were in the high 
(~0.8) FRET state for most of the time. This smFRET data correlates with the 
functional study in vivo. The transition to lower FRET states suggests the lower 
level of complementation (83%) indicates the junction is prevented from 
completely closing.  
For the type 3 mutant (C12), a FRET state of 0.2 was obtained for all 
tested Mg2+ concentrations (1 mM, 10 mM, and 20 mM) (Figure 5.19). This 
predicts that h20 and h22 for this construct are in a wide-open conformation. 
Interestingly, C12 is a single G654C mutant that has the potential to base pair 
with G752. The wide-open conformation observed in the smFRET experiments 
and the ability of G654C to base pair with G752 suggests that h20 and h22 
coaxially stack instead of h21 and h22, which would prevent 30S subunit 
assembly and cause the low function in vivo (1%). In the presence of 10 nM S15 
plus 1 mM Mg2+, the junction was still in the open conformation in most of the 
times. However, unlike the experiments with Mg2+, multiple rapid transitions to 
the higher FRET (~0.6 - ~0.8) were also detected in the presence of S15 (Figure 
5.19). The calculated dynamics (kclose = 2.8 ± 0.1 s
-1, and kopen = 8 ± 1 s
-1 , Figure 
5.16C) in this condition implies that the junction failed to reach the closed 
conformation. These rates are opposite to the rates obtained for the WT under 
the same conditions. Mechanistically, S15 attempted to stabilize the junction to 
the closed conformation but was unable to do so.  
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5.10.4 Conclusions 
The saturation mutagenesis study from the Cunningham lab proposed the 
importance of junction loop for S15 binding and proper assembly of the 30S 
ribosomal subunit. Single-molecule FRET experiments performed in this study 
characterized S15 and Mg2+ induced dynamics for WT and three other selected 
mutants. Both S15 and Mg2+ stabilized a WT junction loop in a closed 
conformation with equivalent closing and opening rates observed from dwell time 
analysis. These results confirm previous data that suggested Mg2+ and S15 both 
cause a similar conformational change in the junction loop. Mutant J58 exhibits 
significantly different behavior as compared to WT in the presence of Mg2+ where 
even high magnesium concentrations did not allow this mutant to fold like S15. 
Similar effects of magnesium were observed for two other mutants J12 and C12. 
The compensatory mutant J12 did not stably form the closed conformation in the 
presence of a low concentration of S15 but an increase in S15 concentration 
resulted in the junction loop folding to the closed conformation. The third mutant 
C12 has a significant folding defect with unique dynamics. In the presence of 
S15, dwell time analysis showed that the opening rate constant was ~ 3 fold 
faster than the closing rate constant; in contrast to WT, here the closing rate 
constant is ~10 times faster than opening. These observations clearly indicate 
that junction dynamics are important for proper assembly of the 30S ribosomal 
subunit. 
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5.10.5 Materials and methods 
[Kris Ann Baker performed the genetic and primer extension studies in Dr. 
Cunningham’s lab. Kris has written and submitted this work as a dissertation 
submitted in 2008 (286).] 
5.10.5.1 Cloning, expression and purification of E. coli S15 (EcS15) 
An expression vector pET15B-EcS15 was constructed by using PCR 
product from E. coli rpsO (encodes for rprotein S15) from a DH5 genomic prep. 
Primers 5p pET15-EcS15 (5’ – AGG AGA TAT ACC ATG GGC AGC AGC CAT 
CAT CAT CAT CAT CAC AGC AGC GGC ATG TCT CTA AGT ACT GAA GC – 
3’) and 3p pET15-EcS15 (5’ – TTA GCA GCC GGA TCC TCG AGT TAG CGA 
CGC AGA CCC AGG CGC TCG ATG A – 3’) were used to do PCR. The product 
was cloned into pET15b (335, 336) using NcoI and XhoI placing EcS15 with a N-
terminus 6X-histidine tag behind a T7 promoter then transformed into 
BL21(DE3)pLysS (F-,dcm, ompT, hsdS(rB
-mB
-), gal, !(DE3), [pLysS CamR] (337) 
for protein over-expression. A colony of pET15B-EcS15 in BL21(DE3)pLysS was 
used to inoculate a 3 mL LB-Amp100 + Cm50 (50 µg/mL of chloramphenicol for 
pLysS) culture that was incubated overnight at 37ºC. The culture was diluted 
1:500 into four flasks of 500 mL of LB-Amp100 + Cm50 and grown at 30ºC until 
OD600 reaches 0.4 to 0.6. Protein expression was induced by adding IPTG to a 
final concentration of 1 mM to the culture then allowing the culture to be grown 
for an additional 16-18 hrs at 30ºC. The cells were pelleted at 6000 X g, 
resuspended in 30 mL of 1X K-eq/wash buffer (50 mM potassium phosphate and 
300 mM KCl, pH7) total, and lysed using a French Press. After lysis, ribosomes 
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were precipitated out of the lysate using standard methods (338) to remove the 
possibility of pulling down other rproteins along with the EcS15. After removal of 
ribosomes, EcS15 was purified by immobilized metal affinity chromatography 
using Profinity IMAC Resin (BioRad) charged with Ni2+ and potassium buffers 
(elution buffer contained 1 M potassium chloride). After purification, EcS15 
protein was concentrated and the imidazole removed by filtering protein column 
fractions through an Amicon Ultra15 filter (MW: 5kD) and washing with K-1M 
buffer (50 mM potassium phosphate and 1 M KCl, pH7). 
5.10.5.2 FRET gel shift assays  
15% non-denaturing polyacrylamide (29:1acrylamide: bisacrylamide ratio) 
gel electrophoresis was performed in 20 mM NaOAc (sodium acetate) and 10 
mM sodium phosphate (pH 7.2) using low-fluorescence glass plates, as 
described (110). 10 pmol doubly labeled RNA samples were used to load on gel 
in combination with other RNA as mentioned in Figure 5.14. For S15 binding 
experiments, 10 pmole junction RNA (WT or mutants) was allowed to equilibrate 
with 20 pmol S15 for 5 minutes prior to loading on gel. The acrylamide gel was 
equilibrated for 15 minutes at room temperature before loading samples.  
Samples were loaded on the gel, and constant electric field of 6 V/min was 
applied immediately. After electrophoresis at 4 °C, the gel was scanned with in 
glass plate in a Typhoon Imager by exciting the donor with a 532 nm laser. The 
fluorescence emission of the donor (Cy3) and acceptor (Cy5) were analyzed with 
Fluorsep program (Amershan Bioscience).  
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5.10.5.3 RNA purification and labeling 
All RNA oligonucleotides with 2’-OH protection groups were purchased 
from Keck Foundation Biotechnology Resource Laboratory at Yale University 
School of Medicine (New Haven, CT), purified and labeled as described in 
Chapter 2. At the time of RNA synthesis, 3’-biotin was incorporated in RNA 
strand 2 (RNA-2) (Figure 5.13A) in order to immobilize RNA on a glass surface 
during single-molecule experiments. A 1 !M solution of the central junction was 
produced by combining the three RNA strands, RNA1:RNA2:RNA3 (Figure 
5.13), in the ratio of 1:2:10 (by concentration) in annealing buffer (10 mM 
NaH2PO4 (pH 7.2) and 20 mM NaCl). The mixture was heated to 90°C for 45 
seconds and allowed to cool down to room temperature. A 15% non-denaturing 
acrylamide gel electrophoresis was used to monitor the formation of the junction 
as previously described (170). 
5.10.5.4 Steady-state FRET 
Steady-state FRET measurements of doubly labeled Junction samples 
were carried out in a spectrofluorometer as described in Chapter 2. A 25 nM 
junction sample in standard buffer (10 mM NaH2PO4, pH 7.2 and 20 mM NaCl) 
was excited and fluorescence was measured in the absence and presence of 
protein S15. Relative FRET efficiencies were calculated by using Equation 2.5.  
5.10.5.5 Single-molecule experiments 
The biotinylated junction construct was immobilized on a PEG passivated 
quartz slide via a biotin-streptavidin interaction and smFRET experiments were 
done in buffer A (50 mM MOPS, pH 7.2, 100 mM potassium chloride, 2 mM 
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Trolox) as described in Chapter 2. For S15 experiments, buffer A containing 1 
mM MgCl2 was used. After detection by total internal reflection fluorescence 
microscopy, data processing and analysis were done as described in Chapter 2. 
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CHAPTER 6  
Kinetic analysis of an RNA kissing interaction and effect of Hfq 
on its resolution into an extended duplex 
6.1 Introduction 
Recently, many RNAs have been discovered that have a role in genetic 
regulation (339, 340). In eukaryotic cells, small interfering and micro RNAs can 
control gene expression where as small non-coding RNA (ncRNA) and 
riboswitches control gene expression in prokaryotic cells (341-343). Genetic 
regulation may occur either co-transcriptionally or post-transcriptionally 
depending on the cell type. Bacterial ncRNA can control post-transcriptional gene 
regulation by recognizing another RNA through RNA-RNA interactions. The loop-
loop contacts between two RNA hairpins are dominant regulatory mechanisms in 
bacterial and viral systems. Frequently, loop-loop interactions act as an initial 
recognition signal between two RNA molecules. In some cases, RNA-RNA 
interactions are sufficient to control the regulatory mechanism but in most cases 
RNA binding proteins are required. For example during the bacterial cold shock 
response, a loop-loop contact between a ncRNA (DsrA) and its mRNA partner 
(rpoS) initially triggers the initial recognition between two RNA partners. With the 
help of the protein cofactor Hfq, a strand displacement reaction takes place to 
form an intermolecular base pairing between DsrA and rpoS sequences to form 
an extended duplex (60, 344). In general, RNA hairpins loop-loop interaction can 
generate more or less stable structure by base pairing with complementary 
sequences, known as kissing interactions. 
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6.2 RNA kissing interaction 
Diverse biological functions are modulated by RNA intermolecular 
interactions and kissing interactions can be the initiation signal for interaction. 
RNA kissing interactions, which vary in stability, consist of Watson-Crick base-
pairing between nucleotides in the loop of two hairpins (345). The stability of 
kissing interactions depends on several factors including, loop complementarity, 
internal loop structure, the loop closing base pairs and the sequence of the stems 
adjacent to the loops and the number of nucleotides in the loop(s) region (277, 
280, 281, 346, 347). A classical example of kissing interactions is the RNA loop-
loop interaction in the packaging of the HIV genome into capsids. In this process 
the dimerization initiation sequence (DIS) forms a transient kissing intermediate 
and resolves it into an extended duplex (348-351). The extended duplex is 
thermodynamically stable that might form through several possible pathways as 
shown in Figure 6.1. At low temperature, the initiation of strand displacement 
reaction takes place either through the formation of 3’/5’ zipper intermediate 
(path A) or through the formation of a kissing intermediate (path B). However, at 
elevated temperatures or in the presence of enzymes (helicases), the hairpins 
may unfold completely and then anneal to the complementary strand (path C) 
(347, 352). Despite their importance in biology, the kinetic and thermodynamic 
stabilities of kissing interactions have not been explored in detail.  
6.3 DsrA and rpoS as a model system to study loop-loop interaction  
Post-transcriptional regulation of rpoS is an example of genetic regulation 
by ncRNA. The rpoS mRNA gene encodes the !S transcription factor that is 
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involved in the bacterial stress response (353, 354). Previous studies have 
suggested that the expression of rpoS is activated by the ncRNA DsrA (87 nt 
ncRNA from E. coli). The 5’-UTR of rpoS mRNA forms a stem loop that inhibits 
the Shine-Dalgarno ribosome binding site and prevents translation at the 3’ end 
of rpoS. DsrA rescues translation by binding and disrupting stem-loop to free the 
Shine-Dalgarno sequence (60, 355). This process requires the protein cofactor 
Hfq that increases the rate of DsrA binding to the rpoS and facilitates the 
formation of DsrA/rpoS extended duplex (Figure 6.2A) (356). 
 
Figure 6.1 Possible pathways for a strand displacement reaction. Strand 
displacement can be nucleated either by zipping 3’/5’ (A) or by formation of 
kissing intermediate (B). At higher temperature and in the presence of helicases, 
two complementary strands might be annealed directly (C) (347). 
6.4 Hfq 
In the cell, the RNA binding protein Hfq helps to convert kissing complexes 
to extended duplexes. Hfq was originally discovered in E. coli as a host factor for 
Q-! bacteriophage that has sequence and structural homology with archeal and 
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eukaryotic Sm and Lsm proteins (59, 356, 357). Further experiments showed that 
Hfq play a role in post-transcriptional gene regulation in which it helps small 
ncRNAs to identify their target mRNA (60-62). During stress response, Hfq binds 
both the ncRNA and its target mRNA simultaneously and forms a stable ternary 
complex in which the complementary sequences of the two RNAs anneal and 
expose the mRNA coding sequence for translation (62, 358, 359). Hfq acts as a 
chaperone and promotes the intermolecular base pairing between DsrA and rpoS 
(359). However, the exact mechanism by which Hfq promotes DsrA and rpoS 
interaction and gene regulation is not yet understood. Besides translational 
activation of DsrA and rpoS system, Hfq also functions as a transcriptional 
repressor of the hns mRNA at low temperature (358). Previous studies have 
shown that Hfq is also involved in mRNA and protein degradation (358, 360, 
361).  
  
Figure 6.2 Translational activation of rpoS gene by DsrA and Hfq. (A) Secondary 
structures of DsrA and rpoS. Basepairing sequences are represented in green. In 
the absence of DsrA, rpoS self inihibit the translation by the formation of stem-
loop that block the SD sequence for ribosome binding. In the presence of DsrA 
and Hfq the SD is free to bind ribosome which signify the gene is turned on. 
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Structural studies of Hfq have revealed a doughnut-shaped homo-
hexameric ring with a ~70 Å diameter and a 12 Å central cavity in the absence of 
RNA (21, 58, 59). The crystal structure of S. aureus Hfq with a short RNA (5’- 
AU5G-3’) revealed that the RNA bind around the basic central pore as shown in 
Figure 1.4B (21). Mutational studies showed that Hfq has two independent RNA 
binding sites on the two flat surfaces of the hexamer (58, 358). The proximal and 
distal ends, which specifically recognize the two different RNAs independently. 
This is further characterized by a crystal structure of E. coli Hfq bound with 
poly(A) tail (53). Now it is clear that the proximal surface of Hfq binds ncRNA 
(AU5G sequence elements) whereas the distal end preferentially binds poly(A) 
sequences (53, 358).  
In this study, I have characterized the kinetics of the kissing interaction of 
RNA hairpins as a model system from DsrA and its partner rpoS mRNA and the 
effect of Hfq on the strand displacement reaction.  
6.5 Results 
6.5.1 RNA hairpin design 
To characterize the energetic and dynamic behavior of the kissing 
complex and its progression into the strand displacement reaction, RNA hairpins 
were designed according to the DsrA and rpoS hairpin sequence with some 
modifications Table 6.1. The modifications allowed this reaction to proceed from 
hairpin to kissing complex and finally to strand displacement. We can also force 
the reaction to stop at the point of kissing interaction. The thermodynamic 
behavior of these hairpins has been characterized by Isothermal Titration 
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Calorimetry (ITC) and UV-melting experiments in a protein free environment. In 
the first part of my experiment, I have used these hairpins to study the kinetic 
behavior of kissing interactions and its resolution into an extended duplex by 
using smFRET. In the second part, I have characterized the effect of the RNA 
binding protein Hfq on the kinetics and energetic of these reactions. These 
hairpins are designed to exhibit a low FRET state in dissociated state, 
intermediate FRET state in the kissing complex and high FRET state in the 
extended duplex (ED) form. 
Table 6.1 List of hairpin sequences 
Name Sequence (5’-3’)a Labeling 
HP1 (BP) ACGAGGCAUUUCCCCUUGU 5’ Cy5 
HP2 AUAACAAGGGGAAAUGCCUUGU 5’ Biotin, 3’ Cy3 
HP3 ACGAUCAGCAUUUCCCUGAUGU 5’ Cy5 
HP3:C1!,C7! ACGAUCAGAUUUCCUGAUGU 5’ Cy5 
HP1:Hfq ACGAGGCAUUUCCCCUUGUAACGAAUUUUUUA 5’ Cy5 
HP2-R  ACAAGGGGAAAUGCCUUGUAUA 5’ Cy3, 3’ Biotin 
HP1-R  ACGAGGCAUUUCCCCUUGdT 5’ Cy5 
HHP1-R  ACGAGGCAUUUCCCCUUGdTCGAAUUUUUUA  5’ Cy5 
a The loop nucleotides are underlined. 
 
HP1 and HP2 are two parent hairpins, which have complementary 
sequences in both loop and stem regions that can form a kissing complex and 
can be resolved into an extended duplex. HP3 was derived from HP1 can only 
form a KC but not able form ED with HP2 because of noncomplementary stem 
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regions. The mutant HP3:C1!,C7! was generated by deleting 1, and 7 
nucleotides from HP3 loop region (Figure 6.3A). The Hfq binding sequence 
AACGAAUUUUUUA was added at the 3’ end of HP1 hairpin to make HP1:Hfq. 
Thermal melting experiment suggest that these hairpins don’t form dimers in 
solution (347).  
6.5.2 Thermodynamic analysis of KI and ED formation  
[This experiment was performed in Prof. Andrew Feig’s Lab (347).] 
Isothermal titration calorimetry (ITC) was used to measure the 
thermodynamic parameters of KI and ED formation. This is a very sensitive 
technique than thermal melting because ITC relies on heat of binding rather than 
hyperchromocity (362). The measured !G°37 for the formation of seven base pair 
kissing interactions between HP2 and HP3 is -8.4 kcal/mol and is stabilized by 1 
kcal/mol in the presence of 10 mM Mg2+. The substitution of a G•C base pair or 
deletion of two bases that form a five base pair interaction (HP3:C1!,C7! ) at the 
end of kissing complex abolish the formation of KC. This suggests that the 
stability of the kissing interaction depends on the G•C base pairs at either ends 
of the kissing complex. The thermodynamic parameters for HP1 and HP2 
interactions are quite different than those for the kissing complex suggesting that 
the formation of ED takes place rapidly under the experimental conditions. The 
potential energy diagram presented in this study indicates an 8 kcal/mol energy 
barrier for the formation of KC from a free hairpins and an 18 kcal/mol barrier for 
dissociation. These experiments also suggest that the kissing interaction is not a 
necessary intermediate state for the strand displacement reaction. 
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Figure 6.3 Schematic representation of single-molecule study. (A) The RNA 
hairpins and positions of fluorophore labeling used in this study. Loop sequences 
are labeled for clarity. (B) Schematic representation of total internal reflection 
setup used in this study. A kissing interaction and extended duplex formation are 
shown in the presence of 35 nM RNA hairpin with acceptor fluorophore. 
6.5.3 Single-molecule study of kissing hairpins 
Single-molecule FRET experiments were used to observe the 
conformational dynamics of the kissing complex and its resolution into an 
extended duplex. For this experiment HP2 was labeled with a FRET donor (Cy3) 
and HP1 or its derivatives with a FRET acceptor (Cy5) (Table 6.1 and Figure 
6.3A). The Cy3 labeled RNA hairpin was immobilized on a quartz slide surface 
with biotin and streptavidin interaction and the fluorescence signals from 
fluorophores were monitored from using a CCD camera, as described (Method 
section) (Figure 6.3B). In the absence of acceptor, the histogram of more than 
100 donor only hairpin (HP2) molecules has a peak near 0 FRET, which means 
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there is no energy transfer from donor fluorophore (Figure 6.4A). Control 
experiments on pre-annealing of HP2 with HP1 (1:2 ratio) yielded predominantly 
an ED complex with a FRET state of 1.0 whereas similar annealing with a control 
RNA (HP3:C1!,C7!) that was labeled but non-complementary yielded a FRET 
ratio near zero (Figure 6.4B and C).  
 
Figure 6.4 FRET histograms calculated for more than 100 single-molecule 
trajectories from control experiments with schematic representation of RNA 
hairpins and extended duplex formation. (A) A donor only RNA hairpin HP2 
exhibits a single FRET state at 0.0. (B) Pre-annealed non-complementary 
hairpins (HP3: C1!, C7!) and HP2 do not form the ED. (C) Two pre-annealed 
complimentary RNA hairpins (HP1 + HP2) show two distributions (0.0 and 1.0 
FRET states) after imaging.  
 
In order to observe an intermediate states in the strand displacement 
reaction, HP2 was immobilized on the slide and 35 nM HP1 was added so that 
binding follows pseudo-first-order reaction kinetics. A typical single-molecule time 
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trajectory (Figure 6.5B) in the given condition (50 mM tris, pH 7.5 and 10 mM 
Mg2+) showed that the fluorescence intensity of the donor and acceptor 
fluorophores jumps stochastically between two states in an anti-correlated 
fashion. The resulting FRET trajectory shows that the jumps correspond to two 
distinct ~0.0 and ~0.5 FRET states. These two states are assigned to donor only 
(HP2) and HP1:HP2 kissing interaction, respectively.  
 
Figure 6.5 Single-molecule study of HP1::HP2 Hairpins. (A) The representation 
of hairpins, kissing interaction and extended duplex formation. (B) Typical single-
molecule time trajectory. The upper panel shows the anti-correlated intensities of 
the donor (blue) and acceptor (red). The second panel shows the corresponding 
FRET trajectory. The third (transition from hairpins) and fourth panels (transition 
from KI) show the FRET trajectories in extended duplex. (C) Cumulative 
histogram showing three distributions at 0.0, 0.5 and 1.0 FRET states. 0.0 FRET 
state is free HP2, 0.5 FRET state represents the kissing complex and 1.0 FRET 
state corresponds to the extended duplex.  
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These kissing complexes can persist for a long time and they can 
associate or dissociate many times before they proceed to extended duplex 
Extended duplex formation is characterized by higher FRET (1.0) values where 
the maximum energy is transferred from donor to acceptor due to the close 
proximity of fluorophores. Under our experimental conditions, a very few (1-2%) 
transitions from KI to ED were observed (Figure 6.5B and C). Once formed, the 
ED state remains effectively trapped and dissociation back to hairpins was not 
observed. The transitions of molecules directly from free hairpins to ED duplex 
were also observed (Figure 6.5B).  
6.5.4 Kinetic analysis of kissing interaction 
Dwell time analysis was performed from more than 100 single-molecule 
traces in order to calculate the rates of each state. From the dwell times in each 
FRET state, the dwell time distributions were calculated to estimate the rates of 
association and dissociation kon and koff (Figure 6.6). The distributions were fit to 
single exponential decays to yield kon = 0.12 ± 0.01 s
-1 and koff = 0.17 ± 0.02 s
-1. 
The kissing free energy calculated from these rates (!G˚22 = -9.9 ± 0.2 kcal/mol) 
agrees well with the ensemble-averaged ITC data from Prof. Feig’s lab and that 
calculated from the FRET distribution histograms (Figure 6.5C) (347). This result 
also shows that the immobilization approach used through this experiment does 
not affect the dynamic behavior of the kissing hairpins.  
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Figure 6.6 Dwell time distributions for the dissociated (A) and kissing (B) states 
from single-molecule trajectories for HP1 and HP2 hairpins. Each distribution 
was fit to a single-exponential decay to yield the pseudo-first order rate constants 
kon and koff. 
6.5.5 RNA hairpin with Hfq binding site  
In order to characterize the Hfq mediated extended duplex formation, the 
RNA hairpin HP1:Hfq was designed with the Hfq binding sequence 
AACGAAUUUUUUA at the 3’ end of the hairpin HP1 (Table 6.1). This RNA 
hairpin was fluorophore labeled with acceptor (Cy5) and was subjected to 
smFRET experiments with Cy3 labeled RNA hairpin HP2. The first experiment 
was performed in the absence of Hfq to characterize the effect of a long tail at 
the 3’ end on kissing kinetics at different salt conditions. A protein free single-
molecule study at 50 mM tris, pH 7.5 and 10 mM Mg2+ revealed very similar 
kinetic behavior (kon = 0.2 ± 0.01 s
-1 and koff = 0.08 ± 0.01 s
-1) to the hairpins 
without the long tail (Figure 6.7A). Experiments with additional 50 mM NaCl  
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Figure 6.7 Dwell time distributions and histograms for HP1:Hfq and HP2 hairpins 
at different conditions. (A) At 50 mM Tris, pH 7.5 and 10 mM Mg2+. (B) At 50 mM 
Tris (pH 7.5), 10 mM Mg2+ and 50 mM NaCl. (C) At 50 mM Tris (pH 7.5), 10 mM 
Mg2+ and 100 mM NaCl. In each histogram, very few extended duplex molecules 
are not included. 
(kon = 0.25 ± 0.01 s
-1 and koff = 0.15 ± 0.01 s
-1) and 100 mM NaCl (kon = 0.16 ± 
0.02 s-1 and koff = 0.10 ± 0.01 s
-1) did not show significantly different kon (0.12 ± 
0.01 s-1) and koff (0.17 ± 0.02 s
-1). This result shows that the long Hfq binding tail 
at the 3’ end of RNA hairpin and increased sodium concentration have no 
significant effect on the dynamics of kissing interaction.  The histograms of more 
than 100 molecules in each condition have clear 2 distributions near 0.0 and 0.4 
FRET states (Figure 6.7). The observed FRET state at 0.4 is assigned as a 
kissing complex, which is 0.1 lower than that of HP1:HP2 (Figure 6.5C). These 
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control experiments are important for further experiments with Hfq because this 
protein is stable only at high NaCl (100 mM) concentrations. 
6.5.6 Hfq promotes extended duplex formation 
Single-molecule experiments were performed in the presence of Hfq at 50 
mM Tris (pH 7.5), 10 mM Mg2+ and 100 mM NaCl. Binding of Hfq to RNA hairpins 
was monitored by native gel electrophoresis. In the smFRET experiment, first 
HP2 was immobilized on a PEG-passivated quartz slide and 35 nM HP1:Hfq 
hairpin was flushed in a slide. After acquiring some data, pre-mixed HP1:Hfq (35 
nM) with different Hfq concentrations were injected while recording. This 
maintained pseudo-first-order reaction kinetics. The number of molecules was 
counted in the KC and ED states in each Hfq concentrations.  
In the presence of 1 nM Hfq (hexamer), the fraction of molecules in the 
high FRET (~1.0) state increases to 18% as compared to ~3% in the absence of 
Hfq. At this point we speculated that the increase in the number of high FRET 
molecules are due to the formation of extended duplex that is promoted by Hfq. 
When the protein concentrations were increased, the numbers of molecules in 
high FRET state increased and the numbers of molecules in low FRET state 
(0.0) decreased (Figure 6.8A). These experiments were repeated in the 
presence of different protein concentrations and the numbers of molecules in 1.0 
FRET state were counted. As shown in Figure 6.8B, increasing the protein 
concentration increases the number of molecules in the 1.0 FRET state, which is 
98% at 30 nM Hfq. The percentage of molecules in an ED were plotted as a 
function of Hfq concentrations and fitted with a binding equation to obtain a 
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binding constant (KD = 11 ± 4 nM, hexamer). The number of molecules in the 
extended duplex state was stable through out the experimental time of ~ 1 hour. 
These data show that Hfq helps to form intermolecular base pairing, but does not 
help to dissociate the duplex in to free hairpins. In this experiment, none of the 
transitions were observed from KI to ED. This might be because either the 
transition is faster than our time resolution (33 ms) or the kissing intermediate 
may not an obligatory intermediate state. To further study the effect of 
fluorophore positions and immobilization on Hfq binding, RNA hairpins were 
designed by flipping the positions of fluorophore and biotin as mentioned in 
Table 6.1. Preliminary experiments in a protein free environment were similar to 
the described experiments. 
 
Figure 6.8 Hfq promoted strand displacement reaction. (a) Single-molecule 
FRET histogram obtained in the presence of 25 nM Hfq hexamer. Three distinct 
peaks are observed that belongs to dissociated hairpins (0 state), kissing 
complex (0.4 state) and extended duplex (1.0 state). The peak height at 1.0 
FRET state represents more molecules are in the extended duplex. (B) Hfq 
binding curve calculated from a number of molecules in ED as a function of Hfq 
concentration. Increase in protein concentration increased the number of duplex 
molecules.  
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6.6 Discussion 
Despite their importance in biology, RNA kissing interactions have not been 
well characterized (345, 363). HIV-DIS is one of the most-studied kissing 
complex and thermal scanning of the transition temperature has shown that the 
stability of the kissing complex depends on the closing base pair of the stem and 
sequence identities (348, 351, 364, 365). The molecular dynamics of the 
formation of kissing hairpins have not been resolved in detail. This study has 
successfully used a single-molecule technique to characterize the dynamics of 
the formation of kissing complex for designed RNA hairpins. The thermodynamic 
and kinetic parameters obtained from the single-molecule study were validated 
with the ITC and SPR data for the same hairpins (347). 
Single-molecule study of RNA hairpins showed a single representative 
intermediate FRET state near 0.5. This suggests that there might be only one 
rearrangement step of strand displacement. This finding is surprising as the 
study of HIV-DIS strand displacement proposed that the rearrangement of KC is 
actually a two-step process. The first step involves the formation of loop-loop 
helical structure and in the second step; three helical elements coaxially stack to 
form a final stable structure (366, 367). The single one kissing species observed 
in this study might be due to our inability to capture a fast second step or lack of 
significant FRET change between two conformations with the current fluorophore 
positions. From this study it has been resolved that the kinetics of kissing 
interaction are quite stable for approximately ~ 6 s at room temperature. When 
the loop size is decreased to 5 nucleotides, not even transient kissing 
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interactions are observed. This information is supported by the thermodynamic 
data from ITC experiment (347).  
The nature of single-molecule FRET trajectories implies that the kissing 
interaction can be made and broken several times before hairpins dissociate or 
resolve into an extended duplex at room temperature. The rarity of extended 
duplex formation throughout this experiment suggests that there is a huge energy 
barrier between the KC and the ED. The two different types of ED FRET 
trajectories in Figure 6.3B show that ED can form either directly from free 
hairpins or they can resolve slowly form kissing intermediate. In the former case, 
the kissing interaction might exist for a very short time, which is not possible to 
capture into our time frame (33 ms). Since the progression of kissing interaction 
to the extended duplex is very rare, they are not enough to measure the kinetic 
parameters at room temperature. However, previous experiment from 
temperature jump (T-jump) study have calculated that nearly 25 % of molecules 
refold into the extended duplex from KC at 67°C. Even though this number is 
lower than KC dissociation (62 %) but have a clear picture of temperature effect 
on ED formation (368). The refolding temperature (54°C) is higher than the 
dissociation temperature (47°C), also suggesting that the activation barrier for ED 
is higher than the dissociation of KC into the free hairpins. This might correlate to 
the number of hydrogen bonds broken and formed during the formation of 
extended duplex than dissociation (368).  
In vivo, RNA binding proteins help to convert kissing complexes to an 
extended duplex. A nucleopsid protein NCp7 is a well-characterized chaperone 
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that facilitates the formation of intermolecular base pairing in DIS system (365, 
367, 369, 370). However, Hfq is involved in many systems to facilitate the binding 
of ncRNA and their targets (62, 371). It has been proposed that under normal 
conditions in the cell, Hfq is not necessary when two RNAs can form a stable 
complex by themselves (372). Hfq facilitates the forward progression of ED 
formation by lowering the high-energy barrier between the KC and ED. Our 
experimental data showed that Hfq binds with model RNA hairpins and helps to 
resolve them into an extended duplex. Hfq accelerated the association of two 
hairpins and its chaperone activity helps to anneal them to form an intermolecular 
base pairing. These results are consistent with previous studies on DsrA and 
rpoS systems (356, 359). When Hfq concentration is low (1 nM, hexamer) 18% of 
molecules were in ED with few molecules in kissing complex. When Hfq 
concentration was increased, the number of molecules in extended duplex 
increased and reached up to 98% at 30 nM Hfq. These suggest that Hfq 
promotes the kissing complex to refold into an extended duplex. After analyzing 
many molecules, we never observed a transition of molecules from kissing 
complex to the ED. This data indicate that the kissing complex may not an 
obligatory intermediate for strand displacement reaction. This is also supported 
by our thermodynamic data (347). The decreased in number of kissing 
intermediate might due to the decrease in background RNA concentration after 
the formation of many extended duplexes. Out of nearly 500 analyzed molecules, 
no molecules in the ED state dissociated back to free hairpins within time frame 
of more than one hour. This is in contrast with previous finding in which Hfq helps 
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to break the intermolecular base pairing between DsrA and rpoS (359). After the 
formation of base pairing between two RNA, Hfq might dissociate from a complex 
leaving stable RNA-RNA interactions as proposed earlier (58, 356, 359, 372). 
This cannot be addressed using fluorophores labeled on the RNA hairpins and 
unlabeled protein. We can clearly observe the formation of extended duplex from 
our construct but we cannot observe whether Hfq leaves or stay intact with the 
RNA-complex. On-going experiments with fluorophore labeled Hfq might address 
this issue where the decrease in fluorophore signal correlates the dissociation of 
Hfq from a protein-RNA ternary complex.  
6.7 Conclusions 
Small ncRNAs regulate gene expression in response to biological stimuli 
through a mechanism that relies on RNA-RNA interactions. When loop 
sequences are complimentary, they form a kissing intermediate that rearranges 
to a stable structure. Single-molecule study of RNA hairpins revealed that the 
kissing interaction forms readily, but strand displacement and extended duplex 
formation is rare. Formation of extended duplex may be inefficient due to a 
higher energy barrier between the extended duplex and the kissing intermediate. 
In the cell, RNA binding proteins often help to overcome high-energy barriers to 
facilitate the formation of functional structures. Our data suggest that Hfq acts as 
a chaperone to facilitate the progression of strand displacement and extended 
duplex formation, thereby preventing the dissociation of free hairpins. 
  
182 
6.8 Materials and methods 
6.8.1 Preparation of RNA hairpins 
RNA hairpins were designed as described before. The designed RNA 
hairpins were purchased with 2’-OH protection groups from Dharmacon RNA 
Technologies and Keck Foundation Biotechnology Resource Laboratory at Yale 
University School of Medicine, purified according to the manufactures protocol 
and labeled as described in Chapter 2. 
6.8.2 Hfq expression and purification 
Hfq protein was expressed and purified in Prof. Feig’s lab according to 
previously described protocol (58). In brief, expression of a C-terminal His6-tag 
wild-type Hfq was induced by 1 mM IPTG at A600 = 0.4 for 4 hours at 37 °C. The 
cell pellets were resuspended in 25 ml lysis buffer (50 mM HEPES, pH 7.5, 500 
mM NH4Cl, 20 mM imidazole, 5% (w/v) glycerol) with EDTA-free Complete 
protease inhibitor cocktail (Stratagene) and lysed by ultrasonication. Cell lysate 
was treated with DNase I (100 U) and RNAse A (100 g) and incubated on ice for 
1 h. After centrifugation, Hfq was purified by Co2+-affinity chromatography. A Hi-
trap metal chelation column (Amersham-Pharmacia) was prepared and 
preloaded with CoSO4. Cell lysate was passed through the column and was 
washed with five volumes of lysis buffer followed by five volumes of wash buffer 
1 (50 mM HEPES, pH 7.5,1 M NH4Cl, 5% (w/v) glycerol). Hfq was eluted with five 
volumes of elution buffer 1 (50 mM HEPES, pH 7.5, 500 mM NH4Cl, 250 mM 
imidazole, 5% (w/v) glycerol) followed by five volumes of elution buffer 2 (50 mM 
HEPES, pH 7.5, 8 M urea, 1 M NH4Cl, 50 mM EDTA, 5% (w/v) glycerol). The 
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pure fraction was monitored by SDS-PAGE, concentrated and dialyzed against 
storage buffer (50 mM HEPES, pH 7.5, 250 mM NH4Cl, 1 mM EDTA, 10% (w/v) 
glycerol). Warburg-Christian method was used to measure the concentration of 
Hfq (373). The proper folding of Hfq was monitored by spectrometer and by 
dynamic light scattering and stored in storage buffer. 
6.8.3 FRET gel shift assays 
15% non-denaturing polyacrylamide (29:1acrylamide: bisacrylamide ratio) 
gel electrophoresis was performed in 50 mM sodium acetate (NaOAc), 10 mM 
magnesium acetate and 50 mM Tris (pH 7.5) using low-fluorescence glass 
plates, as described previously (110). 10 pmol Cy3 labeled HP2 was allowed to 
equilibrate with different combinations of Cy5 labeled HP1:Hfq RNA hairpin and 
Hfq at room temperature for 5 minutes. Samples were loaded on preequilibrated 
gel, and constant electric field of 6 V/min was applied immediately. After 
electrophoresis at 4 °C, the gel was scanned with in glass plate in a Typhoon 
Imager by exciting the donor with a 532 nm laser. The fluorescence emission of 
the donor (Cy3) and acceptor (Cy5) were analyzed with Fluorsep program 
(Amershan Bioscience).  
6.8.4 Single-molecule experiments 
The biotinylated HP2 (10 pM) was immobilized on a quartz slide (PEG 
passivated for Hfq experiments) via a biotin-streptavidin interaction and smFRET 
experiments were done in different buffer conditions in presence of 2 mM Trolox 
as described in Chapter 2. The single-molecule experiments were carried out in 
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large excess (35 nM) of the acceptor hairpin such that the association step can 
be assumed to follow pseudo-first-order reaction kinetics, which greatly simplifies 
the data analysis and allows dissection of the reaction mechanism. All the 
experiments were performed at room temperature. After detection by total 
internal reflection fluorescence microscopy, data processing and analysis were 
done as described in Chapter 2. 
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CHAPTER 7  
Conclusions and future directions 
RNA molecules can adopt different secondary and tertiary structures 
creating a platform for interactions with a wide variety of ligands. These 
secondary structures are recognized by various proteins to form protein-RNA 
complexes (10). These protein-RNA complexes have a wide variety of structural, 
catalytic and regulatory roles from transcription to pre-mRNA processing, nuclear 
export, transport and localization (2-4). For example, during posttranscriptional 
regulation of gene expression, RNA interacts directly with proteins to form 
ribonucleoprotein particles (RNPs) (5) that are important for recognition and 
function of the RNA molecule (6). Since there are many RNAs and a very large 
number of RNA-binding proteins, the biogenesis of RNPs must be performed 
with high fidelity. Incorrect formation of RNP complexes or aberrant expression of 
RNA binding proteins can cause genetic disorders that may lead to diseases (7, 
8). Therefore, understanding the molecular mechanism of protein-RNA 
interactions and their applications to function is an important focus of structural 
and biological research (9). Despite their functional importance in biology, the 
actual mechanisms of protein-RNA interactions have yet to be fully understood. 
Several biophysical methods have been used to characterize protein-RNA 
interactions such as X-ray crystallography, cryo-EM, NMR, computational 
modeling and so on. The development of single-molecule techniques has been 
monumental in understanding the structural and dynamic behavior of protein-
RNA complexes at the molecular level.  In this work, several types of protein-
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RNA interactions were studied by using Fluorescence Resonance Energy 
Transfer (FRET) in combination with Single-molecule FRET (smFRET). All of 
these studied protein-RNA interactions have different biological applications from 
gene splicing to RNA biogenesis and gene expression. 
7.1 Splicing regulation through RNA looping  
Alternative splicing (AS) plays an important role in generating different 
protein isoforms from a single pre-mRNA. This is a highly regulated biological 
phenomenon involving many small RNAs and proteins. Misregulation of AS has 
been linked to several diseases from neurological disorders to cancers (8). There 
are several factors involved in the direct or indirect regulation of alternative 
splicing. These factors can be either splicing enhancers or suppressors 
depending on how they interact with cis-acting elements on pre-mRNA. Several 
models have been proposed to explain how alternative splicing factors control 
this complex mechanism in the cell; however, most of these proposed models 
were built from biochemical studies and lack details of the structural and dynamic 
behaviors of these macromolecular assemblies. 
The polypyrimidine tract binding protein (PTB) is a splicing regulator that 
binds to CU-rich elements in pre-mRNA and represses N1 expression in non-
neuronal cells as observed in c-src pre-mRNA. A structural model proposed that 
domains 3 and 4 of PTB induce RNA looping after binding two polypyrimidine 
tracts within the same pre-mRNA. Fox-1 protein is an important tissue-specific 
splicing enhancer that binds to intronic enhancers to regulate alternative splicing. 
This small protein, with only one RNA recognition motif (RRM), binds specifically 
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to UGCAUGU RNA sequences in pre-mRNAs (200). It has been proposed that 
Fox-1 binds the UGCAUGU element in the c-src gene downstream of the N1 
exon and activates exon inclusion (203), creating an antagonistic effect between 
Fox-1 and PTB to regulate alternative splicing of the N1 exon in neuronal cells. 
The mechanism by which PTB and Fox-1 controls regulation of the N1 exon is 
elusive and remains poorly understood. NMR studies of these proteins in 
complex with RNA have proposed a model describing how these structures 
relate to the splicing in vivo (15, 16, 41). Here, FRET was used to obtain a 
deeper understanding of the molecular mechanism of the interactions between 
these proteins and RNA. The experiments performed here are important and 
innovative as they address key issues about the basic mechanism of alternative 
splicing regulation. 
Using FRET, we were able to observe the unique property of PTB34 
(RRM3 and 4) to bring the 5’ and 3’ ends of RNA in close proximity upon binding, 
forming an RNA loop as suggested previously (15). For efficient looping, the 
separation between the two polypyrimidine-tracts must be greater than or equal 
to 15 nucleotides. The stronger binding affinities (<50 nM) of PTB34 to these 
RNAs of greater than 15 nucleotides imply the synergistic binding of the two 
pyrimidine-tracts. Upon binding of PTB34, the distance between the two ends of 
the RNA decreased with distances agreeing with PTB34-RNA complexes 
previously characterized by NMR. In the case of a 15-nucleotide linker (PPT-15) 
between RRM3 and 4, the 5’ and 3’ pyrimidine-tracts bound to RRM3 and 4, 
respectively, demonstrating this protein’s specific directionality of RNA binding 
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and looping, which was shown to be a result of the non-sequence specific 
interactions between the positively charged residues in the protein and RNA 
linker.  
A mutant PTB34, which disrupts the important interactions between RRM3 
and 4, decreased the binding affinity for PPT-15 by 10-fold; however, the mutant 
PTB34 could still bind longer RNAs (30 nucleotides) with stronger affinity than 
PPT-15. In-vivo splicing assays reported that this mutant actually enhanced the 
exon expression as compared to WT. However, it is still unclear if the difference 
in splicing repression for the mutant and WT is due to defective RNA looping or 
weaker binding affinity. From time-resolved FRET and single-molecule 
experiments on protein-RNA complexes, the structure of the mutant PTB34-RNA 
complex was shown to be different from that of the WT. Therefore, the observed 
increase in FRET of the mutant-RNA complexes are due to the formation of 
higher order protein-RNA complexes, instead of the formation of an RNA loop. 
The higher cooperativity coefficients observed from the mutant are added 
evidence for this hypothesis. Stoichiometric RNA-protein complexes, which 
should be formed at lower concentrations of the mutant PTB34, yield no apparent 
FRET increase, indicating the lack of RNA looping. Based on these results, it 
was proposed that the lower splicing repression for the mutant PTB34 is due to 
the defective RNA looping rather weaker binding affinity as compared to the WT.  
Therefore, the interactions between RRM3 and 4 of PTB34 are important for 
efficient RNA looping and splicing in vivo.  
Fox-1 is a splicing enhancer that has been proposed to compete with PTB 
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for RNA binding. To further understand alternative splicing regulation by Fox-1 
and PTB, a 15-nucleotide spacer RNA that mimics the DCS of c-src pre-mRNA 
was used. Fox-1 was shown to have a higher affinity for its target UGCAUGU 
sequence; furthermore, an increase in FRET upon binding of Fox-1 is consistent 
with previous studies where Fox-1 induced a curvature of the RNA (41). 
Competition experiments suggested that the tissue-specific Fox-1 competes with 
domain 4 of ubiquitously expressed PTB34 for the same binding site in certain 
cell types. Since the binding affinity of Fox-1 for PPT-15F (overlapping target 
sequences with common U) is stronger than that of PTB domain 4, we proposed 
that Fox-1 displaces domain 4 from the PTB-RNA complex. This supports the 
hypothesis that Fox-1 disrupts the RNA loop and enhances splicing of N1 exon of 
c-src pre-mRNA in neuronal cells in vivo. Moreover, competition experiments at 
different PTB34 concentrations suggested that Fox-1 replaces PTB34 in a 
concentration-dependent manner such that it is only an efficient competitor at 
equal or less than 50 nM PTB34, resulting in a K1/2 lower than the Fox-1 
dissociation constant. The formation of RNA secondary structure facilitated by 
PTB34 binding or possible protein-protein interactions between PTB34 and Fox-1 
may aid Fox-1 in identifying UGCAUGU elements more efficiently. On the other 
hand, competition experiments, in which the downstream pyrimidine tracts and 
Fox-1 binding sites were separated by additional adenine nucleotides, resulted in 
K1/2 values slightly higher than those in the absence of separating adenines up to 
20 nucleotides; when the binding sites were separated by 30 nucleotides, the K1/2 
increased. This surprising result may be due to the formation of possible unusual 
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secondary structures in cases where the PTB34 and Fox-1 binding sites are 
separated that keeps the two binding sites in close proximity to enable Fox-1 to 
replace PTB4 from the complex. An alternative explanation may be that possible 
PTB34 and Fox-1 protein-protein interactions, rather than direct competition for 
an RNA binding sites, actually allow Fox-1 to displace PTB34.  
Even though several characteristic features regarding structural and 
functional aspects of both PTB34 and Fox-1 in complex with RNA have been 
explored, it will be interesting to investigate the competition between Fox-1 and 
PTB34 in functional splicing assays. In addition, competition experiments in the 
presence of neuron-specific PTB and U2AF splicing factors will be important for 
understanding the assemblies of these factors and their influence on alternative 
splicing regulation. Further understanding of PTB34-RNA looping and splicing 
regulation at the molecular level in the presence of the spliceosome will also be a 
worthy endeavor. For this purpose, it would be possible to perform a real time 
single-molecule alternative-splicing assay of pre-mRNA in the presence of 
PTB34 and Fox-1 along with splicing extract. This may lead to a better 
understanding of the dynamics of assembly and their importance on splicing 
regulation.  
7.2 Protein-RNA dynamics in the central junction control 30S ribosome 
assembly 
The ribosome is a macromolecular machine that undergoes 
conformational changes during assembly and protein synthesis. The 
conformations of ribosomal RNA are stabilized by ribosomal proteins to 
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assemble into subunits (374). S15 is a primary binding protein that can bind and 
stabilize the central junction into a closed conformation to allow additional 
proteins to bind during 30S assembly. In addition to S15 binding, the junction 
loop also must have the ability to bind Mg2+ and to be dynamic. This junction also 
acts as a pivot point for helices 20, 21, and 22, which are important for the 
dynamics of the junction. This study focused on identifying the key sequences 
around the central junction that are important for S15 binding as well as the 
stability of folded junction.   
Interactions within the conserved region of bacterial junction, including 
nucleotides 652-654 and 752-754, are very important for S15 binding and the 
proper folding of the junction (334). Through saturation mutagenesis, the most 
important interaction observed was the Watson-Crick base pairing between 
nucleotides 654 and 754, which were stabilized by triple base pairing with 752 
and base stacking of 588, 654, 655 and 753. Complementation between the 
sides of the junction loop can restore the function with reestablishment of the 
triple base pair. To determine whether S15 binding was affected by mutations in 
the junction loop, S15 was cloned and over-expressed with the junction mutants. 
S15 complemented mutations in the junction loop in each of the partially 
functional mutants; however, nonfunctional mutants were not complemented by 
over-expression of S15. 
Since the formation of the closed conformation is important for proper 
ribosome function, the loss in function of the junction mutants may be due to their 
defect in S15 or Mg2+ binding. Single-molecule data suggested that S15 and 
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Mg2+ play equivalent roles in folding of the wild-type (WT) but not the mutants. 
Comparison of the structural dynamics of these mutants and WT sequences in 
the presence and absence of S15 revealed specific sequence and structural 
motifs in the junction loop that are important for S15 binding and successful 
ribosomal assembly.  
From original in vitro reconstitution experiments, primary binding proteins, 
including S15, were thought to be important for ribosomal assembly. In recent 
studies, deletion of S15 doesn’t affect 30S subunit assemble but association into 
70S was inhibited since S15 is part of the intersubunit bridge B4.  Alternatively, 
primer extension assays showed that junction loop mutants have significant 
defects in 30S assembly but not in the association with 50S. However, in cases 
where the junction loop mutant is still able to bind S15, the 30S subunits that 
assemble were able to associate with 50S without any noticeable additional 
effects on association. This supports the hypothesis that there are several 
assembly pathways, resulting in an assembled functional 30S subunit. 
Mutations in the junction can prevent the helices 20, 21 and 22 from 
forming the closed conformation by preventing S15 and Mg2+ binding as well as 
assembly. However, both the junction loop and S15 do not have a direct role in 
protein synthesis. The decrease in 30S assembly leads to decreased protein 
synthesis making them an excellent target for antibiotics. Phage display can be 
used to isolate a peptide library that binds the junction loop and, with the help of 
single-molecule FRET assays, the ability of those peptides to prevent S15 
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binding to the junction loop can be determined. Peptides that prevent S15 
binding can be used in further studies as potential drug leads. 
7.3 Kinetic analysis of an RNA kissing interaction and effect of Hfq on its 
resolution into an extended duplex 
Small non-coding RNAs (ncRNAs) regulate gene expression through RNA-
RNA interactions. When the loop sequences are complementary, they can form a 
kissing intermediate that further rearranges into a stable structure. The 
thermodynamic and kinetic details regarding RNA kissing interactions and their 
importance for the regulation of gene expression have remained elusive. 
Previous studies of the HIV-DIS kissing complex have proposed several factors, 
including the closing base pair and the loop sequence, that are involved in the 
stability of the kissing intermediates (348, 351, 364, 365). However, the 
molecular dynamics of the formation of kissing intermediates and their resolve 
into a stable structure have not been studied in detail.  
In vivo, RNA binding proteins help to convert kissing complexes (KC) to an 
extended duplex (ED) by lowering the high-energy barrier between the KC and 
ED. For example, in the DIS system, a nucleocapsid protein, NCp7, facilitates the 
formation of intermolecular base pairing (365, 367, 369, 370). Hfq is another 
RNA binding protein that facilitates the binding of ncRNAs with their target mRNA 
in many bacterial systems (62, 371). This study used single-molecule to 
characterize the dynamics of the formation of a kissing complex and the effect of 
Hfq to resolve the RNA into an extended duplex. The calculated thermodynamic 
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and kinetic parameters were in agreement with the ITC and SPR data for the 
same hairpins (347). 
 Single-molecule studies of RNA hairpins suggest only one rearrangement 
step of strand displacement, contrary to the previously proposed two-step 
rearrangement process for HIV-DIS strand displacement (366, 367). The single 
kissing species observed in this study may be due to our inability to capture a 
fast second step or a lack of a significant FRET change between two 
conformations with the current fluorophore positions. Kissing interactions could 
be formed and broken several times before the hairpins dissociate or resolve into 
an extended duplex at room temperature. From kinetic analysis, the kissing 
interaction is quite stable at room temperature that depends on the loop 
sequence. This information from smFRET was further supported by the 
thermodynamic data from ITC experiments (347).  
Only a few molecules were observed that resolved into an extended duplex 
at room temperature. However at an elevated temperature (67°), previous 
experiments have shown that nearly 25% of the RNA molecules refold into the 
extended duplex from the KC (368). This can be attributed to a huge energy 
barrier between the KC and the ED at room temperature. Since the progression 
from the kissing interaction to the extended duplex is very rare, they were not 
enough transitions to measure the kinetic parameters at room temperature. 
Hfq accelerates the association of the RNA hairpins into an extended 
duplex. The chaperone activity helps to form intermolecular base pairs to anneal 
the RNAs, consistent with previous studies on DsrA and rpoS systems (356, 
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359). The transition from the hairpin to the extended duplex conformation through 
the kissing complex was never observed, suggesting that the kissing complex 
may not an obligatory intermediate for the strand displacement mechanism 
further supporting our thermodynamic data (347). None of the RNAs in the 
extended duplex dissociated back to free hairpins within the experimental time 
frame, more than 30 minutes. This is in contrast with previous findings in which 
Hfq helps to break the intermolecular base pairing between DsrA and rpoS (359). 
Our data suggests that Hfq acts as a chaperone to facilitate the progression of 
strand displacement and extended duplex formation, thereby preventing the 
dissociation of free hairpins. 
It is not yet clear whether Hfq stays bound with RNA duplex or dissociates 
leaving behind a stable RNA-RNA interaction as proposed earlier (58, 356, 359, 
372). It is difficult to address this question with the previously used experimental 
setup using labeled RNA and unlabeled protein. By fluorophore labeling Hfq, 
where a decrease in fluorophore signal would correlate with the dissociation of 
Hfq from the protein-RNA ternary complex, it may be determined whether the Hfq 
remains bound or not. The studies discussed above were conducted using 
engineered RNA hairpin sequences and might not reflect the properties of real 
RNA sequences in cell; therefore, future studies with native sequences are 
necessary to fully understand how Hfq functions in vivo. Further, the single-
molecule assay described above can be adapted to study other ncRNA/mRNA 
interactions, such as the interaction between the ncRNA, DsrA, and its mRNA 
partner, rpoS. 
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Overall, FRET and single-molecule FRET has been successfully used to 
study protein-RNA interactions. Here, we have characterized three different types 
of ribonucleoprotein systems with very different biological roles in the cell from 
splicing to ribosomal biogenesis and regulation of gene expression. 
Understanding the molecular mechanisms of such interactions will help to 
generate platforms for further study on drug design for the treatment and 
prevention of many diseases, as well as understanding the mechanisms with 
which those diseases occur.  
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In the cell, RNA and protein, interact to form ribonucleoprotein complexes 
(RNPs) that have vital structural, catalytic and regulatory roles. Despite their 
functional importance, the mechanistic details and dynamics of RNPs are poorly 
understood. Single-molecule Fluorescence Resonance Energy Transfer 
(smFRET) techniques that provide information about heterogeneity and dynamic 
behaviors of molecules have been developed to investigate inter- and intra-
molecular interactions. Here we have used FRET in combination with smFRET to 
study three very different RNP systems. 
Alternative splicing is a highly regulated biological process that plays a 
crucial role in proteomic diversity in eukaryotes. One splicing regulator, PTB, has 
been proposed to repress splicing by looping RNA between two binding sites. 
Here, we examined the looping activity of a minimal PTB construct (PTB34) on 
various RNA oligonucleotides and found that PTB34 requires at least a 15 
nucleotide linker between binding sites for efficient looping. A PTB antagonist, 
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Fox-1, has been hypothesized to compete with PTB to reduce looping and 
promote exon inclusion. Our data suggest that Fox-1 indeed disrupts PTB 
binding and looping, supporting the hypothesis that Fox-1 breaks RNA looping to 
enhance splicing of alternative exons. 
Interactions between ribosomal proteins and ribosomal RNA facilitate the 
formation of functional ribosomes. Studies of a central junction in 16S rRNA and 
the primary binding protein that triggers a conformational change, S15, show that 
mutations that alter the junction dynamics affect 30S assembly. Although partially 
functional mutants are complemented by over-expression of S15, nonfunctional 
mutants are not. Comparison of the structural dynamics of these mutants and 
WT sequence in the presence and absence of S15 revealed specific sequence 
and structural motifs in the junction that are important for ribosome function.  
Small non-coding RNAs regulate gene expression in response to 
biological stimuli through a mechanism that relies on changes in RNA-RNA 
interactions, for instance switching between two hairpins and an extended 
duplex. In the cell, proteins, such as Hfq, facilitate the formation of functional 
RNA structures. Here we show that Hfq acts as a chaperone to overcome high-
energy barriers and promote the progression of kissing hairpins through strand 
displacement to an extended duplex formation. 
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